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To those, who are missed
There’s no one in town I know
You gave us some place to go.
I never said thank you for that.
I thought I might get one more chance.
What would you think of me now,
so lucky, so strong, so proud?
I never said thank you for that,
now I’ll never have a chance.
May angels lead you in.
Hear you me my friends.
On sleepless roads the sleepless go.
May angels lead you in
- Jimmy Eat World -
I am among those who think that science has great beauty.
A scientist in his laboratory is not only a technician:
he is also a child placed before natural phenomena
which impress him like a fairy tale.
- Marie Curie -
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Eukaryotic translation is a multistep process that utilizes 47 individual translation factor
subunits. eIF3 is the largest and most complex translation factor, acting during initiation
where it promotes assembly of the 43S preinitiation complex and the recruitment of the
mRNA to the ribosome. Here we analyzed the native wheat eIF3 complex, showing that
this 13 subunit factor forms a stable complex in vivo. We were able to recombinantly ex-
press and purify the individual subunits under native conditions. However they failed to
spontaneously assemble into the holocomplex, suggesting that the maturation of the eIF3
complex requires factors and mechanisms not available when produced in prokaryotes.
Another important aspect of eukaryotic gene expression is the spatial-temporal separation
of transcription in the nucleus and translation in the cytoplasm. Cells evolved mechanisms
to keep the levels of translation factors in the nuclear interior continually low. Exportins
actively transport these proteins to the cytoplasm in a RanGTPase-driven manner. Crm1
is known to interact with almost all translation factors; Exportin 4 specifically removes
eIF5A from the nucleus. We could show that addition of Crm1 and Exportin 4 to an in
vitro translation system decreases translation rates of reporter constructs in a RanGTP
dependent manner, supporting the assumption that nuclear transport factors act as com-
partment specific inhibitors of translation.
In addition, we present a new tool for affinity chromatography based on a MADA activated
solid phase and a novel affinity tag system. The solid phase reacts specifically with thiol
groups, allowing to immobilize any ligand that contains an exposed and reduced cysteine.
Affinity resins based on the MADA chemistry compare very favorable to commercially
available systems, in particular in terms of reduced background binding under low salt
conditions.
The streptavidin:biotin system is routinely used as state of the art technique for affin-
ity purifications. Nonetheless it has severe disadvantages, namely the tetrameric state
of streptavidin, poor folding of streptavidin as well as biotin contamination during bac-
terial expression/purification and bait proteins require covalent modification with biotin.
We now developed an alternative based on the extremely tight B.amyloliquefaciens Bar-
nase:Barstar complex (KD=10
-14M). To allow for separate cytoplasmic expression of these
modules, we detoxified the RNase Barnase by a His102Asp mutation and restored high
binding strength by a compensatory Cys42Lys mutation on Barnase inhibitor Barstar.
The 1.98Å crystal structure indeed shows that the mutated residues form a shielded salt
bridge that further stabilizes the complex. Barstar initially showed poor solubility upon
overexpression in E.coli. This problem was solved by switching to the Barnase:Barstar
pair identified in the hyperthermophilic Bacillus relative Geobacillus thermoglucosidasius.
1 Introduction
The “Central Dogma of Molecular Biology” presents the flow of genetic information in a
biological system. It was first stated by Francis Crick in 1958 and re-stated in 1970 (Crick,
1958, 1970). Although by now - 56 years later - more about the multitude of possibilities
of how information is processed in a cell is known, the dogma still guides scientists through
the main steps in gene expression.
The genetic information of all living organisms is encoded in their DNA. When required,
parts of the information is transferred to messenger RNA (mRNA) in a process called
transcription. mRNA molecules are decoded to an amino acid sequence during a process
termed translation. The emerging polypeptide folds to a three dimensional structure,
thereby resulting in a protein that is now able to function in the cell. Although these
major steps are common in bacteria and in eukaryotes, they differ dramatically in terms
of complexity and factors involved.
In comparison to bacteria, eukaryotes evolved compartmentalized cells thereby restrict-
ing certain processes to membrane enclosed organelles. The cell nucleus is the cells most
prominent organelle, first spotted in 1719 by Antonie van Leeuwenhoek (Delphis et al.,
1719). When looking at gene expression, transcription and translation in bacteria act in
a coupled manner and regulation mechanisms mainly affect transcription. In eukaryotes
however, a spatial-temporal separation of transcription and translation can be observed.
Transcription happens exclusively in the nuclear interior. The produced mRNA is further
processed and subsequently transported through nuclear pores to the cytoplasms where
finally translation occurs. Thus, gene expression can be regulated at additional steps in
eukaryotes, being it the processing and transport or the translation itself. That eukaryotic
translation is certainly more complex and thus likely to be more regulated as in bacteria
can already be seen when comparing the amount of proteins involved in translation. Only
nine different polypeptides are required for proper bacterial translation whereas 47 are
necessary in eukaryotes.
In general, translation can be divided into four major steps: initiation, elongation, ter-
mination and ribosome recycling. During translation initiation, an elongation-competent
80S ribosome is assembled on the start codon of the mRNA. Thereby, the correct start
codon is recognized by the initiator tRNA (Met-tRNAi
Met) when located in the P-site of
1
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the ribosome.
Translation elongation generally describes the peptide bond formation between subsequent
amino acids forming the polypeptide chain. After initiation, the start codon is located in
the ribosomes P-site, base-paired with the anticodon of the initiator tRNA. The second
codon of the open reading frame (ORF) is located in the A-site. Cognate aminoacyl-tRNAs
are guided to the A-site by elongation factor eEF1A, a GTPase that upon base-pairing hy-
drolyzed GTP. Thereby the tRNA is released and accommodates into the A-site. Peptide
bond formation between the first methionine and the new amino acid occurs, catalyzed
by the peptidyl transferase center (PTC) of the ribosome. Simultaneously, the peptidyl-
tRNA translocates from the A-site to the P-site, catalyzed by elongation factor eEF2, yet
another GTPase. A new cognate aminoacyl-tRNA can now bind to the free A-site and
the cycle reiterates (reviewed in Dever and Green, 2012).
Translation termination occurs as soon as a stop codon locates to the A-site of the ribo-
some and is facilitated by two proteins that form a 1:1 complex: the eukaryotic release
factor 1 (eRF1) and the GTPase eukaryotic release factor 2 (eRF2). eRF1 recognizes
the stop codon and thereby triggers GTP hydrolysis on eRF2, promoting peptide bond
cleavage and the release of the nascent polypeptide chain (Frolova et al., 1996; Alkalaeva
et al., 2006). The last step of translation is the recycling of the ribosomal subunits. After
nascent chain release, the ribosomal subunits, the mRNA, the deacetylated tRNA in the
P-site and the release factors remain attached to each other, forming the post-translation
complex (post-TC complex). This complex can be dissociated either by the translation ini-
tiation factors eIF3, eIF1 and eIF1A (Pisarev et al., 2007), or by the ATP-binding cassette
(ABC) protein ABCE1 (Pisarev et al., 2010). Re-association of the ribosomal subunits is
prevented by eIF1, eIF1A and eIF3 remaining bound to the 40S ribosomal subunit. In
addition, eIF6 binds the 60S ribosomal subunit at its ribosomal subunit interface (Russell
and Spremulli, 1979).
1.1 Eukaryotic translation initiation
As mentioned earlier, eukaryotic translation initiation requires 47 different proteins to
function properly. Interestingly, the number of factors needed in each of the four steps of
translation is not evenly distributed. Most of the factors - 37 in total - are needed during
translation initiation. Thus, initiation seems to be the most regulated and rate limiting
step during the fundamental process of protein synthesis.
In general, initiation describes the recruitment of the mRNA to the small ribosomal sub-
unit, subsequent scanning of the complex for the first AUG codon and base-pairing of
the initiator tRNA (Met-tRNAi
Met) with the start codon and finally ribosomal subunit
joining resulting in an elongation-competent 80S ribosome placed on the mRNAs ORF.
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The detailed function and action of all initiation factors are described in the following. A
schematic representation of eukaryotic translation (initiation) can be seen in figure 1.1.
Figure 1.1: Eukaryotic translation initiation
Eukaryotic translation initiation factor 2 (eIF2) in complex with GTP binds the initiator tRNA (Met-tRNAi
Met)
thereby forming the ternary complex (TC). The TC associates with the ribosomal 40S subunit, which is already
bound by eIF3, eIF1 and eIF1A. By additional binding of eIF5, the 43S pre-initiation complex (PIC) is formed. In
parallel, the 7-methylguanylate (m7G) cap at the 5’ end of the mRNA is recognized by the cap-binding complex
eIF4F, which contains eIF4E, eIF4G and the ATP-dependent helicase eIF4A (acts together with eIF4B). eIF4G
also interacts with the poly-A binding protein (PABP), thereby circularizing the mRNA transcript. By binding
of the 43S PIC and the complexed mRNA, the 48S pre-initiation complex is formed. The complex now scans the
mRNA for the start AUG (must be located in the P-site of the ribosome), which is recognized by base-pairing
with the anticodon of the Met-tRNAi
Met. Upon pairing, GTP in eIF2 is hydrolyzed and eIF2-GDP, eIF3, eIF5
and eIF1 are released, allowing eIF5B-GTP and the 60S ribosomal subunit to bind. Upon proper subunit joining,
GTP is hydrolyzed and eIF5B-GDP and eIF1A are released. The fully assembled 80S ribosome is now able to
translate the ORF of the transcript (elongation). When a stop codon is located in the ribosomes A-site, translation
termination takes place, performed by the release factors eRF1 and eRF2. The post-termination complex (Post-TC)
is disassembled by ABCE1, eIF3, eIF1A and eIF1 in a process termed ribosome recycling.
(adopted from Jackson et al., 2010)
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Translation is a cyclical process, meaning that ribosomes involved in the translation of
an ORF are recycled and can participate in another round of protein synthesis. During
ribosome recycling, the ribosomal subunits are dissociated either by the ATP-binding cas-
sette (ABC) protein ABCE1 (Pisarev et al., 2010) or by the translation initiation factors
eIF1, eIF1A and eIF3 (Pisarev et al., 2007). The mode of dissociation depends on the
concentration of nucleotide-unbound Mg2+. After dissociation, eIF1, eIF1A and eIF3 ei-
ther remain bound to the 40S ribosomal subunit or they rapidly bind when dissociation
was performed by ABCE1 to prevent re-association of the two ribosomal subunits.
In parallel, the eIF2 complex (in its GTP bound state) binds the initiator tRNA (Met-
tRNAi
Met), thereby forming the ternary complex (TC), which is subsequently attached to
the 40S ribosomal subunit by interactions between eIF2 - eIF3 and eIF2 - eIF1A (Valasek
et al., 2002; Olsen et al., 2003). The resulting 43S pre-initiation complex now comprises
the 40S ribosomal subunit, initiation factors eIF1, eIF1A, eIF2-GTP-Met-tRNAi
Met and
additionally bound eIF5, a GTPase-activating protein (GAP; Saini et al., 2014). eIF2 is
built up from three different subunits: eIF2α, eIF2β and eIFγ. eIF2α is thought to be the
regulatory subunit of the complex, as its serine residue S51 can be phosphorylated upon
distinct types of stress (e.g. amino acid deprivation, ER stress or heme deficiency) leading
to sequestration of the guanine nucleotide-exchange factor (GEF) eIF2B (Kimball et al.,
1998; Donnelly et al., 2013). Therefore, no new ternary complexes can be formed as they
require eIF2 in a GTP bound state, leading to an overall decrease of translation. eIF2β
and eIF2γ both bind the guanine nucleotide and Met-tRNAi
Met (Gaspar et al., 1994).
Eukaryotic mRNAs are modified such that their 5’ end contains a 7-methylguanylate
(m7G) cap and their 3’ end harbors a poly-adenosine (polyA) tail. The tail is recognized
by the Poly(A)-binding protein PABP, the 5’ cap is recognized by the eIF4F complex
comprising the direct binding protein eIF4E, the scaffolding protein eIF4G and a DEAD-
box RNA helicase eIF4A (Pestova et al., 1996). eIF4As activity is enhanced by either
eIF4B or eIF4H (Rogers et al., 2001). Together they are required to unwind the sec-
ondary structures of the 5’ untranslated regions (UTRs) of the mRNA to allow scanning
of the ribosome. The mRNA is recruited to the 43S pre-initiation complex by the direct
binding between eIF4G and the eIF3e subunit (LeFebvre et al., 2006).
Next, the ribosome scans the mRNAs 5’UTR. The scanning-competent conformation of
the small ribosomal subunit is thereby induced by eIF1 and eIF1A (Passmore et al., 2007).
A lack of eIF1 or eIF1A lead to strongly reduced or no scanning ability. Scanning com-
plexes must be able to discriminate between the real AUG start codon and codons that
partially base-pair with the initiator tRNA. Thus, not only the AUG is required to sit in
the P-site of the ribosome, in addition, the AUG codon needs an optimal context. Ideally
a purine is positioned in the -3 position and a guanine in the +4 position (terming the
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A of the start codon as +1 position; Kozak, 1991). The most important initiation factor
enhancing the initiation fidelity is eIF1. When codon anticodon base-pairing between the
start AUG and the initiator tRNA is optimal, a tightening of the eIF1A - 40S interaction
occurs, thereby displacing eIF1 from the P-site. This triggers a conformational change
in the small ribosomal subunit, thereby locking it tightly to the mRNA (Maag et al.,
2005). Initiation codon recognition also triggers the activity of the GTPase activating
protein eIF5 that is bound to eIF2β but activates the GTPase activity of eIF2γ. GTP is
hydrolyzed, thereby reducing the affinity of the eIF2 complex towards the tRNA that can
now occupy the P-site (Kapp and Lorsch, 2004). eIF2-GDP partially dissociates from the
complex. The following 60S subunit joining and the displacement of eIF1, eIF1A, eIF3
and eIF2 is mediated by the ribosome-dependent GTPase eIF5B (Pestova et al., 2000)
resulting in an elongation-competent 80S ribosome placed on the mRNA.
In comparison to the vertebrate translation apparatus, the same process in plants shows
some additional characteristics most likely evolved to match the requirements evoked by
unique cellular process, e.g. photosynthesis or plant hormone signaling. Plants show two
types of the cap-binding complex eIF4F. The eIF4isoF shares the eIF4A helicase with the
eIF4F complex, but the other two subunits, eIF4isoE and eIF4isoG are different. It has
been suggested that the two eIF4F variants can discriminate between cap-dependent initi-
ation and translation starting at internal ribosome entry site (IRES) (Gallie and Browning,
2001). In addition, plants have a noval cap binding protein (nCBP) that was first identi-
fied in A.thaliana, however its detailed function and need is so far unclear (Ruud et al.,
1998).
1.1.1 Eukaryotic translation initiation factor 3 (eIF3)
Eukaryotic translation initiation factor 3 (eIF3) is the largest and most complex initiation
factor first identified and purified from rabbit reticulocyte in 1976 (Benne and Hershey,
1976). eIF3 is involved in most reactions occurring in the initiation pathway, thereby or-
ganizing a web of interactions between several translation initiation factors. In vertebrates
and plants, the eIF3 complex consists of 13 nonidentical subunits, termed eIF3a-eIF3m
and making up a mass of ∼800kDa (Asano et al., 1997; Browning et al., 2001). In budding
yeast, the eIF3 complex is only made up by 5 subunits, orthologous to the mammalian
subunits eIF3a, eIF3b, eIF3c, eIF3g and eIF3i, indicating a conserved core complex. In
addition, budding yeast contains a protein orthologous to eIF3j, which is substochiometric
and nonessential (Phan et al., 1998). However, not only the five eIF3 core subunits seem
to be required for proper eIF3 function. Experiments in fission yeast showed that although
eIF3f and eIF3m are not part of the conserved core complex, they are absolutely essential
for viability (Akiyoshi et al., 2001).
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The first eIF3 subunit interaction studies were performed in vivo using budding yeast. By
genomic deletion of predicted binding domains in tagged eIF3 subunits and subsequent
determination of co-purified sub complexes, first models on yeast eIF3 subunit composi-
tions and their interactions towards other initiation factors were reported (Phan et al.,
1998; Valasek et al., 2002). Similar interactions were also shown in mammals including ad-
ditional information on the interactions between core and non-core subunits, e.g. between
eIF3b and eIF3e (Shalev et al., 2001).
Figure 1.2: Two distinct models on subunit composition of eIF3
Recently, two different subunit compositions for the humane eIF3 complex have been reported. (A) Zhou et al.
(2008) used a mass spectrometry approach to probe the subunit interactions within the complex. By “solution
disruption experiments”, different subcomplexes were determined resulting in the shown model. The color code
represents subunits containing PCI-domains (green), MPN-domains (red) or RNA-recognition motifs (yellow). (B)
shows the subunit composition experimentally validated by Sun et al. (2011) and rephrased by Querol-Audi et al.
(2013). Sun and colleagues reconstituted the 13-subunit eIF3 complex in E.coli by using a stepwise assembly of co-
expressed subcomplexes thereby mapping the interactions between the individual subunits. PCI-domain containing
subunits are depicted in green, MPN-domain containing subunits are shown in red.
(adapted from Zhou et al., 2008; Querol-Audi et al., 2013)
Nowadays, two models on human eIF3 subunit composition are available as shown in
figure 1.2. Zhou et al. (2008) analyzed a natively purified 13-subunit eIF3 complex by
tandem mass spectrometry. By performing “solution disruption experiments”, they were
able to detect three stable modules (eIF3(c-d-e-l-k), eIF3(f-h-m), eIF3(a-b-i-g)), which are
brought together by interactions between subunits eIF3b and eIF3c and eIF3c and eIF3h.
Their model was further confirmed by immunoprecipitation experiments. The second
composition is shown in figure 1.2B, based on a stepwise reconstitution of the human eIF3
complex in E.coli (Sun et al., 2011). The authors claim a stable 8-mer core comprised of
the PCI/MPN subunits eIF3a, eIF3c, eIF3e, eIF3f, eIF3h, eIF3k, eIF3l and eIF3m.
The first 3D structure of human eIF3 was determined using complexes natively purified
from HeLa cell lysate. At a resolution of 30Å, a body-like shape for eIF3 was determined,
showing a head domain, a left and right arm and left and right leg domain (Siridechadilok
et al., 2005). Recent data at higher resolution reveal a more detailed view on the human
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eIF3 complex, however, the five extended domain shape remains as shown in figure 1.3A
(Querol-Audi et al., 2013). Cryo electron microscopy was performed with reconstituted
human eIF3 complexes, using the protocol published by Sun et al. (2011). This strategy
enabled to add tags on certain subunits, thereby being able to determine the localization
of individual subunits in the 3D model. eIF3h (marked in red) seems to be positioned
in the center of the complex, which fits to the mass spectrometry data suggesting eIF3h
to play a role in linking individual subcomplexes. Figure 1.3B shows the obtained eIF3
structure modeled onto the 40S ribosomal subunit. The location of the complex on 40S
was previously suggested by Siridechadilok et al. (2005). The 3D model also contains the
initiation factors eIF1 (blue) and eIF3 (yellow) that play a major role in correct AUG
recognition during scanning of the mRNA by the 43S PIC.
Figure 1.3: 3D structure of the human eIF3 complex
(A) By utilizing genetic tag visualization by electron microscopy at a resolution of 12Å-16Å, the location of the
octameric eIF3 core subunits in the 13-subunit human eIF3 complex could be revealed (Querol-Audi et al., 2013).
(B) The 3D reconstitution of the eIF3 complex was modeled onto the 40S ribosomal subunit together with initiation
factors eIF1(blue) and eIF1A (yellow). eIF3 was placed according to experimental data by Siridechadilok et al.
(2005), eIF1 and eIF1A due to crystal data (Rabl et al., 2011). Potential localization of eIF3j is marked by the
magenta dots.
(adopted from Querol-Audi et al., 2013)
As indicated earlier, eIF3 functions in various steps during translation initiation. These
steps can be categorized as follows: (1) eIF3 acts as assembly platform for 43S PIC forma-
tion. In yeast, eIF3 forms a multifactor complex (MFC) together with eIF1, eIF1A, eIF2
and eIF5. Thereby, eIF3 is the central factor in this complex holding it together. The
MFC then binds the 40S ribosomal subunit in a cooperative manner (Asano et al., 2000).
In mammals eIF3 stimulates binding of the ternary complex to the 40S ribosomal subunit,
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which is strongly impaired when eIF3b is mutated (Phan et al., 1998). In vitro studies
further showed that the eIF3a-eIF3b-eIF3c subcomplex by itself can bind the 40S riboso-
mal subunit and recruits the ternary complex (Phan et al., 2001). (2) eIF3 is essential for
mRNA recruitment to the 43S PIC. Generally, eIF3 interacts with eIF4G, member of the
cap binding eIF4F complex, thereby tethering the mRNA to the small ribosomal subunit
(Korneeva et al., 2000). However, mRNA recruitment can also happen in an eIF4G inde-
pendent manner. In yeast, some mRNAs can be directly recruited by the eIF3 complex;
in mammals, some mRNAs are attached by an interaction between eIF3 and eIF4E bound
to the m7GTP cap (Jivotovskaya et al., 2006). (3) eIF3 is required for mRNA scanning
and AUG initiation fidelity. eIF3c interacts with eIF5, the GTPase activating protein,
and eIF1. When mutating eIF3c, binding of the other two translation initiation factors
is impaired and a dramatic increase of initiation events at non-AUG (e.g. UUG) codons
can be observed (Asano et al., 2000). The chain of interactions between eIF3, eIF1 and
eIF5 seems to be crucial for proper accommodation of the initiator tRNA to the riboso-
mal P-site. When eIF5 triggers GTPase activity on eIF2, eIF3 seems to slightly shifted
thereby displacing eIF1, which is known to bind very close to the P-site. (4) eIF3 can
induce reinitiation events and thereby plays a major role in gene-specific translational con-
trol. In yeast eIF3 is required for reinitiating events when translating the GNC4 mRNA,
in plants eIF3 is miss-used for repeating reinitiating events during the translation of a
viral, polycistronic mRNA (Park et al., 2001). (5) eIF3 prevents rejoining of 40S and 60S.
Although the bulk mass of the eIF3 complex is though to bind to the solvent side of the
40S ribosomal subunit, an extended domain seems to bind to the interface surface thereby
preventing and disrupting intersubunit binding (Siridechadilok et al., 2005). Thereby the
eIF3 subunits eIF3d and eIF3j are though to play a major role in vertebrates, whereas
subunits eIF3a and eIF3c are required for 40S binding in yeast (Fraser et al., 2004; Nielsen
et al., 2006).
Although much seems to be known about the function and interactions of and within the
eIF3 complex, many details remain unclear. So far, mainly human and budding yeast
eIF3 complexes were analyzed; the plant complex however remains greatly unstudied. It
is known that eIF3 in plants also contain 13 subunits, however the arrangement of the
subunits in the complex and their interaction within the complex are unknown and there
might be further eIF3 subunits or isoforms so far not identified.
Recent studies showed that the human eIF3 complex can be reconstituted using either the
Bacoluvirus system (Masutani et al., 2007) or even E.coli (Sun et al., 2011). These major
breakthroughs enable a new level of analyzing this large factor by introducing mutations
or deletions that would lead to a lethal phenotype in in vivo experiments. Recombinant
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reconstitution further allows to create high yields of pure complex that might even be
modified such that flexible regions are deleted and thus could potentially crystalize. In
addition, the striking difference in subunit amount between the eIF3 complexes from
budding yeast and vertebrates/plants raise the question which of the higher eukaryotic
subunits are truly required for eIF3 function and which subunits are needed for the complex
regulatory network eIF3 is involved in.
1.2 Spatial separation of transcription and translation is highly
beneficial
In eukaryotes, the two main processes during gene expression are separated in a spatial-
temporal manner. Transcription occurs in the nuclear interior, translation happens in
the cytoplasm. This separation is highly beneficial for several reasons. Most eukaryotic
mRNAs show an alternating structure of exon and intron regions. During a process termed
splicing, which is exclusively nuclear, the intron regions are cleaved out resulting in fused
exons that make up the open reading frame of the protein to be produced. Intron regions
often harbor pre-mature stop codons as these regions do not (or only slightly) underlie
evolutionary pressure against them. If translation happens in the nuclear interior, the
probability of translating non-spliced or incompletely spliced mRNA greatly increases.
The resulting truncated proteins can have severe dominant negative effects, thereby re-
ducing cell viability. In addition, proteins translated in the nucleus might negatively affect
gene expression as they are mislocalized and usually function in other compartments.
Despite all these negative impacts, ideas about translation taking place also in the cell
nucleus persist since first reported in 1954 (Allfrey, 1954). The author claimed a rapid
incorporation of radioactive amino acids into nuclear proteins. The debate was further
encouraged by Goidl et al. (1975), reporting the isolation of polyribosomes from nuclei.
Nowadays, the hypothesis of nuclear translation is based on three findings: tRNAs are
synthesized, maturated and aminoacylated within nuclei (Lund and Dahlberg, 1998), an
observed coupled process of transcription and translation in isolated nuclei of mammalian
cells (Iborra et al., 2001) and the presence of rRNA and protein components of the trans-
lation machinery at sites of active transcription in Drosophila cell nuclei (Brogna et al.,
2002). However, many of these findings were at least partially disproven or explained dif-
ferently by other laboratories. Nathanson et al. (2003) were able to show that the ability
of isolated nuclei to perform translation reduces in proportion to the purity of the nuclei
sample, concluding that the observed translation events are performed by ribosomes still
attached to the co-isolated endoplasmatic reticulum or other cytoplasmic contaminations.
Concerning the translation machinery components present in the nuclear interior, it must
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be clearly distinguished between presence and function. Ribosomes, respectively, are par-
tially assembled in the nuclear interior, however, the final steps of maturation occur only in
the cytoplasm. In addition, ribosome assembly factors remain associated to the 60S ribo-
somal subunit during maturation, preventing 40S association (Udem and Warner, 1973).
Further, Bohnsack et al. (2002) showed that levels of most translation factors present in
the nucleus are kept low. GFP-tagged translation factors were actively exported to the
cytoplasm by the nuclear transport machinery.
1.2.1 An active transport mechanisms constantly removes translation factors
from the nuclear interior
Although the process of translation is restricted to the cytoplasm, some translation fac-
tors can be detected in the nuclear interior at low concentrations. The factors are either
small enough to freely diffuse through nuclear pore complexes, or they harbor amino acid
sequences that are misinterpreted as nuclear localization signal. In most eukaryotic cells,
an intermixing between nucleoplasm and cytoplasm occurs during nuclear envelope break-
down. Mislocalized proteins need to be actively shuttled back to the cytoplasm.
The nucleus is a membrane-enclosed organelle. Molecules produced in the interior such
as RNAs or ribosomal subunits need to be transported through the membrane (nuclear
envelope) to the cytoplasm whereas proteins translated in the cytoplasm but acting in the
nucleus need to be imported back (Bonner, 1975). Hence, trafficking between nucleus and
cytoplasm is absolutely essential. The main route of transport between the two compart-
ments are nuclear pore complexes, gigantic protein assemblies (125MDa in vertebrates;
Reichelt et al., 1990) punctuating the nuclear envelope. Proteins with a diameter <5nm
can freely diffuse through the pore (Mohr et al., 2009), whereas larger proteins or com-
plexes require nuclear transport receptors (NTRs) for facilitated transport.
Nuclear transport receptors are large molecules with sizes of 90-150kDa, all part of the
importin β (Impβ) family. They can be classified according to the direction of transport in
nuclear export factors (exportins) and nuclear import factors (importins) (Görlich et al.,
1994; Fornerod et al., 1997). The directionality of transport requires the small GTPase
Ran. It can switch between an active RanGTP state that is able to bind to NTRs and a
non-active state after GTP hydrolysis (RanGDP). RanGTP concentrations in the nucle-
oplasm are significantly higher than in the cytoplasm, resulting in a steep gradient across
the nuclear envelope (Görlich et al., 1996).
Importins bind their cargo at low RanGTP levels in the cytoplasm. Most import cargos
harbor classical nuclear localization signals (NLS) that are recognized directly by the
importin. Alternatively, cargos are bound by an adaptor, e.g. Importinα that interacts
with Importinβ via its IBB domain (Görlich et al., 1995). After translocation through the
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Figure 1.4: Facilitated transport between nucleoplasm and cytoplasm
Facilitated transport is mediated by nuclear import receptors (importins) or nuclear export receptors (exportins).
The directionality of transport is thereby generated by a RanGTP gradient between the two compartments: RanGTP
concentrations in the nucleus are high, whereas RanGTP concentrations in the cytoplasm are low (Görlich et al.,
1996). During cargo import (white numbering), the import receptor binds its cargo either directly via the nuclear
localization signals (NLS) or by adaptor proteins such as Importinα. This complex translocates to the nuclear interior
by interacting with FG-domains of nucleoporins that revet the central channel of the pore. In the nucleoplasm, the
receptor-cargo complex disassembles by binding of RanGTP. During protein export (black numbering) the export
receptor binds its cargo in a RanGTP dependent manner. After shuttling through the nuclear pore, RanGAP
activates Ran GTPase activity, GTP is hydrolyzed and the receptor-cargo complex disassembles to RanGDP, the
cargo and the export receptor. NES (nuclear export signal) stretches are recognized by the export factor Crm1,
other exportins recognize their cargo by other sequence characteristics.
(adapted from Terry et al., 2007)
nuclear envelope, RanGTP binds the import receptor, thereby disassembling the receptor-
cargo complex and releasing the cargo. Importins bound to RanGTP shuttle back to the
cytoplasm, where GTP is hydrolyzed and RanGDP is subsequently released (figure 1.4,
white labeling). During nuclear export, exportins bind their cargo in the nuclear interior in
a RanGTP dependent manner. The RanGTP-receptor-cargo complex passes the nuclear
envelope and RanGTP is hydrolyzed to RanGDP in the cytoplasm, triggered by RanGAP.
The complex disassembles, the cargo is released and the export receptor can shuttle back
to the nucleoplasm (reviewed in Görlich and Kutay (1999); figure 1.4, black labeling).
Re-entering of Ran to the nucleus is mediated by the specialized transport receptor NTF2
(Ribbeck et al., 1998).
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Experiments performed by Bohnsack et al. (2002) showed that many translation initiation
and elongation factors are actively removed from the nuclear interior by nuclear export
factors. eEF1A in complex with tRNA and RanGTP can be shuttled to the cytoplasm
by Exportin 5, Exportin 4 mediates export of the translation factor eIF5A (Lipowsky
et al., 2000) and Importin13, a NTR that can transport cargos in both directions, brings
eIF1A back to the cytoplasm (Mingot et al., 2001). It was additionally shown that export
of eIF2β from the nucleus is sensitive to leptomycinB, a drug that inhibits the nuclear
export factor Crm1 (Nishi et al., 1994; Bohnsack et al., 2002). Recent unpublished data
show that almost all translation initiation factors can be pulled out from HeLa cell lysate
by Crm1 in a RanGTP dependent manner (K. Kirli, unpublished).
We hypothesize that nuclear transport factors capable of binding translation factors can
act as compartment specific inhibitors of translation in the nucleus, thereby providing
yet another strong argument against the hypothesis of protein synthesis occurring in the
nuclear interior.
1.3 In vitro translation systems enable a closer look into translation
processes
In vitro translation systems are a widespread tool in the fields of molecular biology and
biochemistry. It can be either used to produce proteins for further downstream applica-
tions or to study the translation mechanisms and the regulatory network involved.
The first cell-free translation system was obtained from unfractionated E.coli extract, con-
taining all components for transcription and translation allowing protein synthesis from a
DNA template (Nirenberg and Matthaei, 1961). The first eukaryotic in vitro translation
system was based on the rabbit reticulocyte lysate, enabling mRNA dependent protein
synthesis (Pelham and Jackson, 1976). The best-studied plant cell-free translation system
is obtained from wheat germ, first reported by Roberts and Paterson (1973). Although
these three systems are well established nowadays and commercially available, new cell-free
translation systems are intermittently reported, based on insect cell lysate (Ezure et al.,
2006), the eukaryotic parasite Leishmania tarentolae (Kovtun et al., 2011) or even human
HeLa cell lysate (Mikami et al., 2008). However, these systems were so far only tested on a
small group of proteins and characterization of posttranslational modifications and proper
protein folding of the synthesized polypeptide are still required. Table 1.1 summarizes the
main aspects of the cell-free translation systems.
The bacterial in vitro translation system has extremely low production costs and pro-
teins can be produced to high yields. The possibility to work with lysates obtained from
genetically modified strains can be highly beneficial, e.g. by deleting regions coding for
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nucleases or proteases. The commercially available recombinantly reconstituted E.coli
translation machinery (PURE system) is a fast and efficient way of protein synthesis and
allows analysis of the bacterial translation apparatus without the unknown and unchar-
acterized activities present in a lysate based system (Shimizu et al., 2001). However, the
production of eukaryotic proteins in a bacterial system is problematic as these are often
produced in an insoluble manner and no posttranslational modifications are introduced.
Table 1.1: Cell-free protein expression systems
Comparison of established bacterial (E.coli) and eukaryotic in vitro translation systems, reviewed in Jackson and Hunt
(1983); Madin et al. (2000); Kigawa et al. (2004); Ezure et al. (2006); Mikami et al. (2008); Kovtun et al. (2011). PTM=
post translational modifications
System Yield Costs PTM Additional Information
E.coli high low no
recombinant system
available (PURE), strains
can be genetically modified
Leishmania tarentolae ng-mg range low not tested
new system, limited
number of proteins tested,
more soluble protein in
comparison to E.coli























To circumvent these problems, large or eukaryotic chaperone-dependent proteins are of-
ten produced in an eukaryotic in vitro translation system. The cytoskeleton protein actin,
respectively, can not be solubly expressed in a bacterial based translation system but func-
tional, proper folded protein can be obtained from eukaryotic based cell-free translation
systems (personal communication). Both, the rabbit reticulocyte lysate (RRL) and the
wheat germ extract (WGE) system are established and well studied systems tested for a
great variety of proteins. Nevertheless, the WGE has significant advantages over the RRL
system. First, the production of RRL is very cost intensive and severe treatment on the
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animals is required. The wheat germ extract is produced from winter wheat seeds, which
is available in unlimited amounts and raises less ethical concerns. Second, the RRL main
protein is hemoglobin, making up ∼90% of the protein content in the lysate interfering
with downstream applications if not removed beforehand. The proteins translated in the
wheat germ extract can however be immediately utilized for a broad range of applica-
tions and assays without prior treatment. Third, although the yields for both systems are
significantly lower as compared to bacterial systems, the wheat germ extract obtains the
highest yields among eukaryotic translation systems (ng - mg range).
In this study, eukaryotic in vitro translation systems based on the RRL and the WGE
system are used to analyze the translation (initiation) apparatus. The main advantage of
a cell-free approach is the ability to massively manipulate the system, introducing loss-of-
function effects that would cause immediate lethality when occurring in living organisms.
1.4 Affinity chromatography
Affinity chromatography is a powerful and fundamental technique used in biochemistry to
separate proteins or protein complexes of interest from crude extracts or other complex
mixtures. It is based on the interaction between a protein and its cognate ligand. The
first purification of a protein due to the biospecific adsorption onto a solid phase was
described in 1910 for α-amylose binding to starch (Starkenstein, 1910). The term “affinity
chromatography” was coined by Cuatrecasas et al. (1968), reporting the purification of
α-chymotrypsin by specific binding to its inhibitor carboxypeptidaseA that was coupled
to a sepharose based solid matrix. Nowadays the technique evolved such that affinity
tag systems enable to purify any protein of interest, thereby not being dependent on a
natural interaction between the target protein and a ligand. Further, the technique is not
exclusively used for protein purification but also for protein interaction analysis such as
immunoprecipitation experiments or pull-down assays.
Protein purification can be performed by a variety of methods, such as selective precipita-
tion, size exclusion or differential centrifugation. However, a highly selective purification
of the protein of interest can be achieved best by affinity chromatography, schematically
depicted in figure 1.5. The protein of interest is genetically fused to an affinity tag, contain-
ing the affinity protein and - if required - a protease cleavage site. This fusion construct
is expressed in E.coli respectively, resulting in a cell lysate containing vast amounts of
different proteins including the expressed fusion protein. The lysate is added to a station-
ary phase, a solid material to which the ligand has been covalently attached. Proteins
containing the affinity tag specifically bind to the resin whereas other sample components
do not show any affinity and are hence washed off. Elution of the protein of interest
can be achieved by two procedures shown in figure 1.5E and 1.5F, depending on further
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Figure 1.5: Protein purification by affinity chromatography
Affinity chromatography is based on a strong interaction between a protein and its cognate ligand. (A) For protein
purification, the protein of interest (yellow) is fused to the affinity tag (green) linked by a protease cleavage site
(orange), if required. The fusion protein is expressed in E.coli respectively resulting in a lysate containing a multitude
of proteins including the fusion protein. (B) The stationary phase during affinity chromatography is a solid material
covalently linked to the affinity pair ligand (violet). (C) The lysate and the resin are mixed, allowing the fusion
proteins to bind to the resin whereas other proteins do not show any binding affinity towards the stationary phase.
After washing (D), the fusion protein (and some contaminants (grey)) remain bound to the resin. All other proteins
are removed. Elution of the protein of interest can be performed either by competition (E) or by protease cleavage
(F). During competitive elution, a strong binder (red) displaces the entire fusion protein from the ligand. During
protease elution, small amounts of highly active protease (blue) are added to the fusion protein bound resin and
during incubate, the protease specifically cleaves at the protease cleavage site of the fusion protein. This results in
release of the tag-free protein of interest and the fusion tag (green and orange) still bound to the resin.
downstream applications. By competitive elution, the entire fusion protein is release from
the stationary phase. A selective competitor is added in high concentrations, thereby re-
placing the fusion protein from its ligand. The most prominent example is the release of
histidine-tagged proteins from a Ni2+-chelate resin by imidazole. The protein of interest
can also be released by protease elution. Thereby specific proteases (depicted in blue in
figure 1.5) act on the protease cleavage site of the fusion construct, releasing the tag-free
protein of interest from the resin. The tag (affinity protein and remaining protease cleav-
age site) remains bound to the stationary phase. This elution procedure is highly selective
as only proteins containing the protease cleavage site are affected and unspecifically bind-
ing proteins remain on the resin. Additionally, elution can also be performed by using
denaturing agents or changing parameters such as pH or ionic strength.
1.4.1 Chemistry for bioactive immobilization of highly selective capture proteins
As mentioned previously, affinity chromatography requires a mobile phase, e.g. the lysate
containing the fusion protein, and a solid phase, usually a stationary material to which
the ligand is covalently attached. The ideal matrix is chemically and mechanically stable,
insoluble in the solvent used during the experiment, has low non-specific binding properties
and a high surface to volume ratio, and should allow chemical activation for efficient
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attachment of the biospecific ligand. Commonly used resins can be classified as follows: (1)
resins based on natural occurring polycarbohydrates such as agarose, dextrane or cellulose;
(2) synthetic materials such as polyacrylamide or polystyrene (Staak et al., 1996); (3)
inorganic particles such as glass or porous silica (Xi and Wu, 2004); (4) superparamagnetic
beads, which are extremely beneficial for accumulation of low abundance proteins in a
complex mixture (Safarik and Safarikova, 2004).
Figure 1.6: Coupling chemistry to immobilize ligands to a solid phase
Immobilization of peptides or proteins to a solid phase require the activation of the phase with compounds reactive
towards functional groups on the protein surface, mostly primary amines or thiolgroups. Coupling through amine
groups can be performed by CNBR-activated cyanate-esters (Reaction 1), NHS-esters (Reaction 2) or aldehyde
groups (Reaction 3), all resulting in an amide bond conjugate. When coupling is performed using a thiol group of
the protein, supports are activated with haloacetamide derivatives such as iodoacetyl (Reaction 4), with maleimides
(Reaction 5) or with pyridyldithiol (Reaction 6). Iodoacetyl and maleimides result in thioester bond conjugates,
the reaction with pyridyldithiol leads to a mixed disulfide bond.
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The covalent attachment of a ligand to a solid phase requires the activation of the phase
with a compound that is reactive towards a functional group on the ligand, most common
primary amines or sulfhydryl groups (overview shown in figure 1.6). Early immobiliza-
tion protocols used cyanogen bromide (CNBr) activated supports able to form an isourea
linkage with the primary amine group of the protein to be attached (Axén and Ernback,
1971; figure 1.6 Reaction 1). However, this coupling chemistry has severe disadvantages,
mainly the formation of a highly instable isourea bond, leading to leakage of the ligand
from the solid phase. Ideal coupling chemistries should neither affect the structure or
function of the ligand, nor the structure of the resin. Furthermore the produced bond
should be absolutely stable to prevent leakage and the activated resin should not promote
unspecific binding of proteins due to chemical properties.
The most commonly used functional group for ligand immobilization are primary amines,
found at the N-terminus of polypeptide chains that are not acetylated and in lysine side
chains. Besides other chemistries, coupling can be performed utilizing aldehyde or NHS-
ester activated solid phases. Aldehyde activated resins react with amino groups, leading
to the formation of a Schiff base intermediate that is further reduced by e.g. sodium
cyanoborohydride (NaCNBH3). Upon reduction, the linkage stabilizes by forming a sec-
ondary amine (Peng et al., 1987; figure 1.6 Reaction 3). NHS-esters are formed by first ac-
tivating carboxylate groups with a carbodiimide, e.g. 1-Ethyl-3-(3-dimethylaminopropyl)-
carbodiimide (EDC) and second, the condensation of the intermediate with NHS (N-
Hydroxysuccinimide; Williams et al., 1981). This intermediate can be easily displaced by
nucleophilic attacks from primary amine groups, resulting in a covalent amide bond be-
tween the carboxyl group and the ligand and an NHS leaving group (figure 1.6, Reaction
2).
Another frequently used functional group for protein immobilization is the sulfhydryl or
the thiol group present in cystein side chains. In contrast to primary amines, thiol groups
are more seldom in a polypeptide chain, allowing a direct and orientated coupling. In
addition ligands can be modified such, that cysteins are placed at defined sites, allowing a
coupling distant from the binding site of the ligand towards its target. Thiol groups tend
to form disulfide bonds, thereby stabilizing secondary or tertiary structures of a protein.
However, this bonds need to be reduced to sulfhydryl groups again prior to immobilization.
Thiol groups are commonly attached to a resin using haloacetamide derivatives such as
iodoacetamides. At neutral or slightly alkaline conditions, the halogen group is displaced
upon a nucleophilic attack by the thiol group, resulting in the formation of a thioether
linkage and release of hydrogen iodide, HI (figure 1.6 Reaction 4).
Maleimide is another reactive compound that can be used to attach cystein containing pro-
teins to a solid phase. Thereby the double bond of the maleimide reacts with the sulfhydryl
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group of the ligand, thereby forming a stable thioether bond (Smyth et al., 1964; figure
1.6 Reaction 5). Interestingly, this chemistry is so far mainly used for fluorescent labeling
of proteins or crosslinking but rarely for immobilization. Yet another possibility to cova-
lently couple ligands with cysteins utilizes pyridyl disulfide derivatives. These compounds
react with thiol groups thereby forming a new, mixed disulfide bond, that can be cleaved
again by reducing agents such as DTT (figure 1.6 Reaction 6). This coupling strategy is
not useful for affinity chromatography, as reductants in lysates would cause leakage of the
ligand from the resin, however it is frequently used for covalent chromatography.
1.4.2 Established affinity tag systems
After discussing the different stationary materials and coupling chemistries that can be
used to generate the solid phase for affinity chromatography, we now focus on the affinity
pair itself that allows the separation of specific proteins or protein complexes from a
complex protein mixture.
All proteins are involved in specific non-covalent interactions with other molecules, termed
ligands, that can be either low molecular weight substances or other proteins. Binding
can occur via hydrophobic or charged patches on the protein surface or by short-range
molecular interactions such as hydrogen bonds or van der Waals forces. These specific
interactions are exploited in affinity chromatography systems, attaching one member of
the affinity pair to the solid phase and fusing the other member - the so-called affinity tag
- to the protein aimed to be purified. In general, one can distinguish small peptide tags,
such as FLAG-, poly-histidine-, S-, c-myc-, or StrepII-tag, and the attachment of folded
domains or entire proteins such as MBP, GST or the ZZ domain.
The most common affinity tag system is the binding of poly-histidine stretched to chelated
metal ions on a resin, based on the immobilized metal affinity chromatography (IMAC)
technique reported by Porath et al. (1975). Divalent transition metal ions such as Co2+,
Ni2+, Cu2+ or Zn2+ are immobilized to the solid phase by surface-bound chelators such
as NTA (nitrilotriacetic acid; Hochuli et al., 1987). Remaining free valencies are able to
form coordinated bonds with the electron donor groups present in amino acid side chains,
most efficiently with the electron donor groups of the imidazole ring found in histidine
side chains. Under native conditions, His3-tags are efficient for stable binding (Janknecht
et al., 1991), however His6- or His10-tags are commonly used as the interaction strength
increases with the number of histidines (avidity effect). Elution of the fusion protein occurs
by addition of imidazole, which competes with the poly-histidine tag thereby replacing it.
This affinity tag system can be used for native or denaturing protein purification, the poly-
histidine stretch can be attached to the C- and N-terminus of a protein and recombinant
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expression was demonstrated in bacteria, yeast and mammals.
Other small peptide affinity tags are:
• the 15 amino acid S-tag that recognized the S-protein. Both fragments derive from
RNAseA, which is naturally exposed to limited proteolysis in the cell. After cleav-
age, the two fragments remain strongly but non-covalently bound to each other
(Karpeisky et al., 1994). The S-tag itself is known to have solubility enhancing
properties and is therefore frequently used as fusion tag, whereas the S-protein is
immobilized to the stationary phase.
• the eight amino acid overall hydrophilic FLAG-tag that is specifically recognized by
M1 antibody (Hopp et al., 1988). It is mostly used under non-denaturing conditions
and elution is performed by either reducing the pH or by specific elution using
antigenic peptides.
• the 11 amino acid c-myc epitope, termed c-myc-tag, that is recognized by the
Mab9E10 antibodies attached to a stationary phase. Elution of the tag is achieved
by decreasing the pH of the buffer or by addition of competitive peptides (Evan
et al., 1985).
Note that c-myc and FLAG-tags are rarely used for preparative affinity purification as
these systems are extremely cost intensive, but are frequently used for protein detection
and characterization techniques due to their high binding specificity and the possibility to
elute by specific peptides.
Instead of fusing small affinity peptides to the protein of interest, folded domains or entire
proteins can be attached as well. These often have a dual function in acting as affinity tag
and as solubility enhancer. However, these fusion tags often need to be removed from the
purified protein to prevent interference with downstream applications due to their size or
chemical properties. The 42kDa ProteinA, found in Staphylococcus aureus, is a commonly
used affinity tag. It contains five homologous domains, which are all capable of binding
to the Fc-domains of immunoglobins (IgGs). One of these domains, the B-domain, was
engineered such that it is more tolerant towards site-specific chemical cleavage, resulting
in the 7kDa Z-domain (Duhamel et al., 1979; Moks et al., 1986; Nilsson et al., 1987).
ZZ-domain or ProteinA fusion proteins can be purified by IgG coupled resins, vice versa
ProteinA resins can be used to efficiently purify IgGs from sera. The recently described
engineered affibody Zpa963 raised against ProteinA (Lindborg et al., 2013) provides yet
another ligand to purify ZZ-tagged proteins. Other frequently used affinity tags are GST
(Glutathione S-transferase), maltose binding protein (MBP) or NusA, which requires addi-
tion of a His-tag. GST is a 26kDa protein that efficiently binds to glutathione immobilized
on a solid phase and can be displaced again by addition of free glutathione (Smith and
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Johnson, 1988). However, GST is not able to fold when the fusion protein is attached
to its N-terminus and it forms homodimers, which might be problematic during the ex-
pression of fusion proteins with exposed hydrophobic surfaces. The 40kDa protein MBP
can be purified on cross-linked amylose and subsequently eluted by high concentrations
of free maltose (di Guan et al., 1988). It is known to increase the solubility of its fusion
partners due to its chaperone-like qualities and thus is often used for the expression of
eukaryotic proteins in a bacterial environment (Sachdev and Chirgwin, 1999; Smyth et al.,
2003). MBP is often used in combination with small affinity peptides such as His-tags
to enable the purification via highly efficient Ni2+-chelate resins and a protease cleavage
site to produce the protein of interest in a tag free form. Another protein frequently used
as solubility enhancer in combination with a His-tag for affinity purification is the E.coli
NusA protein, which is 50kDa in size and extremely hydrophilic (Davis et al., 1999).
To be able to efficiently remove large solubility enhancing affinity tags, the fusion con-
struct should contain a protease cleavage site. The seven amino acid recognition site for
the TEV (Tobacco Etch Virus) protease can be found in a multitude of commercially
available vector systems (Dougherty et al., 1988). However, the usage of small ubiquitin-
like modifier (SUMO) sequences as system for tag removal shows two major advantages
in comparison to TEV. The 10kDa SUMO protein shows solubility enhancing properties
and fusion proteins can be specifically and more efficiently be cleaved off by the SUMO
protease when fused to the C-terminus of the SUMO protein (Marblestone et al., 2006;
Frey and Görlich, 2014a).
An affinity system that is not only used for protein purification but also for high-throughput
screening methods and protein characterization is the streptavidin:biotin system. Strepta-
vidin is produced by Streptomyces avidinii and binds biotin with a remarkable high affinity
of KD ∼10-14 (Chaiet et al., 1963; Green, 1990). Usually, streptavidin is immobilized to
the stationary phase and the biotin moiety is introduced to the protein of interest either
chemically or enzymatically. For enzymatic modification, small peptide tags such as the
15 amino acid Avi-tag were evolved that can be fused to the protein of interest and be in
vivo or in vitro biotinylated by the enzyme BirA (Schatz, 1993).
To avoid additional modification of the fusion protein, Strep-tags were developed that
are able to bind to streptavidin and even more efficient to Strep-Tactin, a streptavidin
derivative (Schmidt et al., 1996; Voss and Skerra, 1997).
1.4.3 RNase Barnase and its inhibitor Barstar
Although the streptavidin:biotin pair is highly beneficial for affinity chromatography due
to their strong interaction, the system has severe disadvantages, mainly due to the homo-
tetrameric nature of streptavidin. Although a single molecule is only ∼15kDa in size, this
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adds up to a large complex when oligomerized and immobilized to a resin. Other natural
occurring binding pairs with comparable binding constants could be more beneficial for
affinity chromatography applications.
Barnase is a small (110 amino acids) secreted extracellular ribonuclease produced by the
bacterium Bacillus amyloliquefaciens. The 89 amino acid Barstar protein, the specific
inhibitor for Barnase, is produced by the same organism and acts intracellularly to protect
itself (Hartley, 1989). The two molecules interact in a 1:1 stochiometric manner with a
KD ∼10-14 and an association rate constant of 4x108M-1/s (Mariani et al., 1992; Schreiber
and Fersht, 1993).
Figure 1.7: Binding interface of the Barnase:Barstar complex
Schematic representation of the binding interface between Barnase (white) and its inhibitor Barstar (gray). Barstars
Asp39 on its α-helix2 forms hydrogen bonds with the basic residues Arg83, Arg87 and His102 in the active site of
Barnase, thereby facilitating the strong interaction between the two molecules. Further the Barnase enzymatic
activity is inhibited by interacting with the catalytic residue His102. Adopted from Buckle et al. (1994)
The X-ray structure of the Barnase:Barstar complex was solved at a resolution of 2.6Å in
1993 (Guillet et al., 1993), revealing the mode of interaction between the two molecules
and the inhibition of the RNase activity. Barnase cleaves RNA molecules using a general
acid-base catalysis mechanism, thereby utilizing Glu73 and His102. The catalytic center is
penetrated by α-helix2 of Barstar and the loop region connecting helix2 and helix3. Mu-
tagenesis analysis identified Asp39 and Gly43 on Barstar to be critical residues in blocking
the RNase activity. Mainly the Asp39 sidechain seems to mimic the interaction between
Barnase and an RNA molecule as the electrostatic interactions are highly similar when
comparing the crystal structures of Barnase in complex with RNA or Barstar (Schreiber,
2001). The interaction between Barstar and Barnase is primarily driven by hydrogen
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bonding utilizing Arg83, Arg87 and His102 sidechaines on Barnase and Asp39 on Barstar
(see figure 1.7).
1.5 Aim of this study
Eukaryotic translation is a highly complex multistep process composed of translation ini-
tiation, elongation, termination and ribosome recycling. In total 47 individual proteins
function during this process, the majority however acts during translation initiation, the
most regulated and thus rate limiting step. Most translation initiation factors consist of
several individual subunits, the prime example being eIF3 containing 13 different proteins.
In this study we aim to analyze the wheat eIF3 complex in more detail, using biochemical
approaches to in vitro reconstitute the factor from recombinantly expressed and purified
subunits, thereby mapping the subunit interactions within the complex. In addition, we
will analyze the native wheat eIF3 complex for so far unidentified plant specific subunits
or assembly factors. By using an in vitro translation assay based on the in-house pro-
duced wheat germ extract, we aim to categorize the eIF3 subunits, but also the other
wheat translation initiation factors for their functional or regulatory role during overall
translation. Further we want to address the question, if the translation efficiency of an
in vitro translation assay is lower as compared to the in vivo situation due to possible
limitations of rate limiting translation factors.
Recent findings showed that almost all translation (initiation) factors can be found in the
cargo ranges of at least one nuclear export factor, specific proteins, that shuttle their car-
goes from the nuclear interior to the cytoplasm. Using an in vitro translation assay based
on the rabbit reticulocyte lysate, we want to analyze if nuclear export factors, mainly
Exportin 4 and Crm1 can act as compartment specific inhibitors of translation, thereby
providing an additional piece of evidence weakening the hypothesis of nuclear translation.
Furthermore, we want to develop a new, beneficial set of tools for efficient, one-step affinity
chromatography based on a MADA activated solid phase and the novel affinity tag sys-
tem Barnase:Barstar. Therefore, the RNase Barnase must be detoxified by site-directed
mutagenesis of the catalytically active amino acids. In parallel, mutations with compen-
satory effects must be incorporated to Barstar to preserve the stability between the two
proteins. Due to the high binding affinity of the two proteins paired with their monomeric
occurrence and small size, this tag system has the potential to replace streptavidin:biotin
as high affinity interaction system in a broad range of applications ranging from protein
purification to high-throughput screenings.
2 Results
2.1 Characterization of recombinant and native wheat eIF3
complex
Eukaryotic translation initiation factor 3 (eIF3) is the largest and most complex eukaryotic
translation factor. It is comprised of 13 individual subunits ranging from 30 to 140kDa
in size and is involved in various steps during translation initiation, e.g. bridging the 43S
PIC and the eIF4F complex and thus recruiting the mRNA to the ribosome (Méthot et al.,
1996).
So far, most studies on eIF3 complex were either performed with the yeast complex, which
only consists of 5 subunits (Asano et al., 1998), or with native complexes obtained from
tissue or cultured human cells, e.g. in structural studies by Siridechadilok et al. (2005).
Recently, the mammalian eIF3 complex was reconstituted using multiple polycistronic
plasmids that were expressed in insect cells (Masutani et al., 2007) or in E.coli (Sun
et al., 2011). However, essential questions on how the complex assembles, the interactions
within the complex and also the interactions between individual eIF3 subunits and other
translation factors still remain unclear.
A stepwise assembly of the eIF3 complex with individually expressed and purified subunits
would greatly increase the understanding of complex assembly and - even further - would
allow to analyze the effect of certain mutations or deletions on the complex formation.
Furthermore, a recombinant eIF3 complex in hand or even subcomplexes could be used
as add-back for depletion experiments in in vitro translation assays.
In this study, the eIF3 complex from the wheat species Triticum aestivum was analyzed.
The decision towards the plant complex was driven by two main reasons: (1) to analyze
the effects of individual initiation factor (sub-) complexes on overall translation rates,
the wheat germ extract was used as an assay system from which certain factors can be
depleted by specific antibodies. In addition, recombinant factors from the same species
can be used for add-back experiments. (2) the interactions within a multimeric complex
are often formed by hydrophobic interactions, thus, when the individual proteins are
expressed in isolation these hydrophobic patches are suddenly solvent exposed and thus
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prone to aggregate. This is the main reason why expression of such subunits is extremely
challenging and by using a wheat species with the ability to adapt to a broad temperature
range in its natural habitat, different expression conditions can be screened with the aim
to find conditions in which the individual subunits can stably fold.
2.1.1 All eIF3 subunits can be expressed and purified in a recombinant manner
Successful protein expression depends on various parameters, including the expression tem-
perature, the duration of expression, the E.coli expression strain, the induction strength,
but also the N-terminal fusion tags. To determine the optimal set of parameters for each
subunit, the proteins were cloned into eight different vector backbones, yielding fusion
proteins with the following N-terminal tags: H14, H14-TEV, H14-brSUMO, ZZ-TEV, H10-
ZZ-TEV, H14-shGFP-brSUMO, H14-MBP-TEV and H14-MBP-brSUMO. H14- and ZZ-
tag are well established affinity tags, binding either complexed Ni2+ ions or IgGs. TEV
(Tobacco Etch Virus) and brSUMO are protease cleavage sites, which are routinely used
for tag - free protein purification (Frey and Görlich, 2014a). shGFP (super hydrophilic
GFP) and MBP (maltose binding protein) are rather large tags with a molecular weight
of ∼40kDa and a stable fold. MBP itself is known to show chaperone-like qualities when
fused to the N-terminus of a protein (Pryor and Leiting, 1997; Smyth et al., 2003).
Table 2.1: eIF3 subunit solubility greatly depends on N-terminal fusion tag
All 13 eIF3 subunits were fused to different N-terminal tags. The constructs were expressed at 18℃ over night in
E.coli Top10F’ cells or E.coli NEB Express cells, induced with 100µM IPTG. The cultures were harvested, lysed and
ultracentrifuged. The supernatant after ultracentrifugation was analyzed by SDS-PAGE for soluble protein. The
solubility of the expressed constructs was rated from insoluble (red) over low solubility (orange), moderate solubility














eIF3a insoluble insoluble insoluble insoluble insoluble insoluble low low
eIF3b moderate high high moderate moderate moderate high moderate
eIF3c high high high high high high high high
eIF3d moderate high high high moderate high high high
eIF3e insoluble insoluble insoluble moderate low moderate moderate high
eIF3f insoluble insoluble insoluble moderate low high high high
eIF3g insoluble insoluble moderate moderate insoluble high moderate high
eIF3h moderate moderate low moderate low moderate high high
eIF3i insoluble insoluble insoluble moderate insoluble insoluble moderate low
eIF3j moderate high high high high high high high
eIF3k high high high high moderate high moderate high
eIF3l insoluble insoluble insoluble insoluble insoluble insoluble low low
eIF3m insoluble insoluble insoluble insoluble low moderate high high
The constructs were transformed into E.coli Top10F’ cells and expressed over night at
18℃. Expression was induced by the addition of 100µM IPTG, which releases repression by
lacI, thereby enabling transcription of the downstream genes. The cells were subsequently
harvested, resuspended in buffer (50mM Tris/HCl pH7.5, 500mM NaCl, 5mM MgAc, 1mM
DTT), lysed by sonication and ultracentrifuged. Soluble protein is expected to remain in
the supernatant after centrifugation, whereas protein aggregates precipitate to the pellet.
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The supernatant samples were analyzed by SDS-PAGE to estimate the solubility of each
construct. The results are summarized in table 2.1.
The solubility of eIF3 subunits was also screened at higher temperatures and shorter
expression times (23℃, 6h). Although some eIF3 subunits such as eIF3c, eIF3d and eIF3j
could be expressed in a soluble manner, the majority of the subunits tends to express
better when induced at lower temperatures for a longer time period (data not shown).
Figure 2.1: Solubility of eIF3 subunits greatly depend on N-terminal fusion tags
eIF3 subunits eIF3a, eIF3c and eIF3m were expressed as fusion constructs with various N-terminal affinity tags.
Expression was performed in E.coli TOP10F’ cells at 18℃ over night with 100µM IPTG (for details see 4.2.2.3).
Samples were taken after lysis of the cells by sonication (aL) and from the supernatant after ultracentrifugation
(aUZ). Soluble protein should remain in the supernatant whereas insoluble proteins should have gone to the pellet.
As control, non-induced E.coli cells were loaded as well (bi). (*) indicates the expressed protein bands. All samples
were loaded at a concentration of 30mOD/lane on a polyacrylamide gradient gel and stained with Coomassie.
shGFP: super hydrophilic GFP variant
In general, one can observe an order of solubility (1) between the individual eIF3 subunits
and (2) between the different affinity tags used. When analyzing the solubility of the
eIF3 subunits under all tested conditions, subunits eIF3b, eIF3c, eIF3d, eIF3j, and eIF3k
are soluble with any tag (see table 2.1 and figure 2.1 eIF3c), indicating a stable fold of
the individual proteins. eIF3h behaves similar to those subunits, however in comparison,
expression and solubility levels are slightly lower. Subunits eIF3e, eIF3f, eIF3g, eIF3i, and
eIF3m can not be expressed in a soluble manner with small tags, but the soluble fraction
increases with increasing tag size (see 2.1 eIF3m). Subunits eIF3a and eIF3l show severe
solubility problems. Both can only be expressed as partly soluble proteins when fused to
MBP (see 2.1 eIF3a).
When grading the affinity tags for their ability to increase solubility of their fusion partners,
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the rule of thumb seems to be: the larger the fusion tag, the more soluble protein can be
produced (see figure 2.1 eIF3m and table 2.1). However, there are some exceptions. When
comparing ZZ-TEV and H10-ZZ-TEV, the slightly larger H10-ZZ-TEV tag is not able to
positively influence the solubility of e.g. eIF3g or eIF3i, whereas ZZ-TEV-fusion proteins
show a moderate solubility. Possibly the biochemical properties of the histidine sidechains
interfere with the folding of these particular eIF3 subunits. Another interesting phenomena
is that although the H14-shGFP-brSUMO, H14-MBP-TEV and H14-MBP-brSUMO tags
are all similar in size, only fusions to MBP enable to produce eIF3a and eIF3l in a slightly
soluble manner. This might be explained by the chaperone-like qualities of MBP.
These screenings show that affinity tags can enhance the solubility of their fusion partners
and that there seems to be a correlation between tag size and soluble fraction of the
expressed protein. However, it also shows that the ideal tag for each protein has to
be individually determined to perfectly match and positively influence the biochemical
properties and folding kinetics of the protein.
Figure 2.2: Purification of eIF3 subunits by protease elution
eIF3 subunits eIF3c and eIF3k were N-terminally fused to an H14-brSUMO-MBP tag and expressed in E.coli NEB
Express cells at 18℃ over night with 200µM IPTG (for details see 4.2.2.3). Samples were taken before induction
(bI), after induction (aI), after lysis by sonication (aL) and from the supernatant after ultracentrifugation (aUZ).
The lysate was applied to 6% Ni2+-chelate 500Å silica and after binding in batch for 1h, the flow through (FT) was
collected. The resin was thoroughly washed and incubated with 0.1µM SENP1 protease cutting at the brSUMO
protease recognition site. After incubation for 1h, the cut protein was washed out. As control, the remaining protein
on the matrix was eluted with 1M imidazole. The full length construct is marked with green asterisks, the cleaved
protein with red asterisks and the remaining tag is marked with light blue asterisks. All samples were loaded at a
concentration of 30mOD/lane on a polyacrylamide gradient gel and stained with Coomassie.
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In summary, expression conditions yielding in soluble proteins could be determined for each
of the 13 eIF3 subunits, allowing to further purify the subunits by affinity chromatography
as shown in figure 2.2 exemplarily for subunits eIF3c (left panel) an eIF3k (right panel).
The proteins were expressed as H14-MBP-brSUMO constructs and elution was performed
by on-column protease cleavage using brSENP1 protease (purification scheme can be seen
in figure 1.5). Due to cleavage, the eIF3 subunit looses its affinity to the matrix and elutes,
whereas the remaining tag (here H14-MBP-brSUMO) remains bound to the beads and can
only be released from the Ni2+-beads with high imidazole concentrations, which displaces
the His-tag and thereby the bound protein.
2.1.2 In vitro reconstitution of recombinant eIF3
The successful expression and purification of all 13 wheat eIF3 subunits as described in
section 2.1.1 was an important step towards the recombinant reconstitution of the entire
complex. Consequently, binding assays were performed to map the stepwise assembly of
the subunits during formation of the ∼800kDa complex. All interaction studies were per-
formed on commercial IgG beads, specifically binding ZZ-tagged proteins (for experimental
details see 4.2.3). First, eIF3 subunits were analyzed pairwise for possible interactions.
Thereby, one protein was ZZ-tagged, the other protein was either tag free or contained
a histidine-tag. Both were mixed in E.coli lysate (50mM Tris/HCl pH7.5, 500mM NaCl,
1mM DTT) and subsequently applied to the beads. After incubation, the flow through
was collected, the beads were washed and the bound fraction was eluted by SDS-loading
buffer. As control, IgG beads were incubated with E.coli lysates containing only the sub-
units without ZZ-tag to analyze its background binding. This screening did not result in
any observed interactions between two subunits, possibly indicating that a stable interac-
tion between the subunits requires more than two subunits. Hence, various combinations
were analyzed, such as the five subunits homologous to the yeast eIF3 complex, the eight
subunits resembling the eIF3 core complex in humans (see section 1.1.1), or all 13 eIF3
subunits. Surprisingly, in neither of the combinations interactions between two or more
subunits was observed. A possible explanation would be that the assembly of the wheat
eIF3 complex requires certain eukaryotic assembly factors or processing enzymes that lack
in E.coli. Thus, the experiments were repeated, now screening for interactions in the
presence of the wheat germ extract instead of the E.coli lysate. However, also these trails
were not successful.
In 1983, the term “molten globule” was coined (Ohgushi and Wada, 1983), describing
a partially folded protein state in which the polypeptide chain is packed similarly as in
the native state, however the protein interior is not (yet) tightly packed and intramolec-
ular interactions are not stably formed. This folding state, that can be either relieved by
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chaperones, respectively, or form a stable non changeable intermediate, might explain the
phenomena that the eIF3 subunits can be expressed in a soluble manner however they
fail in interacting with their natural binding partners. To avoid the formation of potential
molten globule proteins and to further increase solubility of the subunits by providing
possible interaction partners, various eIF3 subunits were co-expressed either in pairs or
triples. Therefore each protein was encoded on plasmids with different origin of replica-
tions and selection markers. Co-expression revealed that indeed solubility of so far less
soluble subunits could be increased. Interestingly, this effect seems to be specific, as not
every subunit can help another to fold more stable. Exemplarily, solubility of eIF3f can be
positively influenced when co-expressed with eIF3b, co-expression of eIF3c however does
not have any effect on eIF3f. Co-expressed proteins were further analyzed for their ability
to be co-purified (only one protein was fused to a ZZ-tag), however, possible interactions
seem to be too weak to enrich both proteins on a resin. Co-expression of multiple tandem
vectors encoding all eIF3 subunits, similar to the approach taken by Masutani et al. (2007)
could enable to produce an entire eIF3 complex in E.coli avoiding misfolded or aggregated
proteins.
Note that during the purification of eIF3b, a ∼60kDa protein co-purified, which was iden-
tified by mass spectrometry to be the E.coli GroEL chaperone. This might indicate folding
problems of the subunit although it results in highly soluble protein.
2.1.3 Characterization of native eIF3 in the Wheat Germ Extract
Although all 13 eIF3 subunits could be expressed in E.coli and further purified, in vitro
reconstitution was not successful. Possibly, eIF3 assembly requires additional factors or
the plant eIF3 complex is comprised out of further subunits so far unknown. To address
these questions, the native wheat eIF3 complex was analyzed in immunoprecipitation (IP)
experiments and the wheat germ extract was fractionated in order to analyze either the
whole eIF3 complex or sub complexes by Western Blot.
Both techniques require antibodies, which specifically recognize the wheat eIF3 subunits.
Thus, in corporation with Dr. Cathrin Enke, antibodies against all wheat eIF3 subunits
were raised and purified. High yields of antibodies were obtained due to the immunogenic
potential of wheat proteins.
2.1.3.1 Purification and characterization of antibodies against eIF3
Individually expressed and purified eIF3 subunits were used to immunize rabbits, thereby
inducing the production of antibodies against the target proteins in the animal. The
antibodies were purified from the rabbit sera using multiple columns containing different
proteins to reduce the amount of cross-reacting antibodies in the final elution: (1) E.coli
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lysate coupled column to remove antibodies recognizing potential co-purified and thus co-
injected E.coli proteins, (2) affinity tag coupled column to remove antibodies recognizing
the tag of the fusion-protein injected into the rabbits (here H14-MBP-TEV) tag, (3) antigen
coupled column to accumulate antibodies recognizing the target protein. Instead of the
entire target protein, also individual domains can be used as antigen. Bound antibodies
were eluted by 0.1M glycine pH2.2, neutralized and precipitated with ammonium sulphate.
For analysis, precipitated antibodies were dissolved in 2xPBS buffer and a Western Blot
was performed on wheat germ extract stripes using 1µg/ml of the purified antibodies
(figure 2.3 A). As shown, antibodies against eIF3h, eIF3i, eIF3l and eIF3m are highly
specific towards their target protein and do not show any cross-reactions to other proteins
present in the wheat germ extract. Antibodies against eIF3e, eIF3f, eIF3g, eIF3j and
eIF3k do show cross-reactivity, however the main signal correlates with the target protein.
Figure 2.3: Purification of antibodies against eIF3 subunits
(A) Antibodies against all 13 wheat eIF3 subunits were purified from rabbit sera as described in 4.2.5.2. (B)
antibodies recognizing wheat eIF3c were further purified via individual eF3c domains to increase the sensitivity
of the antibodies towards the target protein and to remove cross-reacting antibodies. Analysis was performed by
Western Blot on membrane stripes containing wheat germ extract. After blocking the membrane, each stripe was
incubated with 1µg/ml of the purified antibody. After over night incubation and thorough washing with 1xTBS, the
secondary goat α-rabbit IRdye antibody was added (1:50.000) for 1h. After washing, the blot was analyzed using
the Odyssey scanner (settings: 700nm (L2.0, 800nm (1.0))). FL: full length; ctrl: control membrane: the wheat
germ extract containing stripe was incubated with the secondary antibody only.
Antibodies against the four largest eIF3 subunits eIF3a, eIF3b, eIF3c and eIF3d show
cross-reactivity to a multitude of other proteins, either caused by degradation products of
the target protein or by similar epitops in other wheat proteins. To reduce the amount
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of cross-reactions, the antibodies were subsequently purified via individual domains of the
target proteins. For analysis, wheat germ extract was blotted on nitrocellulose, cut into
stripes and incubated with the domain specific antibodies. Figure 2.3 B exemplarily shows
the purification of the eIF3c antibodies against individual domains of the wheat eIF3c
proteins. Antibodies recognizing domains eIF3c459-491 and eIF3c815-936 are highly specific
towards eIF3c and do not show any other cross reactivity whereas antibodies purified via
the full length eIF3c proteins shows significant cross-reactivity with other proteins present
in the extract.
Optimization of antibodies against eIF3a, eIF3b, eIF3d and eIF3j were performed as well.
This work was greatly supported by the lab rotation students Metin Aksu and Ayesha
Khan.
2.1.3.2 eIF3 forms a stable complex in the wheat germ extract
To analyze the composition of the native wheat eIF3 complex, the in-house prepared
wheat germ extract was rebuffered from a low salt HEPES based buffer system to 50mM
Tris/HCl pH7.5, 500mM NaCl, 5mM MgAc, 1mM DTT and fractionated using a SD200
16/60 gel filtration column (Pharmacia).
The eluted fractions were loaded on SDS polyacrylamide gels and analyzed for their eIF3
subunit content by Western Blot using the previously described eIF3 specific antibodies
(see figure 2.3 A). Figure 2.4 shows the gelfiltration profile and a schematic representation
of the tested eIF3 subunit content in each fraction. eIF3b, eIF3c, eIF3m, eIF3h and eIF3k
seem to form a stable complex in the wheat germ extract as they co-migrate through the
column. Members of all described eIF3 subcomplexes (Zhou et al., 2008) were tested in
Western Blot suggesting that also the additional, non-tested eIF3 subunits migrate simi-
larly. eIF3j is an exceptional eIF3 subunit due to the fact that it only associates loosely
to the complex (Fraser et al., 2004). Hence, it eluted later from the column. As control
eIF2α as non-eIF3 subunit was tested as well showing that this subunit did not co-migrate
with the tested eIF3 subunits but eluted later from the column.
To further validate that eIF3 forms a stable complex in the wheat germ extract and
to identify possible additional subunits or assembly factors, immunoprecipitation exper-
iments were performed. Recombinantly expressed and purified ProteinA was coupled to
maleimide 4B Sepharose (produced in the lab by D. Görlich) via a reduced cystein at the
C-terminus of the protein. Next, IgGs against eIF3 subunits were covalently attached and
the beads were incubated with wheat germ extract rebuffered to 50mM Tris/HCl pH7.5,
500mM NaCl, 5mM MgAc, 1mM DTT and centrifuged to remove aggregates. After incu-
bation, the flow-through was collected and the beads were washed. Bound proteins were
eluted with 0.1M glycine pH2.2 and subsequently precipitated with trichloroacetic acid.
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Figure 2.4: Native eIF3 forms a stable complex in the WGE
Wheat germ extract was rebuffered to 50mM Tris/HCl pH7.5, 500mM NaCl, 5mM MgAc, 1mM DTT and subse-
quently pre-cleared by ultracentrifugation. The supernatant was loaded onto a SD200 16/60 gel filtration column
with a constant flow of 1ml/min. For size estimation 0.5ml Gel filtration standard (BioRad) was loaded to the
column under the same conditions. 1ml elution fractions were collected and analyzed for their eIF3 subunit content
by Western Blot (antibodies used at 1µg/ml concentration). The distribution of eIF3 subunits in the individual
fractions is shown schematically, eIF2α distribution is shown in yellow.
Elution samples were loaded onto polyacrylamide gels, stained with Colloidal Coomassie,
the resulting bands were cut and finally analyzed by mass spectrometry to identify the
immunoprecipitated proteins. Initial experiments resulted in elution fractions containing
many proteins binding nonspecifically to the resin. To improve the purity of the immuno-
precipitation elution samples a pre-clearing step of the wheat germ extract via ProteinA
beads without coupled IgGs was performed, which greatly improved the purity of the
samples.
Figure 2.5 exemplarily shows the elution samples for immunoprecipitation experiments
performed with antibodies against wheat eIF3b and eIF3c. The proteins eluted from the
beads used for pre-clearing can be seen as well (pre-clearing), showing the vast amount
2.1 Characterization of recombinant and native wheat eIF3 complex 32
of proteins unspecifically binding to the resin. The bands in the IP elution fractions are
labeled according to the mass spectrometry results, the direct target protein of the used
antibody is highlighted in red. In both cases all eIF3 subunits except the loosely attached
eIF3j subunit co-precipitated with the target protein, strongly arguing for a stable eIF3
complex in the wheat germ extract. In addition, elongation factor eEF1α was identified
in both cases, the chaperone CPN60 was found as a major band in the eIF3b IP sample.
It remains to be elucidated if the chaperone is a complex constituent or co-precipitated
due to cross-reactivity of the antibody.
Figure 2.5: Identification of the native wheat eIF3 complex
To identify the components of the native wheat eIF3 complex, immunoprecipitation experiments were performed as
described in 4.2.5.4. To achieve a higher purity of the elution, the wheat germ extract was pre-cleared over ProteinA
beads not containing any coupled antibodies (bound proteins shown in “pre-clearing”). The IP experiments were
performed with ProteinA beads covalent attached to either α-eIF3b or α-eIF3c antibodies. Elution samples were
loaded on 12% polyacrylamid gels and stained with colloidal Coomassie. The resulting bands were analyzed by
Mass Spectrometry revealing all eIF3 subunits co-precipitating except eIF3j.
Both, the wheat germ extract fractionation and the IP experiments showed that the native
eIF3 complex in the wheat germ extract is present in a stable form. All 13 proposed plant
eIF3 subunits could be identified by mass spectrometry. The aim to find possible additional
eIF3 subunits or factors being attached to the complex and thereby stabilizing it, was not
successful. As already mentioned, the complex could not be reconstitution by mixing
individual recombinant subunits, although these seem to be sufficient to form a stable
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and functional complex in vivo. This once more strongly suggests that the recombinantly
produced eIF3 subunits are folding intermediates. They can be expressed in a soluble form
but are nevertheless non- or misfunctional proteins and thus can not assemble in vitro.
2.2 Use of in vitro translation systems to reveal limitations of and
necessities for individual translation factors
Translation is a highly complex process involving 47 individual proteins in higher eukary-
otes. Thereby translation initiation requires most of the factors, all together 37 individual
proteins. Some function singly, e.g. eIF1, some act as multimeric complexes, e.g eIF3,
eIF2B or eIF2 complex. By looking at these complex factors and comparing their com-
position between yeast and higher eukaryotes, a striking difference in complexity can be
observed, raising the question if all higher eukaryotic subunits are truly essential for a
proper translation or if there are functional and regulatory subunits. However, these
questions are difficult to access in in vivo systems as translation is a fundamental process
in every living organism and depleting or manipulating functional or regulatory subunits
could lead to an overall decrease of translation and thus lethality. Hence, it is highly
advantageous to analyze the necessity of various translation (initiation) factors in con-
text of an in vitro translation assay. Another interesting observation is that although the
wheat germ extract is the most efficient higher eukaryotic in vitro translation system, the
efficiency of protein synthesis compared to the in vivo situation is dramatically reduced.
Most likely certain components in the in vitro systems are limiting, probably even trans-
lation (initiation) factors. To follow up this hypothesis and to analyze which translation
factor subunits play a functional or regulatory role, an in vitro translation assay based on
the wheat germ extract was used.
For the in vitro wheat germ translation assay, the extract is supplemented with amino
acids, an energy regenerating system and mRNA coding for the reporter protein (here
Firefly Luciferase). The reaction is incubated for 90 minutes at 27℃ during which the
mRNA is translated to protein. The more translation efficient the extract is, the more lu-
ciferase is produced. Next, a luminescence assay is performed, in which a luciferin solution
is added to the wheat germ extract, inducing the conversion of luciferin to oxyluciferin
and light. This reaction is catalyzed by the produced luciferase. Thus, by measuring the
luminescence, the amount of luciferase enzyme produced during the translation reaction
can be calculated. Translation (initiation) factors or factor subunits can be either titrated
to the extract in a recombinant form, or they can be specifically depleted by using the pre-
viously described wheat translation factor specific antibodies. The translation efficiency
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of these supplemented or depleted extracts is then compared to the efficiency of non -
treated extracts.
2.2.1 Addition of recombinant initiation factors does not stimulate translation
efficiency
Extensive work by Dr. C. Enke showed that following optimizations can greatly increase
the translation efficiency of the in vitro wheat germ translation system (Enke, 2010):
• addition of translation enhancing elements to the in vitro translation vector
• optimization of extract preparation
• optimization of translation conditions
• usage of winter wheat grains as starting material
However, although it performs ∼8-fold better than commercially available systems, the
translation efficiency is still significantly low compared to the corresponding in vivo system.
If one wants to elevate the in vitro wheat germ translation system to a biotechnological tool
that can be used for the production of high protein amounts, the limitations preventing
highly efficient translation need to be determined and abolished. The wheat germ extract
is produced from translationally inactive embryos, which nevertheless should contain all
relevant translation factors to be able to start protein synthesis once required. However,
the amount of translation factors might be sufficient during early plant development but
be rate-limiting in the in vitro assay. If this is the case, addition of translation factors to
the translation assay should lead to an increased production of firefly luciferase.
Recombinantly expressed and purified translation factors fused to H14-MBP-brSUMO were
titrated to the translation assay in concentrations ranging from 0µM to 1µM. To ensure a
sufficient cleavage of the fusion construct, 40nM SENP1 protease was additionally added
to support the endogenous SUMO protease. Addition of the recombinant protease to the
extract does not affect translation efficiencies. The amounts of produced Firefly luciferase
in the supplemented extracts was measured, calculated and subsequently compared to the
rates obtained from non-supplemented extracts. In the first trails, 16 wheat translation
initiation factor subunit were titrated individually to the extract, resulting in no signifi-
cant improvement of the translation efficiency. Slight increases in translation rates were
observed when members of the mRNA cap-binding eIF4F complex were added. Hence,
combinations of eIF4A, eIF4E, eIF4isoE, eIF4G and eIF4isoG were subsequently tested,
however the first results could not be reproduced.
Obviously, addition of recombinant translation factors was not able to increase the transla-
tion efficiency of the extract. One possible explanation is that the recombinantly expressed
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and purified subunits are not functional in the assay. Although all factors were expressed
as MBP fusion constructs, thereby potentially being positively influenced by the tags
chaperone-like qualities, the folding could still result in non-functional or misfunctional
intermediates or the factors aggregate upon tag removal in the extract. Another explana-
tion refers to the tag removal itself. Although the SUMO protease is known to be highly
efficient, cleavage might take too long and the attached large tag could meanwhile hinder
the factor to incorporate into multi-factor complexes acting during translation. Alterna-
tively, the obtained data could also indicate that translation factors are not the limiting
compounds in the extract, but other parameters such as energy supply and mRNA stability
need to be further analyzed.
2.2.2 Depletion of eIF3 from wheat germ extracts leads to a reduced translation
efficiency
Even if the addition of translation factors to the extract does not positively affect the
translation rates of an in vitro wheat germ translation system, removal of endogenous
factors from the system could however show severe consequences. A significant decrease
in translation efficiency upon depletion of a particular translation factor would strongly
argue that this factor is essential during translation. Add-back of the depleted factor or
subunit should be able to restore the translation efficiency. If translation rates remain
constant even upon depletion of certain factors, these proteins are most likely not essen-
tial during translation. Such depletion and add-back experiments can be used to identify
the minimal set of proteins required in higher eukaryotes for proper protein synthesis.
This would be an important piece of information in terms of eukaryotic translation system
reconstitution.
To deplete translation factors or factor subunits from the extract, the already described an-
tibodies against eIF3 were used (see section 2.1.3.1), additionally also antibodies against
GFP and translation factors eIF2α, eIF2β, eIF5 and eEF1Bβ (characterized in Enke,
2010). Depletion was performed in two consecutive rounds, using 500µl wheat germ ex-
tract and 2x 50µl ProteinA maleimide beads to which the corresponding antibodies had
been covalently attached. After depletion, the extracts were analyzed by Western Blot for
the amount of remaining target protein and potential co-depletions. Further, the depleted
extracts were used in translation assays. Therefore, the samples were supplemented with
the energy regenerating system, mRNA encoding Firefly Luciferase, amino acids and in
case of add-back experiments with appropriate amounts of recombinant translation fac-
tors. The translation reaction was incubated for 90 minutes at 27℃ and subsequently the
amount of produced luciferase was determined.
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Figure 2.6: Depletion of translation initiation factors decreases overall translation efficiency
Translation initiation factors were depleted from wheat germ extract by subunit specific antibodies. (A): Depleted
extracts were analyzed by Western Blot for their remaining target protein content and for possible co-precipitation
of additional subunits. As control, a non-depleted extract (Input) and a mock depleted extract (depleted with
α-GFP antibodies) was analyzed in parallel. Extracts were depleted with antibodies against all 13 eIF3 subunits
(orange), as well as antibodies against two further translation initiation factors and one elongation factor (blue).
Primary antibodies were used at a concentration of 1µg/ml, secondary goat α-rabbit IRyde antibodies were used
at a concentration of 1:50.000. (B): In vitro translation assays were performed with the depleted extracts. The
translation efficiency was analyzed by estimating the amount of produced Firefly luciferase during the translation
reaction by performing a luciferase activity assay using the BioTek Synergy H4 Plate Reader.
First, all eIF3 subunits were individually depleted from the extract by their subunit spe-
cific antibodies. As control, a mock depletion using α-GFP was performed as well as
depletions utilizing antibodies against eIF2α, eIF5 and eEF1Bβ. The depletion efficiency
was analyzed by Western Blot (figure 2.6A) comparing the depleted extracts with extracts
that were not depleted (Input, Input after conc.). Detection was performed using anti-
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bodies against most eIF3 subunits, eIF2α, eIF5 and eEF1Bβ. The amount of detected
proteins in the Input and mock depleted samples are comparable, indicating that the tar-
get proteins do not unspecifically bind to the antibody scaffold or to the resin. When
depleting the extracts with eIF2α, eIF5 or eEF1Bβ, a reduction of the target protein can
be observed whereas all other tested proteins remain unaffected. The depletion efficiency
for eIF2α and eIF5 is high as only slight amounts of protein can still be detected. In case
of eEF1Bβ, the amount of protein in the extract also decreases, however ∼50% of the en-
dogenous protein remains. When depletion was performed with antibodies against eIF3a,
eIF3b, eIF3c or eIF3d, the amount of the target protein and also all other tested eIF3
subunits, except eIF3j, decreases significantly. The fact that eIF3j is only loosely attached
to the native eIF3 complex explains, why no reduction of the protein in extracts depleted
with core eIF3 subunits can be observed. In contrast, when depleting the extract with
antibodies against eIF3j, almost no target protein can be detected any longer, whereas
the other eIF3 subunits remain unaffected.
Analyzing the native wheat eIF3 complex showed that the factor seems to be present in
a stable form in the extract (see figure 2.5, respectively). However, when depleting the
extracts with antibodies against eIF3e-eIF3m, slight decreases in the target protein can
be observed, but other subunits can not be co-depleted, and the depletion efficiency is
generally very low. Note that antibodies against the eIF3 subunits were raised against
individual subunits. Epitops might be shielded when the protein is incorporated into the
eIF3 complex. Thus, these subunits could only be recognized and bound by the antibodies
when present in a non-complexed form.
The (partially) depleted extracts were used in the in vitro wheat germ translation system,
assaying for the amount of produced luciferase in comparison with non- or mock- depleted
extracts (figure 2.6B). Mock depleted samples produce similar amounts of luciferase as
non-treated extracts, showing that the depletion procedure itself does not affect the trans-
lation efficiency of the extract. The extracts depleted with eIF3 subunit specific antibodies
did not lead to conclusive results. Even though the Western Blot analysis showed that
the amounts of all tested eIF3 subunits strongly decreases upon depletion with antibod-
ies against eIF3a, eIF3b, eIF3c and eIF3d, the resulting extracts behave very different in
terms of translation efficiency. The α-eIF3a and α-eIF3b depleted extract show an ∼2-fold
decrease in translation efficiency, the extract depleted with antibodies against eIF3c pro-
duces similar amounts of protein as the non-depleted extracts and surprisingly, extracts
depleted with α-eIF3d antibodies even shows an increase in translation efficiency. On the
other side, depleted extracts that only shows a minor decrease of the target protein and
the other eIF3 subunits in the Western Blot analysis show a strong reduction of translation
efficiency, e.g. when using antibodies eIF3g or eIF3h.
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Depletion of eIF2β leads to an ∼2-fold reduction of the produced protein, the effects upon
eIF5 and eEF1Bβ depletion however are more drastic. eIF5 is the GTPase activating
protein for the eIF2 complex. GTP hydrolysis in eIF2 leads to the stable accommodation
of the initiator tRNA to the P-site of the small ribosomal subunit. Interestingly, depletion
of eIF5 seems to strongly affect the translation efficiency of the extract, however, deple-
tion of eIF2β, a component of the eIF2 complex shows milder effects. eEF1Bβ is part
of the heterotrimeric eEF1B complex, a translation elongation factor acting as nucleotide
exchange factor (GEF) for eEF1A. It plays an important role in recruitment of aminoacyl-
tRNAs onto the ribosome (Janssen and Moller, 1988). Thus, even a slight decrease in the
amounts of endogenous protein could hinder eEF1A to participate in a new round of tRNA
delivery to the ribosome, which leads to an overall delay in protein synthesis and hence
less produced reporter protein.
Figure 2.7: Translation efficiency can be partially restored by adding back recombinant factors
Translation initiation factors were depleted from wheat germ extract by subunit specific antibodies. (A): Depleted
extracts were analyzed by Western Blot for their target protein content and for possible co-precipitation of additional
subunits. As control, a non-depleted extract (Input) and a mock depleted extract (depleted with α-GFP antibodies)
was analyzed in parallel. Primary antibodies were used at a concentration of 1µg/ml, secondary goat α-rabbit
IRyde antibodies were used at a concentration of 1:50.000. (B-D): In vitro translation assays were performed with
the depleted extracts (blue bars). Further, depleted extracts were supplemented with either single recombinant
initiation factors or initiation factor mixes prior to translation (orange: add-back with an eIF3 mix, cyan: add-back
with eIF2α, green: add-back with eEF1Bβ). As control, non-depleted extract was run in parallel. The translation
efficiency was analyzed by estimating the amount of produced Firefly luciferase during the translation reaction by
performing a luciferase activity assay using the BioTek Synergy H4 Plate Reader.
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Next, extracts were depleted with antibodies against GFP (mock), eIF3b, eIF3c, eIF3d,
eIF3j, eIF2α, eIF2β and eEF1Bβ and analyzed by Western Blot. These extracts were
subsequently used in translation assays, supplemented with recombinant translation fac-
tors as add-back to restore translation efficiency. The Western Blot analysis in figure 2.7A
shows that upon depletion with antibodies against eIF3b, eIF3c and eIF3d, other complex
components co-deplete as well. However, the depletion is incomplete as residual amounts
of all tested eIF3 subunits can still be detected. Again, eIF3j is an exception such that
it does not co-deplete with the other eIF3 subunits but can be efficiently removed from
the extract by eIF3j specific antibodies. Depletion with antibodies against eEF1Bβ leads
to an almost complete depletion of the endogenous protein in this experiment. Obviously
the incomplete depletion seen in figure 2.6 was due to technical errors. Depletion with
α-eIF2α results in a drastic reduction of endogenous protein, however, eIF2β levels remain
unaffected. Interestingly, depletion of eIF2β does not only lead to an efficient reduction
of endogenous target protein but also leads to a decrease in eIF2α levels.
Figures 2.7B-D show the translation efficiencies of the depleted extracts (dark blue bars)
and depleted extracts supplemented with recombinant factors in order to restore transla-
tion efficiencies (orange, cyan, green bars). Extracts depleted by α-eIF3b, α-eIF3d and α-
eIF3j antibodies perform ∼2-fold less efficient as non-depleted or mock depleted extracts,
whereas eIF3c-depleted extracts shows a higher amount of produced Firefly luciferase.
Add-back with a mix of recombinant eIF3 subunits (eIF3a, eIF3b, eIF3c, eIF3d, eIF3g,
eIF3i, eIF3j) was able to elevate the amount of produced reporter protein in all cases,
indicating that the drop in translation efficiency might be truly due to a reduction of eIF3
in the extract. However, comparing the measured translation efficiencies of eIF3 depleted
extracts between this experiment and the previously described one (figure 2.6A) reveals a
major problem when working with the in vitro wheat germ translation assay. The extract
seems to be extremely sensitive towards even slight changes in buffer composition and salt
concentrations, so that the reproduction of results is nearly impossible.
Extracts with reduced amounts of eIF2α and eIF2β show less efficient translation as com-
pared to the non-treated or mock depleted extracts. Western Blot analysis showed that
upon eIF2β depletion, the amount of eIF2α is reduced as well, explaining the more drastic
effect in the eIF2β depleted extracts. Add-back experiments were performed with recom-
binantly expressed and purified eIF2α. It is able to restore translation efficiency in the
eIF2α depleted samples, but fails to rescue the effect in eIF2β depleted extracts. Here
eIF2β is still lacking and thus the eIF2 complex can not function properly in initiator
tRNA binding and delivery to the ribosome.
Depletion of eEF1Bβ again greatly reduces translation efficiencies, however adding back
eEF1Bβ seems to hinder proper protein synthesis even further. A possible explanation
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might be that the eEF1B complex in plants consists of three subunits eEF1Bα, eEF1Bβ
and eEF1Bγ. Addition of high concentrations of only one subunit could lead to a compe-
tition in binding resulting in heterodimeric complexes failing to form the heterotrimeric
complex.
In summary, we could show that the in vitro wheat germ translation assay is a possible tool
to analyze limitations and necessities of the translation apparatus, however, the magnitude
of technical hurdles makes it - at least at the moment - impossible to obtain clear and
trustworthy results. So far, we did not succeed to efficiently deplete the eIF3 complex
from the extracts and also depletion of other target proteins resulted in small amounts
of remaining endogenous protein. Yet another problem is that the antibodies used most
likely only recognize a defined isoform of the protein. Possible other versions of target
protein could function in a highly similar manner but cannot be detected by the setup we
used. Furthermore, we can not be certain if all recombinant factors we use for add-back
experiments are fully functional. In principle, each protein used must be priorly analyzed
in depth, considering its folding state, interactions within the wheat germ extract or
posttranslational modifications that might be required for proper function but lack when
produced in E.coli. Further, the assay itself requires optimization such that obtained data
can be reproduced, thereby also determining and abolishing certain limitations in the
extract.
Given the multiplicity of parameters to be improved to eventually receive conclusive and
convincing data we decided that the project can not be successfully completed in the given
time frame and it is hence wisely to change the project.
2.2.3 Eukaryotic translation initiation factor 5A (eIF5A) and its effect on
poly-proline encoding mRNAs
eIF5A is a small eukaryotic translation factor with so far unknown function in higher eu-
karyotes. Its specific interaction with the nuclear export factor Exportin 4 was discovered
in our department (Lipowsky et al., 2000), hence raising interest not only for the inter-
action between the export receptor and its cargo but also for the role of eIF5A during
translation.
Recent studies on the bacterial translation factor EF-P, which is homologous to eIF5A,
revealed that it is essential for the translation of mRNAs encoding for proline rich proteins.
Poly-proline stretches cause the ribosome to pause or even to stall on the mRNA and EF-P
is required to resume translation of the transcript (Doerfel et al., 2013). Subsequently,
Gutierrez et al. (2013) showed in vivo that eIF5A has a similar function in yeast. Is this
also the case in higher eukaryotes?
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Figure 2.8: Reporter constructs
To monitor the effect of eIF5A on poly-proline encoding mRNAs, reporter constructs were designed and cloned
containing either a poly-serine stretch (12xSerine) or a poly-proline stretch (12xProline). A H10-tag was fused N-
terminally to provide a comparable translation start in both constructs. To facilitate proper 35S-Met incorporation,
a short methionine/serine rich stretch (MS) was introduced, followed by parts of the Nup98FG repeat domain in
two different length. Prior to that, all prolines in the Nup98FG repeat domain were exchanged to serines (P→S,
performed by Dr. Aksana Labokha).
To address this question, we used the in vitro rabbit reticulocyte lysate translation system.
Simultaneous translation of poly-serine and poly-proline reporter constructs in extracts de-
pleted of eIF5A by specific antibodies should reveal the necessity of the translation factor
during the synthesis of proline rich reporters. The antibodies used were previously purified
and well characterized, recognizing two different epitops on human eIF5A (described in
Lipowsky et al., 2000). These were positively tested for cross-reactivity with rabbit eIF5A
(data not shown).
The new poly-serine or poly-proline reporter constructs were designed as follows (from
N-terminus to C-terminus): (i) a H10-tag (ii) a stretch of either 12 consecutive serines or
12 consecutive prolines (iii) a methionine rich stretch for proper labeling with 35S-Met
and (iv) parts of the Nup98-FG domain in which all prolines had been mutated to serines
(performed by Dr. A. Labokha). The construct containing the serine stretch is fused to
a longer part of the FG-domain, the poly-proline construct is slightly shorter (see figure
2.8). This enables to distinguish the two constructs after simultaneous translation.
In order to deplete eIF5A from the extract, the rabbit reticulocyte lysate was incubated
with ProteinA Sepharose to which antibodies against an N-terminal human eIF5A epitope
had been covalently attached. As control, the lysate was also incubated with ProteinA
Sepharose (empty beads (e.b.) control) and α-GFP coupled Sepharose (mock depletion).
The depletion efficiency was analyzed by Western Blot (figure 2.9A), showing no change
in endogenous protein amount when comparing the input with the empty bead control or
the mock depleted extract. Depletion of endogenous eIF5A by α-eIF5A specific antibodies
was highly efficient. No endogenous protein was detected when incubating 200µl or 100µl
lysate with 50µl ProteinA-IgG beads, minor amounts of protein were observed when 500µl
extract had been used, thereby exceeding the capacity of the beads.
Next, the rabbit reticulocyte in vitro translation assay was performed, simultaneously
using the long poly-serine and short poly-proline reporter constructs. Untreated lysate
(Input), lysate thawn once (Input thawn), and lysates depleted via empty beads, α-GFP
and α-eIF5A were compared. In addition, the α-eIF5A depleted extract was supplemented
with 5µM natively purified human eIF5A (see figure 2.9B). Interestingly, the two reporter
2.2 Use of in vitro translation systems to reveal limitations of and necessities for individual
translation factors 42
constructs were translated under all tested conditions. A decrease in translation efficiency
of the poly-proline construct in eIF5A depleted lysates could not be observed. Note,
that the lower signal intensity for the poly-proline constructs compared to the poly-serine
constructs was observed in all experiments.
Figure 2.9: eIF5A depletion does not affect translation of a poly-proline reporter
(A): 100µl, 200µl and 500µl Rabbit Reticulocyte Lysate (RRL) were depleted with monoclonal α-hs eIF5A anti-
bodies raised against an N-terminal epitope of human eIF5A. The antibody was coupled to ProteinA Sepharose in
a concentration of 3µg/µl; 50 µl beads were used for depletion. The remaining amount of endogenous protein in
the extracts was analyzed by Western Blot. As control, non-depleted and mock depleted (α-GFP antibody coupled
to ProteinA Sepharose) extracts were analyzed as well. (B): In vitro translation assays were performed using the
empty beads-, mock- and α-eIF5A - depleted extracts, including control samples of non-treated extracts (Input) and
extracts thawn once (Input thawn). In addition, α-eIF5A depleted extracts were supplemented with 5µl natively pu-
rified human eIF5A (eIF5A addition). In all extracts tested, a poly-serine (Poly-Ser) and a poly-proline (Poly-Pro)
reporter construct were translated simultaneously as described in 4.2.6.3. Ammonium sulfate precipitated samples
were loaded on a gradient polyacrylamid gel and subsequently applied to a radiographic film. The film was scanned
after over night exposure using the Fujifilm FLA7000 scanner (Radiograph). In addition, a second Western Blot
was performed with an α-hs eIF5A antibodies recognizing a epitope located on a linker region between two domains
(WB). All primary antibodies were used at a concentration of 1µg/ml, secondary antibodies were used in a 1:50.000
ratio.
As control, the extracts were once more analyzed by Western Blot, this time using a
human α-eIF5A antibody recognizing not the N-terminal amino acid stretch but an in-
ternal epitope located in the linker region between two domains of eIF5A (figure 2.9B,
WB, lower panel). This approach revealed that endogenous eIF5A protein is still present
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in α-eIF5A depleted sample. Most likely, the two different human α-eIF5A antibodies
recognize slightly different pools of eIF5A in the reticulocyte lysate. By using only the
monoclonal antibody recognizing the N-terminal eIF5A epitope for depletion, a residual
pool of eIF5A remained in the lysate, possibly enough to ensure a proper and efficient
translation of the poly-proline containing reporter.
In subsequent experiments, the lysate was depleted with both α-eIF5A antibodies in con-
secutive rounds, however, a complete depletion of the endogenous protein from the lysate
could not be reached. The depleted lysates were also not able to impair the synthesis of
the proline rich reporter.
The following section will describe an alternative approach, in which endogenous eIF5A
is not depleted but sequestered.
2.3 Can nuclear transport factors act as compartment specific
inhibitors of translation?
Despite the theory of nuclear translation, a spatial-temporal separation of transcription
happening in the nucleus and translation acting in the cytoplasm is highly beneficial for
eukaryotic cells. If these two processes were directly coupled, the probability of translating
non- or mis-spliced mRNA molecules to proteins would be high, resulting in proteins that
are mislocalized and might even have dominant negative effects. Eukaryotic cells governed
a multitude of mechanisms to prevent an intermixing of transcription and translation, such
as keeping the level of translation factors in the nucleus actively low. Nuclear transport
factors, mainly nuclear export factors (exportins), can shuttle out proteins from the nu-
cleus to the cytoplasm in a RanGTP dependent manner (see section 1.2.1). Exportin 4,
respectively, is known to interact with the small translation factor eIF5A and to efficiently
remove it from the nuclear interior (Lipowsky et al., 2000).
As already mentioned in the previous section, we aim to analyze the role of eIF5A in
the translation of proline rich proteins in higher eukaryotes. eIF5A should therefore be
depleted from the translation extract by specific antibodies and the ability of the depleted
extract to translate a poly-proline continuing reporter constructs should be analyzed. So
far depletion of endogenous eIF5A from the extract was incomplete. An alternative ap-
proach to analyze the role of eIF5A during translation exploits the feature of Exportin 4
to specifically interact with the translation factor. By supplementing translation assays
with the nuclear export factor endogenous eIF5A can be sequestered and thus hindered
to act during translation.
Interestingly, Exportin 4 is not the only nuclear transport factor binding translation fac-
tors and shuttling them out of the nucleus. Bohnsack et al. (2002) showed interactions
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between e.g. Importin 13 and eIF1A as well as a tRNA mediated interaction between
Exportin 5 and eEF1A. Recent data in the lab further showed that pull down assays with
the nuclear export factor Crm1 were able to enrich most translation (initiation) factors on
the column in a Ran dependent manner (K. Kirli, unpublished data). Thus, the question
arises if nuclear transport factors are not only able to bind translation factors in a direct
or indirect manner but if this binding is also able to sequester translation factors in a
way that the translation efficiency of a supplemented in vitro translation assay decreases.
Even further, it can be hypothesized that transport factors act as compartment specific
inhibitors of translation, which clearly argues against the idea of nuclear translation.
2.3.1 Addition of Exportin 4 to an in vitro translation system can reduce the
translation efficiency of a poly-proline reporter
In previous experiments, a poly-serine construct with a longer version of the Nup98FG
domain and a poly-proline construct with a shorter version of the Nup98FG domain were
used (P→S mutations in the Nup98FG domains, see figure 2.8). However, the translation
efficiencies of these constructs were rather low, leading us to change the N-terminal H10-
tag to a 3xFLAG tag (see figure 2.10, green). When comparing the translation efficiencies
of the different constructs, the 3x-FLAG constructs gave a better signal on the radiograph
and thus these constructs were used for all following experiments (data not shown). In
addition, the Firefly luciferase and the two yeast proteins Eap1 and Ldb17 were fused to
a 3x-FLAG tag and were used as reporters as well. Eap1 and Ldb17 were chosen due to
findings by Gutierrez et al. (2013) that synthesis of these proteins is strongly impaired if
eIF5A is non-functional in yeast. The length of the reporter constructs and the amounts
of prolines per construct are presented in figure 2.10.
Figure 2.10: In vitro translation reporter constructs with N-terminal 3xFLAG tag
To increase the expression levels of the reporter constructs used in the RRL in vitro translation assay, the N-terminal
tag was switched from H10-tag (see figure 2.8) to 3xFLAG tag (green). In addition to the poly-serine and poly-
proline constructs with Nup98FG domains in different length (violet), additional reporters were constructed: Firefly
Luciferase and the two yeast proteins Eap1 and Ldp 17 (pink). The size of the reporter constructs as well as the
amount of prolines are listed for each construct.
Figure 2.11 shows the radiograph of the in vitro translation assay using the reporter
constructs encoding Firefly Luciferase, Ldb17 and Eap1. Each construct was translated
2.3 Can nuclear transport factors act as compartment specific inhibitors of translation? 45
in non supplemented reticulocyte lysate, in lysate supplemented with 5µM mmExportin
4 (Xpo4) and lysate supplemented with 5µM mmExportin 4 and 15µM RanQ69L5-180
(Exportin 4 and Ran were recombinantly expressed in E.coli and subsequently purified
by affinity chromatography and protease elution). All three constructs can be efficiently
synthesized in the reticulocyte translation system. When supplementing the lysate with
Exportin 4 only, the amount of produced protein does not vary much in comparison to non
supplemented lysate in case of Firefly Luciferase and Ldb17. However, full length Eap1 can
not be observed any longer. Instead, two lower molecular bands appear, which possibly
represent partially translated Eap1 protein caused by ribosome stalling. If the lysate is
supplemented with Exportin 4 and Ran, the amounts of produced Firefly luciferase and
Ldb17 drop significantly, no translation product for Eap1 can be observed any longer. This
effect can not be explained by RanQ69L5-180 addition itself. It was shown in independent
experiments that Ran does not effect the translation system (see also figure 2.13A).
Figure 2.11: Addition of Exportin 4 decreases translation efficiency of proline containing reporters
in a Ran dependent manner
Firefly Luciferase and the yeast proteins Ldb17 and Eap1 were translated in the RRL in vitro translation system. The
proteins were either N-terminally tagged with 3x-FLAG (Ldb17 and Eap1) or 3x-FLAG-12xSer (Firefly Luciferase).
The translation was performed in untreated extracts (first lane), extracts supplemented with 5µM recombinantly
purified mmExportin 4 (middle lane) and extracts supplemented with 5µM recombinantly purified mmExportin 4
and 15µM recombinantly purified RanQ69L(5-180) (right lane). The translation reactions were precipitated with
ammonium sulfate, the pellet was resuspended in SDS loading buffer and the samples were loaded on a gradient
polyacrylamide gel. The gel was subsequently fixed, dried and placed over night on a radiographic film. The film
was scanned using the Fujifilm FLA7000 scanner.
Translation of Eap1, which contains 72 proline residues, is already strongly impaired by
addition of Exportin 4 only. Possibly, the nuclear transport factor binds eIF5A to some
extend even in the absence of Ran, resulting in a decreased pool of fully active eIF5A in the
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extract. This might still be enough to overcome pausing events on mRNA molecules caused
by small patches of proline codons, but might be insufficient to release stalled ribosomes.
Further adding Ran might stabilize and increase the interaction between Exportin 4 and
eIF5A, thereby efficiently sequestering the translation factor.
These data suggest a role of eIF5A in the translation of poly-proline containing proteins
also in higher eukaryotes. However, two major experiments are still required to finalize our
results. First, the direct interaction of the recombinantly expressed and purified Exportin
4 and Ran and the endogenous rabbit eIF5A needs to be shown. So far preliminary data
indicate a direct binding of Exportin 4 and eIF5A in a Ran dependent manner. Possible
weak and transient interactions between Exportin 4 and eIF5A in the absence of Ran
could not be proven yet. Second, add-back experiments with eIF5A need to be performed.
Purification of native eIF5A from HeLa cell lysate is a very time consuming, multistep
process yielding in small amounts of native protein. However, the unusual modification
on eIF5A, a hypusination, is required for proper function and also for efficient binding
of Exportin 4 (Lipowsky et al., 2000; Doerfel et al., 2013; Gutierrez et al., 2013). This
modification can not be introduced in vivo by E.coli. Metin Aksu from our lab recently
established an efficient technique to introduce the hypusination to recombinantly expressed
and purified eIF5A in vitro. Titration of functional eIF5A to the reticulocyte lysate
supplemented with Exportin 4 and Ran could restore the translation efficiency of reporter
constructs upon a certain concentration threshold, thereby strongly suggesting that the
decrease in translation efficiency was caused by sequestration of eIF5A.
2.3.2 Addition of Crm1 to an in vitro translation system greatly reduces its
translation efficiency
Nuclear transport factors can either act on a small set of proteins, such as CAS bind-
ing Importin α or Exportin 6 acting on actin:profiling complexes or they can recognize a
multitude of different cargoes via short sequence stretches known as nuclear localization
signal (NLS) or nuclear export signal (NES) (Görlich et al., 1994; Wen et al., 1995; Ku-
tay et al., 1997; Stüven et al., 2003). The nuclear export factor Crm1 binds leucin-rich
NES containing cargoes in a Ran dependent manner and efficiently removes them from
the nuclear interior. Thereby the NES peptide binds to the hydrophobic cleft of Crm1
(Güttler et al., 2010). Recent experiments in our lab showed that Crm1 is able to pull out
the majority of translation factors from HeLa cell lysate in a Ran dependent manner (K.
Kirli, unpublished data).
To experimentally validate the hypothesis that nuclear transport factors recognizing trans-
lation factors are also able to suppress translation, the in vitro reticulocyte translation
assay was supplemented with different recombinantly expressed and purified nuclear trans-
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port factors in the absence or presence of Ran (figure 2.12). As control, a 5µM nuclear
transport factors solution was for 10 minutes to denature the protein and subsequently
centrifuged. The remaining supernatant was used as buffer control in all following exper-
iments (buffer control). This approach was used to create a control situation in which
transport factors are not present, however, possible co-purified substances might remain
in solution and effects of these on overall translation can be ruled out. Even further
this supernatant has the exact same buffer composition as the protein solution used for
supplementing the lysate.
Figure 2.12: Nuclear export factor Crm1 decreases overall translation rates in an in vitro transla-
tion assay in a Ran dependent manner
Reporter constructs coding for Firefly Luciferase or Nup98FG repeat domain (P→S) fused to either 12xProline or
12xSerine were expressed in the RRL in vitro translation system (all constructs N-terminally tagged with 3x-FLAG
tag). The RRL extract was either non supplemented (buffer control) or supplemented with 5µM nuclear export
factors (mmCrm1G502A (Ran independent Crm1 mutant), mmCrm1 WT, mmExportin 4, hsExportin6 or hsCAS).
To observe a possible Ran dependency the extracts were further supplemented with 5µM nuclear export factors and
15µM with RanQ69L(5-180) (marked by +). All nuclear transport factors and Ran were recombinantly expressed
and purified. The translation reactions were precipitated with ammonium sulphate, the pellet was resuspended in
SDS loading buffer and the samples were loaded on a gradient polyacrylamide gel. The gel was subsequently fixed,
dried and placed over night on a radiographic film. The film was scanned using the Fujifilm FLA7000 scanner.
The effects of the nuclear export factors Crm1 (as WT and as Ran independent G502A
mutant), Exportin 4, Exportin 6 and CAS on the translation of the firefly luciferase re-
porter construct and on the poly-serine/poly-proline constructs were tested in absence
and presence of Ran (except Crm1G502A, which does not require Ran). When supple-
menting the lysate with buffer only (buffer control, figure 2.12) efficient translation of
all three reporter constructs can be observed. Addition of Crm1G502A leads to a strong
decrease in signal intensity implying a lower translation efficiency. When adding Crm1
WT, the effect is milder, but by further adding RanQ69L(5-180), the translation efficiency
of all three reporter constructs drops significantly. Addition of Exportin 4 alone does
not affect translation rates, however, adding Exportin 4 and RanQ69L(5-180), leads to a
decrease in translation efficiency for the luciferase and the poly-proline construct whereas
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the poly-serine constructs remains unaffected. Exportin6, the nuclear export factor for
actin:profiling complexes, or CAS, required for shuttling Importinα to the cytoplasm, do
not affect the three tested reporter constructs either in presence or absence of Ran.
The data suggests that nuclear transport factors involved in the export of translation
factors from the nuclear interior have an ability to (partially) suppress translation when
present in an in vitro translation system, whereas other nuclear transport factors that
are highly similar in shape and size but have no function in nuclear export of translation
factors do not effect translation. Further, the observed decrease in translation efficiencies
seems to be Ran dependent.
2.3.2.1 Decrease in translation can not be rescued by blocking or mutating the
hydrophobic cleft of Crm1
Crm1 addition leads to a dramatic decrease in translation efficiency of various reporter
constructs (see section 2.3.2). By adding different concentration of Crm1 and Ran (1:1.5
ratio) to the lysate, we were able to observe that the drop in translation efficiency seems
to be concentration dependent (figure 2.13A). Compared to the buffer control, addition of
1µM WT Crm1 even in presence of Ran does not affect synthesis of the reporter constructs
(here the poly-serine and poly-proline Nup98FG domain constructs), whereas addition of
5µM WT Crm1 or 10µM Crm1 results in significantly less translated reporter protein.
Interestingly, samples treated with Crm1 showed a similar effect as compared to addition
of Crm1 and Ran. Note that the previously described experiment was performed using
Ran in 3-fold excess over the nuclear transport receptor, here the excess was only 1.5-fold.
Figure 2.13A also shows that addition or Ran does not negatively affects translation rates
even at elevated concentrations.
Previous experiments showed that addition of Crm1 to an in vitro translation assay de-
creases overall translation rates. Yet, it remains unclear by which mechanism this effect
occurs. Most likely, Crm1 is able to bind certain translation factors via NES stretches,
thereby not only capturing these subunits but also the attached complexes. Crm1 thus
might act as platform to which more and more factors attach, thereby being hindered to
function in the translation process. If this assumption holds true, the effect should be
reversible by preventing binding of the NES to the hydrophobic cleft of Crm1.
One possibility to block the hydrophobic cleft of Crm1 is to additionally supplement the
translation lysate with a strong binder of Crm1, thereby possibly competing out all other
interactions between Crm1 and its cargoes in the lysate. Thus, the RRL was supplemented
with increasing concentrations of the mmCrm1G502A mutant (1µM, 5µM, or 10µM) or
mmCrm1G502A and NS2 peptide in 5-fold excess over the nuclear transport factor. The
peptide is the NES sequence found in the NS2 protein of parvovirus Minute Virus of Mice
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(MVM) and was shown to bind Crm1 with higher affinity as regular NESs (Engelsma et al.,
2008). Figure 2.13B shows that upon addition of low concentrations of Crm1 (1µM) and
NS2 peptide (5µM), no changes in translation efficiency compared to the buffer control can
be observed. Upon addition of higher Crm1 concentrations, the reporter constructs are
significantly less efficiently translated. However, addition of the NS2 peptide is not able
to reverse the effect, it even seems to further weaken protein synthesis. Note that Crm1
and the NS2 peptide were separately added to the lysate and not as a preformed complex.
Hence, receptor and cargo first need to find each other in the crowded lysate milieu. It
also remains unclear if the peptide is harmed by proteases present in the extract.
Figure 2.13: Decrease in translation upon Crm1 addition can not be reversed by blocking or
mutating Crm1s hydrophobic cleft
The following reporter constructs were used in these experiments: 3xFLAG-12xSer-Firefly Luciferase (Firefly Lu-
ciferase), 3xFLAG-12xSer-Nup98 FG domain P→S(long) (Poly-Ser), 3xFLAG-12xPro-Nup98 FG domain P→S(short)
(Poly-Ser)(for details see figure 2.10). (A): Poly-Ser and Poly-Pro reporter constructs were translated in RRL ex-
tracts supplemented with buffer only, 1µM, 5µM, or 10µM mmCrm1 WT, or mmCrm1 WT and RanQ69L(5-180)
in a 1:1.5 ratio. (B): Firefly Luciferase and the Poly-Ser and Poly-Pro reporters were translated in RRL extracts
supplemented with 0µM, 1µM, 5µM, or 10µM mmCrm1G502A in presence or absence of NS2 peptide, which is known
to strongly bind Crm1 in vitro. The peptide was added in 5-fold excess over the transport factor. (C): Firefly Lu-
ciferase and the Poly-Ser and Poly-Pro reporters were translated in RRL extracts supplemented with 5µM mmCrm1
WT or mmCrm1G502A in combination with RanQ69L(5-180) and the natural Crm1 cargo Snurportin1 fused to the
PKI- or REV-type nuclear export signals. RanQ69L(5-180) was added at a concentration of 15µM, the snurportin
fusion proteins at a concentration of 10µM. (D): Poly-Ser and Poly-Pro reporter constructs were expressed in RRL
extracts supplemented with various mmCrm1 versions at a concentration of 5µM. In addition, RanQ69L(5-180) was
added in 3-fold excess. Crm1G502A is a Ran independent Crm1 mutant, Crm1A541R and Crm1K568E are mutants
known to block the hydrophobic cleft thereby preventing binding of known strong Crm1 binders.
All mmCrm1 versions, the peptides and Snurportin constructs were recombinantly expressed in E.coli and purified
by affinity chromatography. All translation reactions were precipitated with ammonium sulphate, the pellet was
resuspended in SDS loading buffer and the samples were loaded on a gradient polyacrylamide gel. The gel was
subsequently fixed, dried and placed over night on a radiographic film. The film was scanned using the Fujifilm
FLA7000 scanner.
Another approach to block the hydrophobic cleft is the addition of Crm1s natural cargo
Snurportin1 fused to the nuclear export signals PKI or REV for even stronger interaction
between transport factor and cargo. In addition to blocking the hydrophobic cleft, a sub-
stantial amount of Crm1s surface will be additionally shielded by Snurportin 1 (Mönecke
et al., 2009). In the following experiment, shown in figure 2.13C, the RRL was supple-
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mented with either 5µM Crm1 WT or Crm1G502A (5µM) with and without Snurportin1
(10µM) either fused to PKI-NES or REV-NES. When using mmCrm1 WT, RanQ69L(5-180)
in 3-fold excess was added as well. All three tested reporter constructs could be expressed
in the buffer control, whereas addition of mmCrm1G502A and mmCrm1 WT and Ran
to the extracts strongly impaired protein synthesis. Addition of Crm1 WT only showed
a milder decrease in translation efficiencies, once again showing the Ran dependency of
the observed effect. However, addition of the Snurportin1 fusion proteins was not able
to restore translation efficiency. In this experiment, receptor and cargo were also added
separately to the lysate. In future experiments, the complexes need to be preformed, to
be certain that Crm1 is indeed blocked by its cargo.
Finally, instead of blocking the hydrophobic cleft by nuclear export signals, the Crm1
hydrophobic cleft itself was modified. Dr. Hema Chug showed that by mutating certain
residues in the Crm1 hydrophobic cleft, binding of PKI can be completely abolished (un-
published data). Mutants mmCrm1A541R and mmCrm1K568E were analyzed in the context
of the in vitro translation assay in comparison to mmCrm1 WT and mmCrm1G502A in
presence and absence of Ran as shown in figure 2.13D. Upon addition of Crm1 WT and
Crm1G502A, translation efficiency of the poly-serine and poly-proline reporter constructs
are impaired. Surprisingly, this is also the case for the two hydrophobic cleft mutants
mmCrm1A541R and mmCrm1K568E. Two possible explanations are: first, the mutations
in the hydrophobic cleft were analyzed and screened for preventing binding of the PKI
NES peptide. However, natural occurring NES signals can have a great variety of amino
acid compositions and might bind even the mutated Crm1 versions. This theory needs
to be experimentally validated by pull out experiments with the Crm1 mutants. Second,
binding of translation factors to Crm1 might not only occur via the hydrophobic cleft but
also via interactions with the hydrophobic patches on the Crm1 surface. However, this
binding mode would not explain the Ran dependency showed for Crm1 WT.
In conclusion, the nuclear export factor Crm1 can (partially) impair protein synthesis in
a Ran dependent manner when added to an in vitro translation assay. Combined with
the findings that almost all translation factors can be found in the broad cargo range
of the NTR, sequestration most likely occurs via a direct or indirect interaction between
Crm1 and the translation factors. However, blocking or mutating the hydrophobic cleft of
Crm1 and thereby preventing cargo binding, does not lead to a rescue of the translation
efficiency of the extract. Hence, the mode of translation sequestration by Crm1 remains
unclear and needs to be further analyzed.
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2.4 A activated resin as novel tool for affinity chromatography
Affinity chromatography is a crucial technique in biochemistry. It allows purification
of proteins or protein complexes of interest from heterogenous protein mixtures, e.g. a
cell lysate, but it also allows to study binding interactions to a particular protein or
substance. The technique is based on the interaction between two molecules. These can
be two proteins, e.g. an antibody and its corresponding antigen, but also receptor-ligand
pairs as it is the case for streptavidin and biotin. For affinity chromatography, one of the
interaction partners is immobilized on a stationary phase (Sepharose, silica or magnetic
beads) whereas the other partner either is the protein of interest itself or additionally
attached to the protein of interest. Attachment occurs either by creating fusion constructs
or by chemical modification. When applying a protein mixture to the stationary phase, the
affinity tag-containing protein of interest can specifically bind to the resin, whereas other
proteins cannot. Many proteins, such as streptavidin or ProteinA can be immobilized to
the stationary phase. These systems are commercially available and are well established
tools. Other proteins, such as nanobodies or affibodies can be used for immobilization as
well. Nonetheless, a toolbox allowing to easily create tailor-made affinity resins specifically
for a desired target protein and the corresponding experiment, would be highly beneficial
for many applications in protein biochemistry.
Figure 2.14: Coupling chemistry using maleimide and MADA
Peptides or proteins can be immobilized to a solid material by functionally activating the phase with maleimide
derivatives forming a stable thioester conjugate upon reaction with thiol groups on the peptide. A shows the reaction
occurring when using maleimide, B shows the reaction utilizing MADA.
Here, a MADA activated resin is presented, to which proteins containing reduced cysteins
can be covalently attached. The chemistry can be applied to Sepharose, silica and mag-
netic beads and thus further broadens the field of applications.
Immobilization of a ligand to a solid phase requires the activation of the phase with a com-
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pound reactive towards a functional group present on the ligand, most commonly used
are primary amines or thiol groups. Thiol groups can be found in the side chains of cys-
teins and coupling is mainly performed by utilizing haloacetamide derivatives. Maleimids
and maleimid derivatives can be alternatively used for immobilization of ligands via thiol
groups (see figure 2.14, A and B).
We use here matrices into which MADA groups had been introduced by solid-phase chemi-
cal synthesis, starting either from amino-substituted Sepharose or aminopropyl trimethoxy
silane-modified silica particles (prepared by Prof. Dirk Görlich).
2.4.1 MADA Matrix is highly specific for reduced cysteins
The created MADA 2B Sepharose was analyzed for its coupling specificity towards pro-
teins with reduced cysteins (figure 2.15). Therefore mCherry and mCherrycys were recom-
binantly expressed and purified and both proteins were freshly reduced with 10mM DTT.
Note that mCherry itself does not contain any cysteins.
Figure 2.15: MADA matrix is highly specific towards reduced cysteins
500µl 5µM mCherry or mCherrycys solution (recombinantly expressed, purified and freshly reduced with 10mM
DTT prior to use) were incubated with 50µl MADA 2B Sepharose. Input: 5µM protein diluted in 5005µM buffer
(50mM Tris/HCl pH 7.5, 500mM NaCl); Beads after incubation: settled beads after 1h incubation at RT; Flow
Through: non-bound fraction after incubation; Beads: MADA 2B Sepharose after washing
Next, 5µM of each protein was diluted in 500µl buffer (50mM Tris/HCl pH 7.5, 500mM
NaCl, Input) and added to 50µl MADA 2B Sepharose. After 1h incubation at RT, a
covalent binding of mCherrycys to the beads was observed, whereas mCherry lacking the C-
terminal cystein did not show accumulation on the beads (Beads after incubation). Hence,
the collected flow through shows a high fluorescence in case of mCherry, whereas only a
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faint fluorescence can be observed in the mCherrycys sample (Flow through). Finally,
after extensive washing (50mM Tris/HCl pH 7.5, 500mM NaCl), the beads were analyzed
(Beads), showing no binding of mCherry, whereas mCherrycys significantly enriches on the
beads.
This data shows that the covalent coupling of proteins to the matrix happens exclusively
via the reduced cysteins.
2.4.1.1 Evaluation of coupling under various conditions
The coupling ability of the MADA 2B Sepharose towards proteins containing reduced
cysteins should ideally tolerate a variety of buffer system. Therefore, the initial experiment
was repeated using three different buffers: the previously tested Tris-based buffer (50mM
Tris/HCl pH 7.5, 500mM NaCl), a potassium phosphate-based buffer (20mM K2HPO4
pH7.4, 500mM NaCl) and a Hepes-based buffer system (20mM Hepes/KOH pH7.4, 500mM
NaCl). The salt concentration was kept constant at 500mM NaCl. As shown in figure
2.16A the coupling specificity towards proteins with reduced cysteins could be observed
in all three tested buffer systems: mCherrycys covalently attaches to the resin whereas
mCherry without a cystein does not attach.
Figure 2.16: Evaluation of coupling under various conditions
(A): 500µl 5µM freshly reduced mCherry and mCherrycys were coupled to 50µl MADA resin under different buffer
conditions. Pictures were taken from the Input, the beads after incubation, the Flow Through and the beads after
washing. (B): 500µl 5µM freshly reduced mCherrycys was coupled to 50µl MADA resin in Tris buffer (50mM
Tris/HCl pH 7.5, 500mM NaCl) containing various additives (1mM DTT, 1mM TCEP, 1mM NaBH4, 1% NaN3).
Pictures were taken from the Input, the beads after incubation, the Flow Through and the beads after washing.
It is known that even trace amounts of free DTT (Dithiothreitol) in the protein sample
interfere with covalent attachment of the protein to a maleimide activated resin. DTT
itself has a thiol group and thus can covalently attach to the maleimide itself (see figure
2.16B, second column). That means, after fresh reduction of the cystein using DTT, the
sample needs to be rebuffered to a DTT free solution prior to coupling. To possibly avoid
2.4 A activated resin as novel tool for affinity chromatography 54
this time consuming step, it was tested, whether other reducing agents such as TCEP
(Tris(2-chloroethyl) phosphate) or NaBH4 (Sodium borohydride) would permit coupling.
In addition, the effect of sodium azide (NaN3) was analyzed, due to the fact that the
compound is frequently used as additive for long time storage of materials.
Figure 2.16B shows the corresponding coupling assay. The coupling reactions were per-
formed in a Tris buffer system (50mM Tris/HCl pH7.5, 500mM NaCl). As expected, 1mM
DTT abolishes coupling of mCherrycys to the resin completely, as does the reducing agent
TCEP by presumably reacting with the MADA double bond. However, neither 1mM
NaBH4, which also has an reducing effect, nor the additive NaN3 hinder mCherrycys to
covalently attach to the MADA 2B Sepharose.
To evaluate further tolerable coupling conditions, different salt concentrations and pH
values will be tested in the future. Additionally, various conditions for long-term storage
conditions of the MADA resin will be analyzed.
2.4.2 MADA matrix capacity and background
Next, the capacity of the MADA 2B Sepharose for direct coupling of ProteinA and strepta-
vidin was analyzed as well as the unspecific binding of proteins to the resin upon incubation
with lysate (figure 2.17).
First, a constant amount of MADA Sepharose (20µl) was incubated with increasing con-
centrations of Streptavidin (0.5µg/µl beads - 5µg/µl beads) diluted in 200µl Tris buffer
(50mM Tris/HCl pH7.5, 500mM NaCl). Input and flow through samples were analyzed
by SDS-PAGE. Slight amounts of non-bound streptavidin can be detected in the flow
through sample after addition of 5µg/µl streptavidin. The other flow through samples do
not contain any unbound protein (figure 2.17A). Hence, the MADA 2B Sepharose tested
seems to have a capacity of ∼4µg streptavidin/µl beads.
Next, not only the capacity for the direct coupling of ProteinA to the MADA 2B Sepharose,
but also the capacity for binding of the affinity partner (here IgGs) was analyzed. There-
fore a constant amount of MADA 2B Sepharose (20µl) was first incubated with increasing
amounts of freshly reduced ProteinA (0µg/µl beads - 5µg/µl beads), followed by incuba-
tion with rabbit sera. The bound IgGs were eluted by SDS loading buffer and analyzed
by SDS-PAGE (figure 2.17B). When looking at the flow through sample, it is obvious that
the ProteinA sample used for coupling was not fully reduced. The non-bound fraction
detectable in the first samples with rather low concentrations of ProteinA might resemble
this non-reduced pool. Nonetheless, a significant portion of ProteinA is able to covalently
attach to the beads (estimated by comparing Input and flow through sample intensity).
With increasing ProteinA concentrations on the beads, the amount of IgGs pulled out
increases as well (only IgG heavy chain is shown). Enrichment of IgGs reaches a plateau
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Figure 2.17: MADA matrix capacity and background
(A): Streptavidin with a C-terminal cystein was freshly reduced and coupled to the MADA resin in concentrations
from 0.5 to 5µg/µl beads. The input and flow through samples were loaded on SDS-PAGE to estimate the binding
capacity of the resin. (B): ProteinA with a C-terminal cystein was freshly reduced and coupled to the MADA resin
in concentrations from 0 to 5µg/µl beads. The beads were further incubated with rabbit sera (diluted 1:3 with
1xPBS) in order to pull out IgGs. The binding capacity of ProteinA to the matrix was analyzed by loading input
and flow through samples to SDS-PAGE. In addition, IgGs bound to the resin were eluted with SDS and analyzed
by SDS-PAGE as well (only heavy chain shown here). (C): Commercially available magnetic streptavidin beads
and MADA magnetic streptavidin beads were analyzed for their background binding when incubated with HeLa S10
lysate. (1) MyOneTMStreptavidin T1 (Invitrogen) (2) Streptavidin MADA magnetic beads quenched with 0.1M
β-mercaptoethanol. All samples were analyzed by using gradient polyacrylamide gels.
at a concentration of ∼4µg ProteinA/µl MADA 2B Sepharose.
Finally, the background binding of proteins to the resin was analyzed. Here, two different
streptavidin magnetic beads were incubated with HeLa S10 lysate (adjusted to 50mM
Tris/HCl pH7.5, 300mM NaCl) for 1h at 4℃. The beads were briefly washed, the bound
proteins were subsequently eluted with SDS loading buffer and analyzed by SDS-PAGE
(figure 2.17C). The first lane shows the background binding on commercially available
MyOneTM beads (Invitrogen). A significant number of proteins binds the resin unspecif-
ically, which is disadvantageous when performing highly sensitive binding assays. Lane 2
represents the background binding of the HeLa cell lysate to streptavidin MADA magnetic
beads generated in this study and quenched with 0.1M β-mercaptoethanol after strepta-
vidin immobilization. The resin shows significantly less background binding as compared
to the commercial streptavidin beads. Remaining contaminants could possibly be further
reduced by prolonging the washing procedure prior to elution.
In summary, the MADA chemistry introduced on Sepharose and magnetic beads shows a
high specificity towards reduced cysteins. The resins show an adequate capacity towards
its direct coupling partners and significantly less background binding as compared to com-
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mercial available products can be observed. These features are beneficial for biochemical
approaches and thus can now be used for a wide range of different approaches.
2.4.3 MADA matrix can be used for a variety of applications
The chemistry for a MADA activated resin can be introduced to a variety of stationary
phase substances such as silica, Sepharose or magnetic beads. Further, a multitude of
different proteins can be covalently attached to the resin via thiol groups present in cys-
tein side chains. This modularity allows the use of MADA resins in a broad range of
applications. Some possible applications will be described in the following chapter.
2.4.3.1 ZZ-Affibody MADA matrix shows less background as commercial IgG
matrix
A commonly used affinity tag system is ProteinA (or its engineered ZZ-domain) recogniz-
ing the Fc region of antibodies. Proteins fused to ProteinA or the ZZ-domain are hence
able to bind IgG Sepharose, which acts as the stationary phase. However, commercial IgG
Sepharose (GE Healthcare) shows strong background binding mainly under low salt con-
ditions. Here, the commercial IgG Sepharose was compared with a ZZ-affibody MADA 2B
Sepharose. The affibody ZpA963 binds a five-domain ProteinA fragment with an average
KD=24nM and is further able to bind to each of the five domains individually with similar
kinetics (Lindborg et al., 2013). The affibody was recombinantly expressed in E.coli and
purified by affinity chromatography prior to coupling to the MADA resin by a reduced
cystein introduced to the C-terminus of the affibody.
First, the two resins were incubated with E.coli lysate prepared with different salt con-
centrations (10-500mM NaCl in 50mM Tris/HCl pH 7.5). After 1h incubation, the beads
were washed with the corresponding buffer and the unspecifically binding proteins were
eluted with SDS loading buffer and analyzed by SDS-PAGE (figure 2.18A). IgG Sepharose
shows significant unspecific background binding of proteins over a broad size range when
incubated with low salt E.coli lysate (10mM NaCl). The ZpA963 MADA resin in contrast
shows less background binding. Bands can be observed however, in comparison to the
IgG Sepharose these are significantly weaker. Nevertheless the unspecific binding must
be further reduced to ideally end with an inert resin towards background binding. With
increasing salt concentrations, the background binding of the IgG Sepharose decreases,
however it still remains higher as compared to the ZpA963 MADA resin under all tested
conditions. In addition, when eluting the bound proteins from the IgG Sepharose with
SDS loading buffer, the IgGs heavy and light chain elute as well.
Next, the ZpA963 MADA Sepharose and the IgG Sepharose were compared in binding
assays with ZZ-tagged Ran (construct: H14-ZZ-SUMOStar-RanQ69L5-180). Ran was in-
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Figure 2.18: Comparing commercial IgG Sepharose and ZZ-affibody MADA Sepharose
(A): Background binding of E.coli lysate to either IgG Sepharose or ZpA963 MADA resin (affibody ZpA963 (Lind-
borg et al., 2013) recognizing the ZZ-domain was expressed and purified, reduced and coupled to MADA resin) was
compared under different salt conditions (10mM, 50mM, 100mM, 250mM and 500mM NaCl in 50mM Tris/HCl,
pH7.5). The proteins unspecifically binding to the resin were eluted with SDS and analyzed by SDS-PAGE. (B):
Pull-out experiments were performed with IgG Sepharose (right panel) and ZpA963 MADA resin (left panel). H14-
ZZ-SUMOStar-tagged Ran was incubated with HeLa S10 lysate (20mM Tris/HCl pH7.5, 100mM NaCl) and was
subsequently pulled out using the two different resins. Elution was performed by protease elution and subsequent
SDS elution (indicated with +). All samples were analyzed by SDS-PAGE using gradient polyacrylamide gels.
cubated with HeLa S10 lysate (adjusted to 20mM Tris/HCl pH7.5, 100mM NaCl) and
subsequently pulled out by either the affibody or the IgG Sepharose. The beads were
washed with the low salt buffer, pre-eluted with SumoStar protease and subsequently
eluted with SDS loading buffer. Both resins were able to efficiently pull out Ran and its
binding partners (mainly nuclear transport receptors) from the lysate (see figure 2.18B).
Elution with the protease results in a clean elution of cleaved Ran and the NTRs, the sub-
sequent SDS loading buffer elution contains also other, presumably unspecifically binding
proteins. However, the amount of unspecifically binding proteins seems to be higher when
using IgGsSepharose. In addition, the IgG comes off the resin when elution is performed
with SDS loading buffer resulting in a prominent band on the gel (∼25kDa) that might
interfere with proper evaluation of data.
In conclusion, the ZpA963 MADA resin is more suitable for pull-out experiments or bind-
ing studies recognizing ZZ-tagged proteins. The efficiency of pulling out bait proteins and
their associated binding partners is comparable to commercial available IgG Sepharose,
nevertheless the background binding to the affibody MADA resin is significantly lower as
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compared to IgG Sepharose. This can be observed mainly under low salt conditions which
are often required when analyzing low affinity interactions between proteins.
2.4.3.2 ProteinA MADA matrix can be used for IP experiments
Immunoprecipitation (IP) experiments are a powerful tool to analyze the composition and
binding interaction of native complexes in vitro. This approach usually requires a Pro-
teinA stationary phase to which IgGs against the target protein are covalently attached
(for experimental details see 4.2.5.4). The beads are then incubated with a lysate of
choice containing the target proteins. After extensive washing, the IgG bound proteins
are eluted by low pH buffers. During this study, IP experiments were performed to ana-
lyze the composition of the endogenous wheat eIF3 complex. The stationary phase used
during these experiments was 4B Sepharose activated with maleimide. ProteinA was at-
tached via its reduced cystein. However, unspecific background binding to the resin was
high and the wheat extract needed to be pre-depleted by ProteinA Sepharose without at-
tached antibodies to result in final elution samples that could be further analyzed by mass
spectrometry (see figure 2.5). The additional depletion step should be neglectable when
using the new MADA 2B Sepharose, as it was previously shown to have significantly less
background binding. To test this aspect, ProteinA was covalently coupled to the MADA
2B Sepharose and subsequently antibodies against wheat initiation factors were attached.
IP experiments were performed without any pre-depletion of the extract and the resulting
elution samples were analyzed by SDS-PAGE and mass spectrometry (see figure 2.19).
IP experiments were performed using antibodies against wheat eIF1, eIF2α and eIF2Bβ.
In all samples, the target protein was efficiently pulled out from the extract. eIF1 does not
co-precipitate in a stochiometric manner with any other protein, which was also expected
as eIF1 is not known to stably interact in multisubunit complexes. When pulling out
eIF2α from the wheat germ extract, stochiometric co-precipitation of eIF2β and eIF2γ
was observed. The three subunits form the naturally occurring, stable eIF2 complex.
When pulling out eIF2Bβ from the extract, the associated complex, comprised out of 5
subunits (eIF2Bα - eIF2Bε) can be co-purified in a stochiometric manner. Additional
bands in the eIF2α and the eIF2Bβ IP experiment can be observed. These were identi-
fied to be ribosomal proteins (marked with asterisks, figure 2.19). It needs to be further
elucidated if these proteins do interact with the resin in an unspecific manner of if they
indeed interact with the translation complexes precipitated. Same holds true for the faint
smir that can be observed at around ∼60kDa.
Although a certain level of unspecific binding could be observed, the purity of the elution
samples greatly increased in comparison to previously performed IP experiments by switch-
ing from 4B maleimide Sepharose to 2B Sepharose using the MADA activation chemistry
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Figure 2.19: IP experiments with MADA ProteinA Sepharose
Freshly reduced recombinant ProteinA was coupled to the MADA 2B Sepharose in a concentration of 3µg/µl.
Subsequently, IgGs were covalently attached as described in 4.2.5.3 and IP experiments were performed as described
in 4.2.5.4. Here, antibodies against eIF1, eIF2α and eIF2Bβ were used. Samples were analyzed by SDS-PAGE
(12% polyacrylamide gel) and stained using Colloidal Coomassie. The bands were identified by mass spectrometry.
Bands marked with asterisks were identified as ribosomal proteins.
(see figure 2.5). Pre-clearing of the wheat germ extract was not required. However, the
captured proteins or complexes are eluted from the IgGs by acidic elution, precipitated
and then analyzed further. A purification of complexes under native conditions is not
applicable by this method.
2.4.3.3 Large complexes can be pulled out by MADA matrix
A major advantage of MADA activated resins is that potentially every protein can be
covalently attached to it as long as it contains an exposed and reduced cystein that is not
functionally relevant in context of the protein itself or interactions of the protein towards
other polypeptides. Here, this feature is exploited with the aim to purify large complexes
in a native manner from lysates (in contrast to the IP technique, where proteins are eluted
under extremely acidic conditions). Figure 2.20A shows the designed construct that had
been attached to the MADA 2B Sepharose in the following experiment. It contains an
N-terminal His-tag for purification from E.coli lysate, followed by a binding domain and a
protease cleavage site. At the very C-terminus, an exposed cystein is located for covalent
attachment to the resin. The binding domain can be varied depending on the individual
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approach, e.g. a ZZ-domain recognizing IgGs or the ZZ-affibody recognizing ZZ-tagged
proteins or complexes. The protease cleavage site is required for elution of the bound
proteins by specific protease cleavage.
Figure 2.20: Large complexes can be pulled out by MADA magnetic beads
(A): Schematic representation of the construct covalently attached to the 2B MADA Sepharose in B. The N-terminal
His tag was used for affinity purification of the construct. The following binding domain can be either ZZ-domain,
the ZZ-affibody (ZpA963) or streptavidin. This domain enables to pull-out the target protein from an extract. Next,
a protease cleavage site for specific protease elution was included. The C-terminal cystein allows efficient coupling
to the MADA resin. (B): To pull out large complexes such as eIF3 from wheat extract, the affinity construct
containing a ZZ-domain as binding domain was coupled to the MADA resin. In parallel, WGE was incubated
with antibodies against eIF3c, eIF3d and eIF3m. Subsequently, the IgG supplemented WGE was incubated with
the beads. After thorough washing, the elution via SUMOStar cleavage followed. Elution samples were taken and
analyzed by SDS-PAGE. To remove the remaining parts of the affinity construct, the α-eIF3d elution (Input) was
loaded on ZZ-Affibody MADA Sepharose. The flow through should now contain the complex, the remaining tag
should attach to the column. Input, Flow through and SDS elution samples were analyzed by SDS-PAGE. eIF3
complex pull out can be seen in the left panel, the removal of the tag in the right panel. JS395 expression construct:
H14-ZZ-domain-SUMOStar-Spacer-Cys
As proof of principle, the system was used to purify the ∼800kDa eIF3 complex from
the wheat germ extract. The binding construct, containing the ZZ-domain as binding
domain, was covalently coupled to the MADA 2B Sepharose. In parallel, the wheat germ
extract was supplemented with antibodies raised against eIF3c, eIF3d and eIF3m. Note
that the antibodies were not covalently attached to the resin as in IP experiments. Af-
ter incubation the binding construct coupled MADA resin was incubated with the IgG
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supplemented WGE. After 1h incubation, the beads were thoroughly washed, elution was
performed using SUMOStar protease and the samples were analyzed by SDS-PAGE. The
SUMOStar cleavage site was used in this experiment due to the fact that it can not be
cleaved by any endogenous proteases in the extract (Panavas et al., 2009). Note that the
complexes were eluted in neutral pH Tris buffer and thus can be potentially used for any
further experiments right away.
Figure 2.20B (left panel) shows the protease elution fractions. The control sample repre-
sents the pull-out from wheat germ extract, which was not supplemented with IgGs. The
background is significantly low. The predominant band at ∼30kDa represents the cleaved
tag: H14-ZZ-SUMOStar. When the wheat germ extract was supplemented with antibodies
recognizing single subunits of the eIF3 complex, the entire complex can be co-purified in
a stochiometric manner. Again, the cleaved binding construct can be seen in the elution
as well. Note the IgG heavy chain running at ∼50kDa.
In order to remove the remaining binding construct (H14-ZZ-SUMOStar), the elution frac-
tion was incubated with the ZZ-affibody MADA resin, described in 2.4.3.1. The ZZ-domain
binds to the resin, whereas the eIF3-IgG complex passes the resin without binding. This
can be seen in figure 2.20B (right panel). The amount of binding construct is significantly
reduced in the flow through fraction, whereas it enriches on the beads as shown in the
elution fraction (SDS loading buffer).
Here, a system is presented to specifically pull out large complexes from a cell lysate in a
native manner by affinity chromatography. We suggest that the system is not yet at its
limit and can be further exploited to purify even larger objects such as ribosomes. These
can be genomically tagged with a ZZ-domain, respectively, and can then be pulled out
directly by a binding construct containing the ZZ-affibody. In principle, entire organelles
such as mitochondria can be natively affinity purified from a lysate by using the MADA
resin to which a suitable binding construct is covalently attached.
2.4.3.4 MADA - Streptavidin matrix
Streptavidin is a 16 kDa protein naturally produced by the bacteria Streptomyces avidinii
and able to bind biotin with an affinity of KD=10
-14M (Tausig and Wolf, 1964; Green,
1990). Due to this very strong interaction streptavidin became a powerful tool for the
purification and characterization of biotinylated substrates. In the following experiment,
streptavidin was covalently attached to the MADA 2B Sepharose.
Streptavidin, containing an exposed C-terminal cystein, was expressed in E.coli and fur-
ther purified. After coupling the protein to the MADA 2B Sepharose, the resin was
incubated with either E.coli lysate alone to analyze the background binding or with E.coli
lysate supplemented with in vivo biotinylated Ataxin or Nup98 anchor domain (supplied
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by Metin Aksu and Tino Pleiner). Elution was performed using SDS loading buffer at
95℃ to break the streptavidin:biotin bond.
Figure 2.21: Streptavidin MADA Sepharose efficiently pulls out biotinylated bait from an extract
Reduced streptavidin was coupled to MADA 2B Sepharose beads, which were incubated with either E.coli lysate
only or E.coli lysate supplemented with in vivo biotinylated ataxin or Nup98 anchor domain. The beads were
thoroughly washed after incubation and the bound proteins were eluted with SDS loading buffer at 95℃. Samples
were taken from the lysate input (Input) the flow through after 1h incubation (flow through) and the SDS elution.
The samples were analyzed by SDS-PAGE using gradient polyacrylamide gels. During elution, streptavidin leaks
off the resin, marked with asterisks.
When the resin was incubated with E.coli lysate only, the elution sample contained only
streptavidin running at ∼17kDa but no additional unspecifically binding proteins, which
once more shows the low background binding of proteins to the resin (figure 2.21). The
presence of streptavidin in the elution sample can be explained by the following: strep-
tavidin forms a homo-tetramer. As soon as not all of the four subunits are covalently
attached to the Sepharose, non covalent streptavidin subunits leak off the resin upon SDS
elution. When E.coli lysate supplemented with biotinylated bait proteins (here Ataxin
or the Nup98 anchor domain) was added to the beads, the bait proteins enriched on the
beads and could be eluted from the resin. Similar experiments were also performed with
streptavidin coupled to magnetic MADA beads, again showing specific enrichment of bi-
otinylated proteins, whereas overall background binding remains low.
Although the streptavidin MADA 2B Sepharose performed extremely well as affinity resin
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for biotinylated proteins, it is however challenging to obtain large amounts of recom-
binantly expressed and purified streptavidin in a biotin free form, which is required to
produce streptavidin matrix in feasible amounts. Without an N-terminal fusion tag, strep-
tavidin expresses in an insoluble manner. Fusion to larger, solubility enhancing tags such
as IF2domain-MBP increase solubility (Sørensen et al., 2003), nevertheless the problem
persists that upon purification under native conditions pre-bound biotin (present in E.coli)
will be co-purified. When coupling at least partially biotin bound streptavidin to a resin
for affinity purification, the capacity of the resin towards biotinylated bait proteins would
be extremely low. Besides the problematic expression and purification of recombinant
streptavidin, it additionally assembles to a tetrameric complex of streptavidin which could
cause steric hinderance once immobilized to a resin and leads to leakage (see figure 2.21).
Furthermore, proteins purified by streptavidin resins need to be chemically or enzymati-
cally modified in order to introduce the biotinylation. Most common, a biotinylatioon site
is introduced to the bait protein (e.g. Avi-tag), which can be either in vivo or in vitro
biotinylated by the enzyme BirA (Schatz, 1993).
An ideal protein:ligand pair for affinity chromatography would meet the following param-
eters: (1) extremely high affinity towards each other (2) both individual molecules should
be small and monomeric (3) expression and purification should be simple and result in
large amounts of recombinant protein (4) no further modification should be required (5)
the proteins should not contain disulfide-bonds, as these might complicate the coupling of
the protein to the MADA resin. In the following section, an affinity pair fulfilling all these
criteria will be presented.
2.5 Barnase:Barstar as novel affinity tag system
Barnase is an extracellular ribonuclease produced by the bacterium Bacillus amylolique-
faciens. It is a small, single chain protein with a molecular weight of 13kDa that does not
contain any disulfide bonds or relies on any non-peptide components for proper folding and
function. To protect itself towards the toxic effects of the ribonuclease, Bacillus amyloliq-
uefaciens also produces an intracellular inhibitor specific towards Barnase, termed Barstar.
Barstar is a single chain protein as well with a molecular weight of 11kDa. It contains two
cysteins residues that do not form a disulfide-bond. Barnase and Barstar form a 1:1 non-
covalent complex, thereby completely preventing Barnase toxicity (reviewed in Hartley,
1989). The barnase:barstar complex is known to bind with extremely high affinities with a
KD=10
-14M (Schreiber and Fersht, 1993). So far, studies on the Barnase:Barstar complex
were mostly performed by co-expression of the two proteins. The individual expression of
Barnase in E.coli respectively, would cause lethality of the cells.
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2.5.1 Identification of Barstar mutants as binding partner for enzymatically
inactive Barnase versions
To use Barnase and Barstar as an affinity tag pair, it is essential to produce both proteins
separately. However, when expressed alone, the ribonuclease Barnase is highly toxic. The
catalytic residues are Glu73 and His102 acting together in a general acid-base mechanism.
By mutating one of the catalytic residues, the toxicity of Barnase is impaired and the pro-
tein can be expressed in E.coli even without its inhibitor. However, mutations of His102
to other residues weakens the affinity towards barstar. When mutating the His102 residue
to aspartic acid or glutamine, the binding affinity decreases to KD=1.3
-10M, replacement
by alanine leads to a KD=7
-9M (Hartley, 1993).
In order to detoxify Barnase, the catalytic histidine residue was mutagenized to alanine,
phenylalanine, methionine or aspartic acid. To compensate for a decrease in binding affin-
ity, a cysteins residue on Barstar (Cys42) was mutated as well to either alanine, valine,
isoleucine or lysine. Replacements by alanine served as control, introduction of hydropho-
bic residues to both proteins should provide a hydrophobic docking site, the introduction
of the negatively charged aspartic acid and the positively charged lysine could potentially
lead to the formation of a shielded salt bridge in the interior of the complex.
To find the strongest pair among these mutations, competition experiments were per-
formed. For these, the barnase versions were either fused to H14- or H14-brSUMO; the
Barstar versions were fused to ZZ- or ZZ-brNEDD8 tags. All constructs were expressed
in E.coli and resulted in lysates containing soluble protein. This already shows that the
introduced mutations in Barnase are sufficient to prevent Barnase toxicity.
Figure 2.22 shows a competition experiment where H14-BarnaseH102D:Barstar complexes
were pulled out by 6% Ni2+-chelate 500Å silica. The complexes formed in an E.coli
lysate mixture containing Barnase and different Barstar versions either fused to ZZ- or
ZZ-brNEDD8 tag (the tags ensure a size difference of the constructs and thus a discrimina-
tion of two Barstar versions). As control, each Barstar version was individually incubated
with the BarnaseH102D, showing that all of them are able to bind BarnaseH102D (lane 1-8).
Next, two Barstar versions were mixed and added. The version with a stronger affinity
towards Barnase should outcompete the other and thus should be more enriched on the
resin. For BarnaseH102D, BarstarC42K shows the strongest binding. In presence of this mu-
tant, all other versions can not be pulled out by Barnase. BarstarC42A and BarstarC42V
bind equally strong, whereas BarstarC42I is outcompeted by all other mutations. We as-
sume that the isoleucine residue might sterically clash upon complex formation, still enable
BarstarC42I to bind but disfavored in comparison to the other Barstar variants.
The same experiments were performed with the Barstar mutants on the other Barnase
versions with the following results:
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Figure 2.22: BarnaseH102D and BarstarC42K as ideal affinity pair
E.coli lysate containing H14-BarnaseH102D was incubated with lysates containing various Barstar mutants (C42
mutated to either K, A, V or I) tagged with ZZ-brNEDD8-tag or ZZ-tag. The formed complexes were bound to 6%
Ni2+-chelate 500Å silica and eluted with SDS loading buffer. The Barstar mutants were either incubated separately
with the Barnase lysate or two Barstar versions were added simultaneously to see which mutant has a higher affinity
towards the Barnase. All samples were analyzed by SDS-PAGE.
BarnaseH102F BarstarC42V > BarstarC42A > BarstarC42I
BarstarC42K does not bind
BarnaseH102M No difference between BarstarC42V, BarstarC42A and BarstarC42I
BarstarC42K does not bind
BarnaseH102A BarstarC42V > BarstarC42A > BarstarC42I
BarstarC42K does not bind
Interestingly, BarstarC42K is only able to bind to Barnase if the histidine residue is mu-
tated to an aspartic acid. Most likely, the positive charge on the lysine side chain and the
negative charge on aspartic acid form a stable, shielded salt bridge in the protein complex
interior, thereby drastically increasing the stability of the complex. When introducing hy-
drophobic amino acids to Barnase, the BarstarC42V mutant is slightly advantageous over
the BarstarC42A version, possibly explainable by hydrophobic interactions on the complex
interface.
Next, the salt sensitivity of the BarnaseH102D and BarstarC42K pair was analyzed. When
using it as a tag system in affinity chromatography, a stable interaction even under high
salt conditions is beneficial. The H14-tagged Barnase was immobilized on 6% Ni
2+-chelate
500Å silica and the beads were incubated with a lysate containing ZZ-brNEDD8-tagged
Barstar. Complexes were formed in 50mM Tris pH7.5, 300mM NaCl. Next, the beads were
continuously washed for ∼20 minutes with buffer containing increasing salt concentrations
(300mM NaCl - 4.75M NaCl) and subsequently eluted with SDS loading buffer. As con-
trol, beads were only briefly washed with the 300mM NaCl buffer and the complex was
immediately eluted with SDS loading buffer (control). The elution samples were analyzed
by SDS-PAGE to see if the complex dissociates with increasing ionic strength. Figure
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2.23 shows that even under very high salt conditions (4.75M NaCl), the complex remains
stable and both proteins can be eluted from the column as a stochiometric complex.
Figure 2.23: BarnaseH102D:BarstarC42K complex is extremely salt tolerant
His-tagged BarnaseH102D was bound to 6% Ni
2+-chelate 500Å silica (red box). Subsequently, ZZ-brNEDD8 tagged
BarstarC42K was added and the complex was formed on the beads. After thorough washing with a buffer containing
300mM NaCl, the complexes were washed for 20 minutes (constant flow) with buffers containing increasing salt
concentrations (300mM-4.75M NaCl). As control, the beads were washed only once with 300mM NaCl buffer and
eluted immediately with SDS loading buffer (control). After washing, the remaining protein on the beads was eluted
with SDS loading buffer. All samples were analyzed by SDS-PAGE using a gradient polyacrylamide gel.
In summary, the BarnaseH102D and BarstarC42K pair seems to be a highly stable and
thus well suited pair for further use as tag system and was therefore chosen to be further
characterized.
2.5.2 Structure determination of Barnase:Barstar complex
To learn more about the BarnaseH102D:BarstarC42K complex, the two proteins were indi-
vidually expressed in E.coli either tagged with H14-brSUMO or ZZ-brNEDD8. The lysates
were mixed and purified according to Frey and Görlich (2014b), resulting in pure and sto-
chiometric complexes as shown in figure 2.24A. The lysate mix was applied to 6% Ni2+-
chelate 500Å silica and elution was performed by SENP1 (SUMO Elution). The elution
fraction was subsequently applied to the ZZ-affibody resin, to which the ZZ-tagged Barstar
in complex with Barnase can bind. Non-complexed Barnase does not bind the resin and
passes through the column. Elution was performed using NEDP1 protease (NEDD8 Elu-
tion). The pooled elution fractions, containing the stochiometric Barnase:Barstar complex
were additionally purified by gel filtration using a SD200 16/60 (GE Healthcare) column.
The gel filtration profile and the peak fractions on SDS-PAGE are shown in 2.24B. The
two proteins form a stable complex as no dissociation of one component can be observed
and the absorption peak shows a high symmetry. The complex containing fractions were
pooled and concentrated to 10mg/ml in 20mM Tris/HCl pH7.5, 100mM NaCl, 1mM DTT.
These samples were used by Dr. Sergei Trakhanov for successful crystallization trails. The
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Figure 2.24: Purifying the BarnaseH102D:BarstarC42K complex
(A) Purification of a stochiometric and highly pure BarnaseH102D:BarstarC42K complex using a purification ap-
proach with two affinity chromatography steps and two orthogonal protease systems (Frey and Görlich, 2014b).
H14-brSUMO-BarnaseH102D and ZZ-brNEDD8-BarstarC42K were individually expressed in E.coli. Samples were
taken before induction(bi), after induction (ai), after lysis using sonication (aL) and from the supernatant after
ultracentrifugation (aUZ). Subsequently, the two lysates were mixed (Input (Ni beads)) and incubated with 6%
Ni2+-chelate 500Å silica. The flow through was collected (Flow through) and elution was performed using 0.1µM
SENP1 protease (SUMO Elution). The eluted fraction was subsequently incubated with ZZ-affibody MADA beads
(Input (Affibody beads)), the flow through was collected (Flow through) and elution was performed with 1µM
NEDP1 protease (NEDD8 Elution). This step was repeated due to high protein content in flow through fraction
(flow through 2 and NEDD8 elution 2). The elution fractions were pooled and run over SD75 16/60 gelfiltration
column (Input Gefi). The elution fractions were pooled (Gefi pool), concentrated and used for crystallization trials.
(B) Gel filtration chromatogram and peak fractions on SDS-PAGE.
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complex crystallized in the following conditions and diffracted to a resolution of 1.98Å:
50mM BTP-citrate pH 7.1, 1.2M LiCl, 15% PEG 6000. The structure was solved by
Dr. Sergei Trakhanov by molecular replacement using the crystal structure published by
Buckle et al. (1994) (pdb code: 1BRS). Crystallization details are presented in table 4.5.
Figure 2.25: Crystal structure of the BarnaseH102D:BarstarC42K complex
The crystal structure of the BarnaseH102D:BarstarC42K complex was solved at a resolution of 1.98Å using molecular
replacement. The Barnase molecule is marked in magenta, the Barstar molecule in green, Barstars α-helix2 is
marked in yellow. The mutated residues (H102D on Barnase and C42K on Barstar) are represented as sticks, red
marks the oxygen atoms, blue the nitrogen atoms.The distance between the residues was measured and is shown by
the black dashed line.
Figure 2.25 shows the crystal structure of the BarnaseH102D:BarstarC42K complex at a
resolution of 1.98Å. The Barnase molecule is presented in magenta, the Barstar protein in
green. The mutated residues Asp102 on Barnase and Lys42 on Barstar are highlighted in
white, showing the nitrogen atoms in blue and the oxygen atoms in red. In addition, the
distance between the two side chains was measured to be 2.7Å and thus a close enough
proximity to form a stabilizing salt bridge. The Barnase protein shows the characteristic
antiparallel β-sheet and the α-helix packed against one side of the sheet. The Barstar
protein shows a parallel β-sheet and four α-helix regions. α-helix2 (shown in yellow)
reaches into the catalytic center of Barnase. In a wild type situation, this intrusion is
known to block the ribonuclease activity of Barnase (see figure 1.7).
2.5.3 Protein Evolution on Barstar
For further experiments, the Barstar protein was fused to a variety of different N-terminal
fusion tags, such as H14-brSUMO or H14-MBP-brSUMO, and subsequently expressed in
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E.coli. Surprisingly, these constructs lead to insoluble protein (data not shown). In
previous trails Barstar was fused to ZZ- or ZZ-brNEDD8 resulted in high amounts of
soluble protein.
For usage of the Barnase:Barstar pair as affinity tag system, it is of great importance
that both proteins can be expressed to high levels in a soluble manner. Large amounts
of recombinantly purified proteins will be required for coupling to the MADA resin but
also when the protein as a fusion tag, it should support folding and thus solubility of the
fusion partner. The Barnase protein fulfills these criteria, however, the Barstar protein
requires further improvement.
2.5.3.1 Specific mutations increase Barstar solubility without interfering with
Barnase binding
When looking closer at the obtained crystal structure, the very N-terminus of the Barstar
molecule seems to be imperfectly packed. Hydrophobic residues that should be buried
in the core of the protein are exposed more towards the outside and rather hydrophobic
patches seem to be not properly shielded by the β-sheet. As previously discussed, proteins
are more prone to aggregation, when these hydrophobic areas are solvent exposed.
Figure 2.26: Mutations on BarstarC42K to increase solubility
To increase solubility of BarstarC42K various mutations at imperfectly packed regions were introduced: at the N-
terminus (grey), a loop region (orange) and a single mutation of an isoleucin at the C-terminus (yellow). The
Barnase molecule is highlighted in magenta, Barstar is drawn in green, the priorly mutated residues H102D on
Barnase and C42K on Barstar are shown in blue.
In order to decrease the amount of hydrophobics potentially facing the solvent, mutations
were introduced by mutagenesis PCR. The following amino acid stretches were randomized
(see also figure 2.26):
• the very N-terminal sequence MKKAV was mutated to GKKVT, GVKVT, GIKVT,
GVKIT or GIKIT (grey)
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• the second strand in the parallel β-sheet has a VEY stretch that was mutated to
either VEL, IEL or VEF in order to stabilize the overall β-sheet and to shield the
underlying hydrophobic core of the protein (orange)
• at the very C-terminus of Barstar, a prominent Ile (Ile87) points towards the solvent
but seems misplaced in the structure. It was changed to a Glu residue (yellow)
Table 2.2 summarizes the solubility of the mutated Barstar versions. As previously de-
scribed, the WT versions with an N-terminal MKKAV sequence and the C-terminal Ile
results in insoluble protein. Neither changing only the Ile87 residue, nor mutating the
N-terminal stretch to GVKVT resulted in soluble protein. However, when rendering the
N-terminal stretch to GKKVT, the protein shows a moderate solubility. A high solu-
bility was achieved when mutating the N-terminal stretch either to GVKVT or GIKIT
and in addition mutating Ile87. Another possibility is to change the N-terminal stretch to
GVKVT and in addition mutating the VEY stretch on one of the β-sheet strands to IEL
instead.
Table 2.2: Mutations in Barstar slightly increase solubility
Different stretches on B.amyloliquefaciens Barstar were mutated with the aim to increase the solubility of the
protein. The colored cells represent the various mutations or mutation combinations, the color code represents the
solubility: insoluble (red), moderate solubility (yellow), high solubility (green). Note, that even for the soluble
proteins, the effect depends on the optical density of the E.coli culture.
Mutations introduced to Barstar N-terminus
MKKAV
(WT)














I87 - + -








So far we can only speculate that by changing the position of hydrophobic side chains in
the mutated stretches, these are buried in the protein interior and thus are less solvent
exposed. This of course can only be validated by low result ion structure determination.
Hence, Barstar containing a combination of beneficial mutations in complex with Barnase
will be used in further crystallization trails.
Interestingly, soluble protein was only obtained when the E.coli culture did not grow to
higher optical densities than a certain threshold (∼OD600=4). As soon as the cultures
grew to higher densities, Barstar was expressed but no soluble protein could be obtained.
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2.5.3.2 Phage Display
With the aim to find a B.amyloliquefaciens Barstar sequence that results in a stably
folding and well expressing soluble protein, a rather unbiased, second approach was taken.
Instead of introducing mutations that in theory and according to the obtained structure
should stabilize the protein, the Barstar protein was applied to random mutagenesis and
subsequent analysis by Phage Display. The BarstarC42K protein as well as the Barstar
mutations presented in 2.5.3.1 were randomly mutagenized. The resulting library was
cloned into phagmids and a phage pool, displaying the Barstar variants as fusion to their
coat protein pIII, was created (detailed protocol see 4.2.9). Prior, it was experimentally
validated that Barstar can be displayed by phages (detection by Western Blot using α-
mouse pIII or α-rabbit HA antibodies). In multiple rounds of panning, where phages able
to bind to BarnaseH102D are accumulated, the selection stringency was increased using
decreasing concentrations of Barnase as binding partner (1nM - 1pM). The phagmids from
the pool of bound phages were isolated and sequenced. Ideally, specific mutations would
enrich throughout the sequences, representing a beneficial sequence/a beneficial protein
compared to other sequences. Unfortunately, by analyzing the obtained sequences, no
enrichment of specific mutation or combination of mutations could be identified.
2.5.4 Barnase:Barstar complex from different species are advantageous
compared to the B. amyloliquefaciens complex
So far, the Barnase and Barstar proteins from Bacillus amyloliquefaciens were analyzed.
The complex was expressed in E.coli, purified and crystallized. It was shown that the
complex itself is very stable, as it does not dissociate on the gel filtration column and can
tolerate up to 4.75M salt. The Barnase protein can be expressed and purified from E.coli.
By contrast, the Barstar protein can not be solubly expressed in E.coli when fused to
certain tags. Mutation of potential imperfect amino acid stretches only slightly increased
the overall solubility, however, these variants can still not be purified to high amounts.
In order to find a Barnase:Barstar pair, of which both proteins can be efficiently expressed
and purified in isolation and can still form a highly stable complex, the Barnase and
Barstar sequences from other bacterial species were examined.
2.5.4.1 Barstar from different species show higher solubility than
B.amyloliquefaciens Barstar
Using the B.amyloliquefaciens Barstar sequence as starting point, similar proteins in other
Bacillus sub-species were detected and analyzed by Protein BLAST (http://www.ncbi.nlm.
nih.gov/Blast.cgi). The Bacillus pumilus and Bacillus plantarum Barstar sequences were
chosen to be further analyzed. Bacillus plantarum itself has a variety of further sub-
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species, each containing slightly different Barstar sequences. Thus, two consensus se-
quences were designed and used for further analysis. In all Barstar variants, the cystein
residue corresponding to Cys42 in Bacillus amyloliquefaciens was mutated to lysine to be
able to bind the Bacillus amyloliquefaciens BarnaseH102D with high affinity. The sequence
comparison is shown in figure 2.27, the mutated residues are boxed in yellow.
Figure 2.27: Barstar sequence alignment
Barstar protein sequences of B. amyloliquefaciens, B. pumilus, B.plantarum (here, two consensus sequences were
designed) and G. thermoglucosidasius were aligned using the Clustal 2.1. multiple sequence alignment tool
(http://www.ebi.ac.uk/Tools/msa/clustalw2). All sequences already contain the cystein to lysine mutation (aa
41, respectively aa 50 for G. thermoglucosidasius, highlighted in yellow).
In addition, a more thermophil organism producing Barnase and Barstar proteins was
analyzed. Proteins of thermophil organisms need to adapt to high temperatures and
thus often have a more stable fold. Geobacillus thermoglucosidasius is a thermophilic
aerobic or facultatively anaerobic bacterium, capable of growing at temperatures from
40℃ to 70℃ (Nazina et al., 2001). The Barstar and Barnase sequences were identified
and the mutations corresponding to the B.amyloliquefaciens H102D and C42K mutants
were introduced.
The new Barstar and Barnase sequences was obtained by genesynthesis, subsequently
cloned into H14-ZZ-brSUMO backbones and expressed in E.coli. After harvest, the cells
were lysed by sonication and subsequently ultracentrifuged. The supernatant was analyzed
by SDS-PAGE for the amount of soluble protein (for experimental details see 4.2.2).
In general, all Barstar variants could be expressed to high levels in E.coli (figure 2.28).
As previously observed, B.amyloliquefaciens Barstar can not be detected in the super-
natant after ultracentrifugation, strongly suggesting that the protein is insoluble and
thus precipitates during the centrifugation step. In comparison, the Barstar protein from
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Figure 2.28: Barstars from various species show increased solubility
BarstarC to K mutants from various species were expressed in E.coli and analyzed for their solubility. Samples were
taken before induction (bi), after induction (ai), after lysis using sonication (aL) and from the supernatant after
ultracentrifugation (aUZ). All samples were analyzed by SDS-PAGE using gradient polyacrylamide gels. Barstars
from B.amyloliquefaciens, G.thermoglucosidasius, B.pumilus, and B.plantarum were analyzed. For B.plantarum,
two different consensus sequences were designed. All proteins were expressed as N-terminal fusion constructs to
H14-ZZ-brSUMO.
G.thermoglucosidasius and the first B.plantarum consensus sequence are highly soluble,
as nearly 100% of the expressed protein can also be found in the supernatant after cen-
trifugation. The second B.plantarum consensus and the B.pumilus Barstar proteins can
be partially expressed in a soluble manner.
It is worth mentioning that the E.coli cultures were grown to optical densities of OD600=8.0
and the Barstar proteins from other species than B.amyloliquefaciens could be (partially)
expressed in a soluble manner. For the B.amyloliquefaciens Barstar and also its mutant
forms (see 2.5.3.1) no soluble protein could be optioned when growing the E.coli cultures
to an OD600>4.0.
In addition, binding assays were performed revealing that all new Barstar proteins are
able to bind the B.amyloliquefaciens BarnaseH102D (data not shown).
2.5.4.2 Geobacillus thermoglucosidasius Barnase
The previous experiment showed that the G.thermoglucosidasius Barstar can be solubly ex-
pressed to high amounts in E.coli and can also bind the B.amyloliquefaciens Barnase pro-
tein. The G.thermoglucosidasius Barnase was also analyzed, as it most likely is an even bet-
ter binding partner for the G.thermoglucosidasius Barstar. When looking at the sequence
of G.thermoglucosidasius Barnase, an extended N-terminal sequence can be observed,
which most likely serves as recognition stretch for the secretion of the extracellular ribonu-
clease. To find an ideal G.thermoglucosidasius Barnase construct, the protein was cloned
with different N-terminal truncations (see figure 2.29A) and expressed in E.coli to analyze
the expression levels and the solubility of the constructs (all tagged to H14-brSUMO).
The truncations were designed according to an alignment of the G.thermoglucosidasius
Barnase sequence and the sequence of the B.amyloliquefaciens expression construct used
so far.
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Figure 2.29: G.thermoglucosidasius Barnase versions
(A): Barnase(H108D) from G.thermoglucosidasius contains a pre sequence, which is cleaved off in living cells. In
order to find a Barnase version that has a stable fold, various N-terminal truncations were designed. (B): The
truncated versions were expressed in E.coli and analyzed for their solubility. Samples were taken before induction
(bi), after induction (ai), after lysis using sonication (aL) and from the supernatant after ultracentrifugation (aUZ)
and analyzed by SDS-PAGE (gradient polyacrylamide gels). All proteins were expressed as N-terminal fusion
constructs to H14-brSUMO.
Figure 2.29B shows the solubility assay of the various Barnase versions. Interestingly, the
two constructs with the longest N-terminal extension (blue and yellow) failed to solubly
express in E.coli. With shortening the N-terminal extensions, the expression levels for the
constructs increase. The G.thermoglucosidasius versions G.t.Barnase(36-154) (green) and
G.t.Barnase(42-154) (red) expressed to high levels and resulted in soluble protein. Thus,
these two versions were further analyzed in order to create a G.thermoglucosidasius Bar-
nase:Barstar pair for affinity chromatography.
2.5.4.3 Geobacillus thermoglucosidasius complexes are highly stable
To estimate the binding strength of the new Barstar versions towards the B.amylolique-
faciens BarnaseH102, competition assays were performed. As previously describes, the
Barstar versions were expressed as either ZZ- or ZZ-brNEDD8- fusions proteins to create
a difference in molecular weight. Next, the constructs were either incubated alone with
the immobilized Barnase protein or in combinations. Figure 2.30 shows that all Barstar
versions are able to bind B.amyloliquefaciens BarnaseH102D. When adding two Barstar
versions, the G.thermoglucosidasius Barstar has the highest affinity towards the Barnase
protein, as it is able to compete out all other Barstar variants. The binding affinity of the
B.pumilus and the two B.plantarum Barstar proteins towards Barnase are similar to each
other.
Next, a variety of different Barnase:Barstar complexes was formed and purified as de-
scribed previously for the B.amyloliquefaciens complex (see figure 2.24). The G.thermo-
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Figure 2.30: G.thermoglucosidasius Barstar strongly binds to B.amyloliquefaciens Barnase
E.coli lysate with H14-B.amyloliquefaciensBarnase(H102D) was incubated with lysates containing Barstar versions
from various species tagged with either ZZ-brNEDD8-tag or ZZ-tag. The species used were: Geobacillus thermoglu-
cosidasius (G.t.), B.pumilus (B.pu.), B.plantarum 1 (B.pl1.), and B.plantarum 2 (B.pl2.). The formed complexes
were bound to 6% Ni2+-chelate 500Å silica and eluted with SDS loading buffer. The Barstar versions were either in-
cubated separately with the Barnase lysate or two Barstar versions were added to perform competition experiments.
All samples were analyzed by SDS-PAGE using gradient polyacrylamide gels.
glucosidasius Barstar was complexed with three versions of the G.thermoglucosidasius Bar-
nase and the B.amyloliquefaciens Barnase was complexed with the Barstar proteins from
G.thermoglucosidasius, B.pumilus, and B.plantarum (consensus 1 and 2). All complexes,
including the B.amyloliquefaciens complex, were analyzed by Thermofluor assays (for ex-
perimental details see 4.2.4.2). Small amounts of the protein samples are mixed with
SyproOrange, a dye that binds to hydrophobic protein patches, and starts to fluoresce
upon binding. The fluorescence is measured while the samples are applied to increasing
temperatures (ranging from 30℃ to 110℃). The fluorescence increases upon protein de-
naturation and thus the resulting melting curves help to estimate the stability of a certain
protein or protein complex.
Figure 2.31 shows the Thermofluor assay for the various Barnase:Barstar complexes. The
previously analyzed B.amyloliquefaciens complex, depicted in blue, starts to denature
at around 60℃. Complexes containing either B.pumilus and B.plantarum Barstar pro-
teins and the B.amyloliquefaciens Barnase seem to be less stable, as the melting tem-
perature is lower (light green, cyan, dark green). All complexes containing at least one
G.thermoglucosidasius component seem to be more stable as melting temperatures are
all shifted to higher temperatures. The most stable complexes are G.thermoglucosidasius
Barstar in complex with either G.thermoglucosidasiusBarnase(36-154) (brown) or G.thermo-
glucosidasius Barnase(32-154) (red).
This experiment together with the competition experiments and the solubility and ex-
pression assays strongly suggest that the G.thermoglucosidasius Barnase(36-154) and the
G.thermoglucosidasius Barstar are suitable to use as an affinity tag system.
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Figure 2.31: G.thermoglucosidasius Barnase:Barstar complexes are extremely stable
The following Barnase:Barstar complexes were formed and analyzed by Thermofluor: G.thermoglucosidasius
Barstar(A50K) bound to (1) G.thermoglucosidasius Barnase(H108D, 42-154) (pink), (2) G.thermoglucosidasius
Barnase(H108D, 36-154) (brown), (3) G.thermoglucosidasius Barnase(H108D, 32-154) (red).
B.amyloliquefaciens Barnase(H102D) bound to (4) B.amyloliquefaciens Barstar(C42K) (blue), (5)
G.thermoglucosidasius Barstar(A50K) (orange), (6) B.pumilus Barstar(C41K) (dark green), (7) B.plantarum
1 Barstar(C41K) (cyan), (8) B.plantarum 2 Barstar(C41K) (green)
2.5.4.4 Structure determination of new Barnase:Barstar complexes
Recently, the various complexes were used for crystallization trails, so far resulting in nee-
dle shaped crystals for the G.thermoglucosidasius Barnase(36-154):G.thermoglucosidasius
Barstar complex (200mM Ammonium Sulphate, 100mM MES monohydrate pH6.5, 30%
PEG monomethylether 5000, 20℃, first crystals appeared 3 days after setting the drops)
and the G.thermoglucosidasius Barnase(42-154):G.thermoglucosidasius Barstar complex (200mM
Ammonium sulphate, 100mM Tris Sodium citrate dihydrate pH5.6, 25% PEG 4000,
20℃, first crystals appeared 3 days after setting the drops). In addition, small net-
like crystals were obtained for the G.thermoglucosidasiusBarstar in complex with the
B.amyloliquefaciens Barnase in the following conditions: 200mM Ammonium sulphate,
100mM Hepes pH7.5, 16% PEG 4000, 10% isopropanol, 20℃, first crystals appeared 1
days after setting the drops.
However, the conditions need to be refined in order to obtain crystals that can be further
analyzed.
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2.5.5 Evolved Barnase:Barstar complex can be used as tag system for affinity
chromatography
The Barnase:Barstar system is a suitable pair for affinity chromatography. They bind with
high affinity to each other, are both small, monomeric proteins and do not contain any
disulfide bonds that might interfere with coupling to the MADA resin. The Barnase protein
can be efficiently expressed and purified in E.coli. Barstar from B.amyloliquefaciens seems
to have folding problems when expressed in E.coli, however, this problem was circumvented
by switching to Barstar from the thermophil G.thermoglucosidasius.
Figure 2.32: Barnase:Barstar system can be used for affinity chromatography
(A): BarnaseH102D-brSUMO-GFP was expressed in E.coli. The lysate (Input) was incubated with MADA beads
to which BarstarC42K had been covalently attached. As control, empty beads were incubated with the lysate as
well. In this experiment, 25µl MADA resin were incubated with either 200 or 500 µl lysate. After binding for 1h,
the flow through was collected (Flow through), the beads were washed and protease elution (0.1µM SENP1) was
performed (Elution (protease)) resulting in a cleaved GFP protein. Samples were analyzed by SDS-PAGE using
gradient polyacrylamide gels. (B) shows the same experiment. Pictures were taken of the Input samples (E.coli
lysate containing expressed BarnaseH102D-brSUMO-GFP), the beads after incubation, the beads after wash and
after protease elution and the elution samples containing GFP only.
As proof of principle that a protein purification using the Barnase:Barstar pair is feasi-
ble, the Barstar protein (from B.amyloliquefaciens), was expressed in E.coli, purified by
Ni2+-affinity chromatography and elution was performed by protease cleavage resulting in
an 11kDa sized protein. Its C-terminal cystein was freshly reduced and the protein was
covalently coupled to the MADA 2B Sepharose. This Barstar MADA resin was used as
stationary phase during affinity chromatography. Next, an expression construct contain-
ing the B.amyloliquefaciens Barnase as N-terminal fusion tag was designed and cloned.
As the Barnase sequence does not start with a methionine, an additional methionine was
introduced to the very N-terminus to enable translation initiation, resulting in an Met-
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Barnase-brSUMO-GFP construct. This construct was expressed in E.coli and the resulting
lysate was used for affinity chromatography by mixing it with the Barstar MADA resin.
After incubation for 1h at 4℃, the flow through was collected and the beads were washed
with buffer. Subsequently, elution was performed using 0.1µM SENP1 protease and the
cleaved protein was collected. All samples were analyzed by SDS-PAGE. In addition, the
procedure was also documented by recording the fluorescence signal of GFP.
Figure 2.32 shows the first protein affinity chromatography purification using the Bar-
nase:Barstar system. The input fraction in figure 2.32A shows the E.coli lysate containing
the expressed Barnase-brSUMO-GFP construct. Two different amounts of lysate (200
and 500 µl) were incubated with empty beads (MADA 2B Sepharose only) and beads
covalently linked to Barstar. The flow through samples still contain the expressed pro-
tein, indicating the beads were over-saturated. The protease elution samples contain the
cleaved GFP protein (∼30kDa) but no a additional proteins. The empty beads do not
show any eluted protein, once more proving the extremely low unspecific binding to the
MADA resin. The low amounts of eluted protein from the resin might be caused by insuf-
ficient cleavage or by incomplete elution of the cleaved GFP product. Figure 2.32B shows
the purification procedure step by step. The Input samples show a bright GFP signal.
After incubation, the GFP signal is enriched on the Barstar MADA beads whereas no
enrichment can be seen on the empty beads. This can also be observed after thorough
washing. The protease cleavage leads to complete removal of the GFP from the beads,
due to the high cleavage efficiency of the SENP1 protease. The GFP can be visualized in
the protease elution fraction for the MADA Barstar beads.
It is noteworthy that Barnase can indeed be used as N-terminal tag and does not nega-
tively influence the solubility or expression of the following fusion protein. However, this
needs to be further analyzed also with more challenging fusion partners.
In summary, the tested Barnase:Barstar pair performs extremely well as affinity tag sys-
tem and is - in many aspects - highly beneficial in comparison to the well-established
Streptavidin:Biotin system.
3 Discussion
3.1 Analyzing the eukaryotic translation initiation apparatus
Eukaryotic translation is a multistep process requiring the ribosome and 47 individual
polypeptides, either acting as monomeric factors or as multisubunit complexes. In compar-
ison, translation in bacteria requires only 9 individual proteins. One possible explanation
for the drastic increase in complexity of the translation apparatus is the compartmentaliza-
tion in eukaryotic cells. Gene expression is divided into two major processes: transcription
and translation. In bacteria, these to processes are tightly coupled and thus most of the
gene expression regulation happens at the level of transcription. In eukaryotes however,
transcription and translation are spatially separated: DNA is transcribed to mRNA in
the cell nucleus, the mRNA is exported to the cytoplasm where finally translation takes
place. This separation requires and allows new mechanisms for gene expression also on
the translational level, mainly during the initial step of translation, termed translation
initiation. A strong argument for translation initiation being the most regulated and thus
rate limiting step during eukaryotic translation is that out of the 47 proteins acting during
this process, 37 operate during initiation.
Although protein synthesis is a major and absolutely fundamental step in all living cells,
surprisingly less is known about the detailed interactions within the translation factor
complexes or between different complexes in eukaryotes. Studies addressing these ques-
tions mainly focus on the yeast factors, which are often comprised of less subunits making
them less complex. Another advantage when using yeast is that this model organism can
be easily genetically modified and by use of temperature sensitive mutants, even mutations
with lethal phenotypes can be introduced and analyzed.
In this study we aimed to shed light on the wheat translation initiation process by two
main approaches: first, in vitro reconstitution of translation initiation factors, mainly
eIF3; second, a wheat germ extract based translation assay to reveal the necessity of in-
dividual translation factor subunits and possible limitations in the system.
Studying the wheat apparatus is interesting and also advantageous for various reasons.
First of all, wheat is a higher eukaryote with a complex and highly regulated translation
system. Interestingly, plants do show differences in their translation apparatus composi-
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tion when compared to human or mouse, respectively. Plants have certain novel translation
factors, e.g. the isoforms for eIF4F complex subunits eIF4isoE and eIF4isoG, or the so
far only in plants identified nCBP (novel Cap Binding Protein). Next, for biochemical ap-
proaches, protein sequences from wheat are highly beneficial. The wheat species Triticum
aestivum has a very broad temperature range, being able to survive under frost condi-
tions but can also tolerate heat up to 50℃. Thus, the proteins expressed in these species
should have a stable and robust fold, which can be exploited during protein expression by
screening over a wide range of expression conditions.
3.1.1 In vitro reconstitution of the wheat eIF3 complex
For in vitro reconstitution of an eukaryotic multisubunit complex, the individual proteins
are ideally expressed singly in E.coli, purified and assembled step by step in a test tube.
However, this can be a highly challenging approach for a variety of reasons. Interactions
within a complex happen mostly via hydrophobic interactions, meaning that the isolated
subunits have one or more hydrophobic patches on their surface. These however, are sol-
vent exposed when expressing the subunits individually, due to the fact that their natural
binding partners normally shielding the hydrophobic areas are not present. Thus, these
subunits are highly prone to aggregate, leading to the production of insoluble proteins.
In addition, eukaryotic proteins might also depend on the eukaryotic chaperone system or
specific factors needed for complex assembly that lack in E.coli.
In this study, we were able to express and purify all 13 subunits of the wheat eIF3 complex
after excessive screening of expression conditions and N-terminal fusion tags. In general,
the amount of soluble protein increases when the proteins are expressed at lower tempera-
tures and lower induction strength. When E.coli cells are exposed to lower temperatures,
the entire cellular machinery slows down, potentially giving the proteins produced more
time to fold properly prior to release from the ribosome. When additionally lowering
the induction strength, less mRNA molecules are produced and transcribed, preventing
partially folded proteins to accumulate, which would otherwise greatly increases the pos-
sibility of aggregation. Interestingly, the eIF3 subunits that perform well also with higher
induction strength and slightly higher expression temperatures , such as eIF3b, eIF3c and
eIF3d are among the largest eIF3 subunits with molecular weights from 65kDa to 105kDa.
When applying the sequences to secondary structure predictions, these proteins contain
distinct domains with known stable folds, e.g. PCI- or WD40-domains. Perhaps, these
domains fold quick enough to shield the remaining emerging polypeptide chain towards
the solvent, whereas smaller proteins with less defined domains and partially disordered
regions can not act in a self-supporting manner.
This shielding effect can also be mimiced by large N-terminal fusion tags. All 13 eIF3
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subunits were analyzed for their expression and solubility when fused to eight different
N-terminal fusion tags (see table 2.1). For some subunits (eIF3b, eIF3c, eIF3d, eIF3j and
eIF3k), the N-terminal fusion tag only marginally affects the proteins expression level and
solubility. The remaining eIF3 subunits tend to be insoluble when expressed with small
N-terminal fusion tags such as H14- or H14-TEV-, but the solubility increases with increas-
ing tag size. The two most problematic eIF3 subunits are eIF3a and eIF3l. These two
subunits can only be solubly expressed when fused to H14-TEV-MBP/H14-brSUMO-MBP
but remain insoluble when fused to GFP, which is similar in size. MBP (maltose binding
protein) was previously described to have chaperone - like qualities, utilizing its hydropho-
bic cleft as an ideal folding environment for the emerging polypeptide chain (Pryor and
Leiting, 1997; Smyth et al., 2003). Hence, MBP is not only large enough to shield an
emerging polypeptide towards the solvent, it also positively influences the folding of the
newly synthesized protein.
Assuming that the model of subunit arrangement for the human eIF3 complex published
by Zhou et al. (2008) and Querol-Audi et al. (2013) (see figures 1.2 and 1.3) is similar
to the wheat eIF3 complex, it is surprising that subunits buried inside the complex seem
to have the least solubility problems, such as eIF3c respectively. It brings together three
eIF3 subcomplexes and consequently should have a highly hydrophobic surface. But as
previously mentioned, eIF3c can be expressed to high amounts with small tags even at
elevated temperatures (see panel 2 in figure 2.1). In comparison, subunits eIF3a and eIF3l
seem to be rather peripheral and hence should have surface properties tolerating solvent
exposure. However, we can not rule out that additional factors in the wheat system pro-
mote the proper folding or assembly of these proteins. During synthesis in E.coli these
factors are not available and thus folding might be problematic.
All 13 subunits could be further purified by affinity chromatography and protease elution
resulting in tag-free proteins. Interestingly, even the proteins showing low solubility do
not precipitate upon cleavage, indicating a stable fold that might be supported by the
N-terminal tag but once formed is stable on its own. However, when performing binding
assays with the purified proteins, no interactions could be observed. Technical issues were
excluded by performing control experiments in parallel showing the interaction between
the nuclear transport factor Importin β and the IBB domain of Importin α (Görlich et al.,
1995). Binding assays with the eIF3 subunits were performed pairwise but also with
mixtures resembling the sub-complexes described by Phan et al. (1998) and Zhou et al.
(2008) to exclude the possibility that a pairwise interaction might be too weak and the
subunits bind in a corporative manner. In addition, experiments were also performed in
the presence of wheat germ extract to provide possible further subunits or assembly factors
missing in the E.coli system.
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Failing to reconstitute the eIF3 complex or at least sub-complexes in vitro, we were in-
terested in the stability and composition of the native wheat eIF3 complex. Possibly,
the complex itself is very fragile, assembling only upon requirement or presence of other
translation factors such as eIF2. However, wheat germ extract fractionation by gelfil-
tration and IP experiments revealed the presence of a stable pre-assembled complex in
the native system only lacking the loosely attached eIF3j subunit. In addition, the high
abundant elongation factor eEF1α co-precipitated with the eIF3 complex. Further factors
were not identified, suggesting that no additional factors are stably attached to the eIF3
complex in vivo. Possible assembly factors only transiently interacting with the complex
can not be identified by IP experiments but can be addressed by cross-linking experiments
in the future.
Besides the hypothesis that in vitro binding of recombinantly produced eIF3 subunits does
not occur due to a lack of essential factors, another explanation might be that although
the proteins can be expressed in a soluble manner, the folding is not correct resulting in
molten globules that are non- or misfunctional. When purifying eIF3b from E.coli lysate,
the bacterial chaperone GroEL co-purifies and seems to form a stable complex with the
eIF3 subunit as they also co-migrate through a gel filtration column (data not shown).
The presence of a bacterial chaperones strongly argues for folding problems of the eukary-
otic protein in a bacterial environment. eIF3 subunits are also heavily posttranslationally
modified. These modifications might be essential for subunit interaction and can not be
introduced when the proteins are expressed in E.coli.
As previously mentioned, the lack of the eukaryotic chaperone system in bacteria in general
is an immense burden for all eukaryotic proteins expressed in E.coli. The main cytoplasmic
eukaryotic chaperone is the TRiC complex, first identified in 1990 (Gupta, 1990). TRiC
is composed of two rings of eight different but related subunits and shows an intrinsic
ATPase activity. In addition, prefoldin, another heterohexameric chaperone functions to-
gether with the TRiC complex to promote proper folding of produced proteins, mainly
cytoskeletal proteins such as actin or tubulin. Stemp et al. (2005) showed that actin ex-
pressed in E.coli can be converted to a soluble protein when the TRiC complex (purified
from HeLa cells) was added to the lysate. This strategy could be used to obtain properly
folded eIF3 subunits but could be even further exploited, e.g. by co-expressing the TRiC
complex in bacteria. This is indeed a challenging approach but would be highly beneficial
for the expression of eukaryotic proteins in a bacterial expression system in general.
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3.1.2 In vitro wheat germ translation assay as tool to study effects of translation
(initiation) factors
Another approach to study the eukaryotic translation apparatus is to look at an in vitro
translation assay. The system can be manipulated, e.g. by depletion of certain transla-
tion factors, thereby validating their necessity for overall translation. It is important to
mention that in such a system only the effect on translation is monitored. This enables
to introduce manipulations that would immediately cause lethality in an in vivo system.
The assay used in this study is based on the in-house produced wheat germ extract, which
is supplemented with the mRNA of the reporter construct (Firefly Luciferase), amino acids
and an energy regenerating system. The translation efficiency of the extract can then be
validated by the amount of produced luciferase, measured by a luminescence assay.
The manipulation was performed by either depleting certain translation factors or transla-
tion factor complexes by subunit specific antibodies or by adding recombinantly expressed
and purified translation factors to the extract. In case of further addition of translation
factors, no significant changes in overall translation efficiencies were observed compared to
non-supplemented extracts. This might have several reasons: first of all we do not know
the limitations of the system. Dr. Enke showed that the wheat germ extract produced
in-house shows an 8-fold better translation efficiency than commercial available extracts
(Promega; Enke, 2010), indicating an extremely high quality of the system. Addition of
certain translation factors would only show a positive effect, when the factor is limiting
in the system, however, this does not seem to be the case. It remains to be elucidated,
if the added recombinant translation factors are correctly folded and thus functional and
if lacking posttranslational modifications are required for proper function. Additionally,
the timescale of cleavage of the added H14-MBP-brSUMO fusion constructs needs to be
monitored. If cleavage requires too much time, formation of multisubunit complexes might
have already occurred without the incorporation of the recombinant factors.
Depletion of translation factors however, resulted in a decreased translation efficiency in
most of the cases (see figure 2.6). After depleting the wheat germ extract using eIF subunit
specific antibodies, the extracts were analyzed by Western Blot. When using antibodies
recognizing the large eIF3 subunits (eIF3a, eIF3b, eIF3c and eIF3d), all other eIF3 sub-
units (except eIF3j) co-precipitate, once again strongly arguing for eIF3 being present as a
stable complex in the wheat germ extract. However, depletion is still incomplete probably
caused by capacity effects or by shielded epitops as soon as the subunits are incorporated
into the complex. Future depletions might be performed such, that the extract is applied
in consecutive rounds to beads coupled to antibodies against different eIF3 subunits caus-
ing an avidity effect.
Interestingly, although eIF3 is still present in the extract, overall translation rates decrease
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∼2-fold. As eIF3 is a multiplayer during translation initiation, even small changes in eIF3
concentration could reduce the efficiency of protein synthesis, e.g. by requiring more time
for proper 43S PIC assembly or recruitment of the mRNA to the 40S ribosomal subunit.
In addition, lower amounts of eIF3 in the system could also affect the initiation fidelity
and translation could start at non-AUG codons. Ribosome profiling experiments could
reveal, if ribosomes accumulate at alternative start-codons upon reduction of eIF3 in the
wheat germ extract.
The strongest effect however, with an approximate translation efficiency decrease of 8-
fold, was observed when depleting the extract with eIF5 specific antibodies. Western Blot
analysis revealed an almost complete removal of endogenous protein. eIF5 is a GTPase
activating protein (GAP), hydrolyzing GTP of the eIF2 complex upon codon-anticodon
pairing (reviewed in Marintchev and Wagner, 2004). If eIF5 gets limiting in the extract,
hydrolysis in eIF2 is impaired, causing problems in correct and stable binding of the ini-
tiator tRNA to the P-site of the ribosome. A strong reduction in translation rates also
occurs when eEF1Bβ levels are reduced. The subunit is part of the GEF eEF1B, acting on
eEF1A. If the GEF is non-functional due to the lack of one of its subunits, GDP exchange
to GTP in eEF1A is impaired, preventing the elongation factor to participate in a new
round of translation elongation.
However, although preliminary answers to the question, which translation factors/factor
subunits are required for proper translation could be obtained by using the wheat germ
in vitro translation assay, it is extremely difficult to obtain conclusive and trustworthy
data. The wheat germ extract itself is highly sensitive towards even minimal changes in
the buffer composition, making it nearly impossible to reproduce experiments. In addi-
tion, each newly produced wheat germ extract batch must be screened for its own optimal
salt conditions and even if extracts with their optimal salt composition are compared,
the values for the amount of produced Firefly luciferase varies greatly. It is difficult to
hypothesize why these extracts are so sensitive, and by what means the robustness could
be increased. In general, working with undefined systems containing vast amounts of dif-
ferent proteins, lipids and small molecules entails the risk of undefined side reactions that
might lead to misinterpretation of the obtained data. Alternatively, an in vitro reconsti-
tuted translation system would be an ideal basis for analysis of individual components.
Alkalaeva et al. (2006) introduced a human in vitro translation system reconstituted from
purified ribosomal subunits, initiation, elongation and termination factors and aminoacyl
tRNAs (purified from HeLa lysate). The effects of certain translation factors can be ana-
lyzed by excluding the component of interest in the reconstitution mix. However, also this
system has limitations such that only entire complexes can be analyzed. A reconstituted
eukaryotic system using only recombinantly expressed and purified translation factors
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would allow to study the effect of single subunits or even more in detail what happens,
when certain truncated or mutated proteins are added to the system. This challenging
but groundbreaking technique would finally allow to study the highly complex eukaryotic
translation apparatus in depth.
3.2 Nuclear transport factors might act as compartment-specific
inhibitors of translation
In eukaryotic cells the processes of transcription and translation are spatially separated:
transcription happens in the nuclear interior whereas translation occurs in the cytoplasm.
Nevertheless, there are reports suggesting translation also taking place in the cell nucleus
(Goidl et al., 1975; Iborra et al., 2001), although this would have dramatic effects on over-
all cell viability and is under strong debate. Most mRNA molecules are spliced in the
nuclear interior prior to transport to the cytoplasm. During splicing, the intron regions
are removed resulting in the final ORF of the protein to be translated. If mRNAs were
translated prior to splicing, the possibility of creating truncated protein products would
be extremely high as intron regions often harbor premature stop codons. These truncated
versions might cause dominant negative effects in the cell. Further disadvantages of nu-
clear translation would be that an important level of regulation would be abolished and
certain proteins that could have negative influence on gene expression might mislocalize
to the nucleus.
Eukaryotic cells evolved many mechanisms to avoid translation occurring in the nuclear
interior. Ribosomes, although partly pre-assembled in the nucleus, gain their final mat-
uration only in the cytoplasm and the concentration of translation factors in the nuclear
interior is actively kept low. Mislocalized or freely diffusing translation factors are shut-
tled back to the cytoplasm by active transport via nuclear export factors. The nuclear
export factor Exportin 4 is known to transport the small translation factor eIF5A back to
the cytoplasm (Lipowsky et al., 2000), eEF1A in complex with tRNAs is exported from
the nucleus by Exportin 5 and eIF2β is removed from the nucleus by Crm1 (Bohnsack
et al., 2002). For Crm1 it was additionally shown that it binds a wide range of different
translation factors (unpublished data).
These findings lead us to the hypothesis that nuclear transport factors might act as
compartment specific inhibitors of translation, thereby contributing another argument
to weaken the hypothesis of nuclear translation.
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3.2.1 Depletion or sequestration of eIF5A has only subtle effects on the
translation of poly proline containing reporters
Recent studies suggest that yeast eIF5A and its bacterial homologue EF-P play a role in
the translation of mRNAs coding for poly-proline stretches (Doerfel et al., 2013; Gutierrez
et al., 2013). In bacteria, the ribosome stalls upon incorporation of at least two con-
secutive prolines to the emerging polypeptide chain and yet another incoming proline or
glycine residue. The deacetylated tRNA leaves the E-site and due to stalling this site is
not further occupied by the next tRNA. EF-P binds to the ribosome and accommodates
between the E- and the P-site, promoting peptide bond formation of ProPro or ProGly
pairs (Doerfel and Rodnina, 2013). In the absence of EF-P, stalling can not be resumed
and a full length proline rich protein can not be synthesized.
eIF5A is a direct transport cargo of the nuclear export factor Exportin 4, efficiently re-
moving this small translation factor out of the nucleus in a Ran dependent manner. To
test the hypothesis whether the presence of a nuclear transport factor can indeed inter-
fere with translation, a rabbit reticulocyte lysate in vitro translation assay was performed
using a poly-proline and a poly-serine containing construct as reporters (see figure 2.8).
The lysate was supplemented with recombinantly expressed and purified Exportin 4 and
Ran. According to findings in bacteria, clusters of ProProPro or ProProGly are sufficient
to stall the ribosome on the mRNA transcript. No full length protein can be produced in
case EF-P is missing. In yeast, ribosome stalling occurs in the absence of fully functional
eIF5A on poly-proline motives with the second or third proline sitting on the P-site of
the ribosome (Gutierrez et al., 2013). The poly-proline reporter construct used in this
study contains one poly-proline cluster with twelve consecutive prolines and thus should
be sufficient to cause an immediate stalling of the ribosome on the transcript as soon as
eIF5A is sequestered. When supplementing an in vitro translation assay with Exportin 4
and Ran, the poly-proline reporter is indeed translated less efficiently compared to either
the poly-serine reporter or translation in a non-supplemented extract. The effect however
is very subtle possibly indicating rather a pausing of the ribosome and thus a delay in
translation rather than a complete stalling (see figure 2.12). Interestingly, when translat-
ing other reporters, namely the Firefly luciferase containing 29 prolines or the two yeast
proteins Ldb17 (23 prolines) and Eap1 (72 prolines), the effect upon Exportin 4 and Ran
addition is strongly enhanced. Note that in general the decrease in translation efficiency
can only be observed, when Exportin4 and Ran are added. Supplementing the extract
with Exportin4 alone does not effect the translation rates, strongly suggesting that the
binding and thus sequestration of eIF5A by Exportin 4 happens in a Ran dependent man-
ner as expected for a nuclear export factor.
Studies showing that eIF5A is involved in the translation of poly-proline containing pro-
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teins were so far only performed in yeast, a simple eukaryote. Nevertheless, the observation
that a cluster of twelve consecutive prolines does not show a very strong effect in a transla-
tion system derived from higher eukaryotes was rather surprising. When briefly comparing
the translation apparatus of yeast to the process in plants or mammals, it is obvious that
the process increased dramatically in complexity and thus effects shown in yeast might be
hints that factors function in a similar manner also in other eukaryotes, but the results
are not directly transferable. Specific sequence characteristics causing the ribosome to
pause or to stall on the mRNA in higher eukaryotes could potentially be identified by
two experimental approaches: 1) reporter constructs with different proline cluster lengths
or clusters combining prolines with other amino acids could be analyzed in the presence
or absence of eIF5A (depleted or sequestered). 2) A rather unbiased approach could be
to purify endogenous mRNA from tissue and translate this mRNA pool in an in vitro
translation assay with and without eIF5A activity. Upon comparison of the translated
proteins, changes in translation rates of certain proteins could be identified and the un-
derlying amino acid sequence could be analyzed.
In conclusion, we were able to show that by sequestering eIF5A by its nuclear export fac-
tor Exportin 4, the translation efficiency of reporter constructs rich in prolines decreased.
Nonetheless, add-back experiments with recombinantly expressed, purified and in vitro
hypusinated eIF5A need to be performed. However, it is the first hint that eIF5A also
in higher eukaryotes is required for proper synthesis of proline rich proteins. Its putative
role in peptide bond formation between consecutive prolines in general might raise the
discussion if eIF5A is an initiation factor, as implied by the name, or if its actual function
is taking place during translation elongation.
3.2.2 Addition of Crm1 to an in vitro translation assay decreases translation
efficiency dramatically
Due to the wide cargo range of Crm1 and the finding that this nuclear export factor can
pull out almost all translation (initiation) factors from a HeLa cell lysate in a Ran de-
pendent manner (unpublished data by K. Kirli), we wanted to analyze the effect upon
Crm1 addition to an in vitro translation assay. In comparison to Exportin 4, that only
interacts with specific cargo proteins and thus the reporter constructs needed to fulfill
certain requirements, translation rates of a variety of different reporters should be affected
upon Crm1 addition. Here, the poly-serine, poly-proline and Firefly luciferase reporters
were used.
When adding recombinantly expressed and purified Crm1 WT, the reporter constructs are
translated slightly less efficient as compared to a non-supplemented extract. However, by
additionally supplementing the extract with Ran (in 3-fold excess over Crm1), the trans-
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lation efficiency drops significantly so that no reporter signal can be observed any longer.
The same holds true when adding Crm1G502A, a Ran independent Crm1 variant. The ef-
fect seems to be concentration dependent, as it can only be observed when adding >3µM
Crm1. When supplementing the in vitro translation assay with other nuclear transport
factors such as Exportin 6, mediating actin export (Stüven et al., 2003) or CAS, respon-
sible for recycling Importin α to the cytoplasm (Kutay et al., 1997), the effect can not
be observed, neither in absence nor presence of Ran (see figure 2.12). These observations
argue that the decrease in translation is related to the addition of nuclear transport factors
indeed being known to interact with translation factors.
However, it is unlikely to assume, that Crm1 is able to bind each single subunit directly.
When analyzing the translation factors pulled out from HeLa cell lysate by Crm1, only a
minor portion harbors a sequence stretch that has the properties to act as a nuclear export
signal (NES). Interestingly, each multisubunit complex contains at least one subunit with
a predicted NES, which seems to be enough for co-purification of the entire complex in
the pull-out assay. But what happens in the in vitro translation assay?
If one assumes that certain translation factors or translation factor subunits bind to Crm1
via their NES, they most likely are sequestered because important interaction sites are
shielded by Crm1. Another explanation might be that even if a functional site of a trans-
lation factor would still be exposed, the Crm1:translation factor complex could simply be
too large to act during translation (initiation). Crm1 might also promote a platforming
effect, meaning that once a translation factor is bound, further interacting factors assemble
on to it. Thereby more and more translation factors are taken out of the actual transla-
tion process and translation efficiency drops. The observed slight decrease when adding
Crm1 only might be explained by some non-Ran mediated binding of translation factors
to Crm1.
So far, we hypothesize that binding and thus sequestration of the translation factors to
Crm1 happens by NES binding to the hydrophobic cleft of Crm1. Hence, blocking or mu-
tating the hydrophobic cleft should be able to reverse the decreased translation efficiency.
The hydrophobic cleft was blocked by either supplementing the extract with NS2 peptide,
which shows high affinity towards Crm1s hydrophobic cleft (Engelsma et al., 2008), or
Snurportin1 fused to either PKI-NES or REV-NES to further strengthen the interaction
between Crm1 and its natural cargo. In addition, the translation assays were performed
with mutant versions of Crm1, which at least in vitro are not able to bind a PKI peptide
any longer (see figure 2.13). Surprisingly, the observed decrease of translation efficiency
upon Crm1 and Ran addition could not be reversed by any of the applied approaches.
There are a variety of possible explanations why the observed effect could not be reversed
so far. Although it is known that the NS2 peptide can bind Crm1 strongly in an in vitro
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binding assay, the conditions in a lysate are very different. Not only that the peptide could
easily be degraded by proteases in the extract, there might in addition be structures in
the lysate to which the NS2 peptide is attracted. Thus, we can not ensure that the NS2
peptide reaches and binds Crm1, thereby blocking the hydrophobic cleft or competing out
translation factors. Even if it does reach Crm1, the affinity of the NS2 peptide towards
Crm1 might not be strong enough to displace pre-bound cargos.
Next, the PKI-Snurportin or REV-Snurportin proteins were added with the aim to block
the hydrophobic cleft of Crm1 in the extract. The first Crm1 crystal structure was ob-
tained in complex with Ran and Snurportin1, a natural Crm1 cargo described in 1999
(Paraskeva et al., 1999; Mönecke et al., 2009). Interestingly, the interaction between
Crm1 and Snurportin1 is not exclusively via the hydrophobic cleft but Snurportin1 also
interacts with several other residues on Crm1s HEAT-repeats 12-14, thereby shielding a
considerable portion of Crm1s surface, making it inaccessible for other cargoes. Snur-
portin1 was used as fusion protein to either PKI-NES or PEV-NES to further increase
the binding affinities. Surprisingly, also supplementing the in vitro translation assay with
these proteins did not lead to a rescue of translation efficiency. However, Crm1 was not
pre-complexed with the Snurportin1 fusion proteins before addition to the extract. Thus,
the problems of accessibility and competition for binding in the lysate still remains. As
already described, addition of Crm1 hydrophobic cleft mutants (Crm1A451R, Crm1K568E)
which can no longer interact with PKI-NES peptides in vitro (unpublished data, H. Chug),
also led to a significant decrease in translation efficiency of the reporter constructs. Yet
another approach to block Crm1 towards NES binding is to use the toxin leptomycin B
that specifically binds to the hydrophobic cleft, thereby covalently modifying a cysteine
residue (Nishi et al., 1994; Kudo et al., 1998). However, leptomycin B can not be solube-
lized to high concentrations needed to efficiently block Crm1 in the lysate.
When looking at Exportin 4, the decrease in translation efficiency is - as expected - only
observed on poly-proline containing proteins, which once again claims that eIF5A, the
cargo of Exportin 4 plays a role in the translation of poly-proline proteins. In case of
Crm1 however, a broad range of cargoes can be recognized and the binding mode of nu-
clear export factor and cargo is different to the binding mode of other NTRs. Most nuclear
export factors bind their cargos by wrapping around them; the cargo interacts mainly with
the inner surface of the transport receptor. Crm1 however, has in comparison a rather
small interacting surface with the cargo which is also located more at the outer side of
the HEAT repeats. The interaction between the NES and the hydrophobic cleft of Crm1
is based on a short, hydrophobic amino acid stretch. Also more and more non-classical
NES motives are identified. Taking together, Crm1 seems to have less stringent modes
of binding towards its cargo, thus the binding and sequestration of Crm1 towards the
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translation factors must not necessarily happen via the hydrophobic cleft only, explaining
why even in presence of hydrophobic cleft mutants, Crm1 seems to be able to efficiently
block translation. One can nevertheless also argue that the effect might be unspecific,
caused by a folding stress mechanism acting on translation and triggered upon addition
of possibly misfolded eukaryotic proteins expressed in E.coli. This would explain, why
the effect can not be reversed by specifically blocking the interaction between Crm1 and
its cargos. Other findings, namely the decrease of translation rates in a Ran dependent
manner and the possibility to add other nuclear transport factors expressed in E.coli to
the extract without affecting translation rates, however do suggest that Crm1 (or Exportin
4) are specifically provoking the observed translation efficiency decrease.
3.2.3 Is nuclear translation possible, if NTRs interfere with translation?
The hypothesis of nuclear translation appeared the first time in 1954, showing that ra-
diolabeled amino acids can be rapidly incorporated in nuclear proteins (Allfrey, 1954).
Another major experiment trying to validate the hypothesis was performed by Goidl et al.
(1975), showing that polyribosomes can be isolated from nuclei. Nowadays, the hypothesis
builds on two main arguments: (1) nuclei contain all necessary components for translation
(e.g. Lejbkowicz et al., 1992), (2) isolated nuclei can aminoacetylate tRNAs and incorpo-
rate radio labeled amino acids into proteins (Lund and Dahlberg, 1998). However, both
arguments can be easily refuted because even if all proteins required for translation would
be present in the nucleus, it is not proven that these are also fully active. Ribosomes
for example maturate in the cytoplasm and no re-import of fully mature and assembled
ribosomes to the nucleus is known. The second argument is in parts even questioned by
supporters of the nuclear translation theory themselves, stating that these effects might
possibly also be caused by “contaminating cytoplasmic machinery on the outer nuclear
membrane” (Iborra et al., 2001). The finding of “newly synthesized proteins” in the nu-
cleus labeled by heavy amino acids is more likely to be caused by rapid import of proteins
from the cytoplasm to the nuclear interior (Ribbeck and Görlich, 2001). So far, the loca-
tion of synthesis was not addressed.
As previously mentioned, protein synthesis in the nuclear interior would have dramatic
negative impact on the cell. Truncated protein products could be synthesized due to
translation of non-or misspliced mRNAs. Further, proteins interfering with proper gene
expression could be mislocalized to the nucleus. The cells active mechanisms to remove
mislocalized translation factors from the nucleus back to the cytoplasm is one of the
strongest arguments for us that translation in the nucleus is unlikely to occur. The find-
ings that nuclear transport factors, which are known to bind to translation factors can
indeed interfere with translation in an in vitro translation system strongly indicates that
3.3 Novel tools for protein purification: a MADA resin and Barnase:Barstar as high affinity pair 91
nuclear transport factors might play a dual role in this context: shuttling out the transla-
tion factors from the nuclear interior and - during binding in the nuclear interior - active
sequestration of the translation factor function.
3.3 Novel tools for protein purification: a MADA activated resin and
Barnase:Barstar as high affinity pair
Affinity chromatography is a widespread tool for efficient protein purification, based on
the interaction between two molecules. These can be either two proteins, e.g. antibodies
and their corresponding antigen, or a protein/peptide chelating a metal ion (e.g. a poly-
histidine peptide recognizing Ni2+ ions) or recognizing a biochemical modification as it
is the case for streptavidin and biotinylated proteins. One member of the affinity pair is
usually immobilized on a solid phase (silica, Sepharose or magnetic beads), the other one
is added to the desired protein as fusion tag or chemical modification.
In this study, we developed and characterized not only a novel and profitable procedure
to immobilize proteins to a solid phase, but also a new affinity pair, which has major
advantages to other commercial available tag systems.
3.3.1 MADA activated resins as tailor-made supports for a broad range of
applications
An efficient way to covalently attach proteins to a stationary phase is by forming a
thioether bond between an activation group on the resin and the sulfhydryl group of
an exposed and reduced cysteine on the protein to be immobilized. SulfoLink (Thermo
Scientific) is the most commonly used commercial available resin containing sulfhydryl-
reactive chemistry. It is based on iodoacetamide groups that form stable thioether bonds
preferably at physiologic or alkaline conditions. Interestingly, a long, hydrophobic spacer
is introduced between the resin and the active group, which can be disadvantageous for
downstream experiments, e.g. by causing unspecific binding of proteins. In addition,
haloacetamide derivatives predominantly react with cysteine side chains, but also other
residues such as tyrosines, histidines and tryptophan can be modified.
Another possibility to activate resins to react with thiol groups is using maleimide chem-
istry. The reaction occurs at almost neutral pH conditions and the formation of a cova-
lent thioether bond does not result in any side products. Surprisingly, the chemistry is
widespread for labeling of proteins with biotin or fluorophores but is not routinely used
for immobilization of proteins to beads, although it is very straight forward and requires
mainly cost-efficient compounds during production.
The MADA 2B Sepharose characterized in this study is activated by MADA (a propri-
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etary chemistry on beads developed in our lab) that reacts with the sulfhydryl group of
the cysteins (see figure 2.14). In addition, a Tris moiety is introduced to the resin as
well, providing an overall hydrophilicity of the resin. This moiety can also be exchanged
for charges or weak hydrophobicity, according to the needs of the respective application.
As expected, the resin is highly specific towards reduced cysteins, enabling to couple a
variety of different ligands such as ProteinA, the ZZ domain-recognizing affibody ZpA963,
streptavidin or designed binding constructs as depicted in figure 2.20A. Ideally, the cou-
pled proteins contain only one exposed cysteine to enable directed immobilization. Hence,
cysteine residues were introduced to the extreme C-terminus of the proteins after a short
glycine-serine rich spacer, enabling a defined distance between the resin and the folded
structures of the protein.
Efficient coupling was observed in presence of the main standard buffer systems at neu-
tral and slightly alkaline conditions (pH 6.5 - 8.5) and at temperatures from 4℃ to 37℃.
Coupling is prevented in presence of the reducing agents DTT or TCEP but thioether
formation occurs in presence of NaBH4 and the routinely used bacteriostatic NaN3.
The MADA activated 2B Sepharose or magnetic beads can be used for a broad range of
biochemical applications. (1) Affinity chromatography (2) Pull-down assays (3) Immuno-
precipitation experiments and (4) Purification of large protein complexes from a lysate.
In all applications tested, an extremely low background binding was observed and in com-
parison to commercially available affinity resins, the MADA resin was either as efficient
as the commercial products or even performed superior in terms of background binding
or capacity.
The easy and cheap production of the MADA resin and its modularity is highly beneficial.
In principle, it allows every laboratory to create an affinity resin tailor-made for their
respective application without the need to compromise. The chemistry can be applied
to all common resins, such as Sepharose, silica or magnetic beads. Sepharose and silica
resins are mainly used for protein purification purposes but also small scale interaction
studies. Magnetic beads however are not used for protein purification as the yield is in
the µg range. But this support is commonly used in interaction studies and for high-
throughput screenings such as phage display, respectively. Depending on the application,
the coupling density of the affinity protein to the MADA resin can also be individually
adjusted. The larger the complexes or structures are that should be pulled out from a
lysate, the lower the coupling density of the resin should be to prevent steric hinderance or
clashes of the complexes of interest. As coupling is performed in-house, these parameters
can be influences, whereas this is not the case for commercial available systems that tend
to have a rather high coupling density for a maximal yield of “normal sized” proteins. To
further decrease the probability of steric hinderance on the resin, the spacer introduced
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to the affinity protein between the C-terminal cysteine and the folded domain structure
can be elongated. As mentioned previously, the MADA resin used in this study contains a
hydrophilic Tris moiety. Depending on the application, this hydrophilic component can be
exchanged to charged or hydrophobic moieties. For basic proteins, e.g. histones or ribo-
somal proteins, a slightly positive charged resin could be beneficial to avoid ion exchange
effect that might interfere with proper elution of the protein from the resin.
Depending on the application, various ligands can be immobilized to the resin. Most
common are streptavidin, ProteinA/ZZ-domain, or the affibody ZpA963 recognizing ZZ-
tagged proteins. Besides these obvious affinity proteins, binding proteins can be designed
for a specific purpose (see figure 2.20). Here, the construct enables to perform immuno-
precipitation experiments, where the pulled out complexes are not eluted by acidic elution
but can be eluted in native buffer by protease cleavage. This is a novel technique to purify
large protein complexes or even cellular structures by affinity chromatography without
utilizing multistep protocols including different density centrifugation cycles, respectively.
Another binding construct could make use of the Importinβ mutant fused to a protease
cleavage site and the C-terminal cysteine. Coupled to MADA magnetic beads, the resin
should be able to specifically pull out nuclear pore components or even annulate lamellae
from a lysate as the Importinβ mutant is known to bind nucleoporins (Kutay et al., 1997).
3.3.2 Barnase:Barstar affinity tag system
Affinity chromatography is based on a pair of molecules that ideally strongly bind to each
other in a highly specific manner. One of the most prominent affinity pairs is streptavidin
binding to the small molecule biotin. Streptavidin is a 16kDa protein produced by the
bacteria Streptomyces avidinii and was first described by Tausig and Wolf (1964). It binds
biotinylated proteins with extremely high affinity of KD=10
-14M (Green, 1990) and once
formed the bond can resist broad ranges of pH, temperatures, organic solvents or dena-
turing compounds. However, besides these advantageous features, the affinity pair also
has severe disadvantages. (1) Biotin is present in all living cells at least in small amounts.
Hence, whenever using streptavidin resins to extract proteins from a lysate, endogenous
biotin will cause background binding, which might interfere with proper evaluation of re-
sulting data. (2) Streptavidin itself is rather small, but it forms a homotetramer with
a size of around 60kDa. Coupling the tetramer to the resin causes two major problems:
either the tetramer is attached by four streptavidin subunits building up a meshwork
which might interfere with binding and accessibility of large molecules to the resin, or,
if a tetramer is attached by fewer than four subunits, a leakage of streptavidin from the
matrix is possible. (3) Streptavidin itself is difficult to express and to purify in large
amounts from E.coli. Even shortened versions, that are reported to show a higher level of
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expression as the wild type (Sano et al., 1995), have severe solubility problems. (4) Strep-
tavidin recognizes biotinylated proteins, a modification, that is not efficiently introduced
to proteins containing a biotinylation site when expressed in E.coli. Thus, the protein has
to be either co-expressed with the biotinylation enzyme BirA, or a chemical or enzymatic
modification has to be performed in vitro after purification. In both cases, the production
of biotinylated proteins that can be recognized by streptavidin, requires additional hands
on time as compared to simply expressing a fusion protein.
The extracellular RNase Barnase and its intracellular inhibitor Barstar show advantages
over the streptavidin:biotin affinity pair in all four aspects. The pair is formed by two
polypeptide chains, thus a target protein must be fused to either Barstar or Barnase but
no additional modification is required. The small size of the proteins and their monomeric
nature enable the direct coupling of defined amounts to a stationary phase without the risk
of forming an intertwined layer that is prone to interfere with proper target protein bind-
ing or leakage of non covalently bound subunits. The strong interaction between Barnase
and Barstar (KD= 10
-14, Schreiber and Fersht, 1993) that even tolerates ionic strengths of
∼5M NaCl, prevents leakage of the fused target protein once bound to the affinity partner.
This however requires elution of the target protein by protease cleavage and not by any
means of competition as it is the case for His-tagged proteins and imidazole, respectively.
Elution by protease cleavage is highly specific. Only proteins containing the protease
recognition site are efficiently cleaved off the resin whereas proteins unspecifically binding
the resin remain unaffected. This is beneficial in sample preparation, mainly for subse-
quent experiments that either depend on sensitive detection such as mass spectrometry
or require highly homogenous samples, e.g. dynamic light scattering or protein crystal-
lization. In addition, also unspecific binding of endogenous proteins to the immobilized
affinity protein is very low as the Barnase:Barstar interaction is highly specific. Barstars
only function in the bacterial cell is to bind and thus sequester the enzymatic activity of
barnase. Barnase however functions extracellularly.
As previously described, it must be possible to efficiently express and purify both proteins
of the affinity pair also in absence of the binding partner. Barnase, which hydrolyzes ri-
bonucleotides by an acid-base mechanisms using residues Glu73 and His102 (Mossakowska
et al., 1989), causes lethality when expressed in E.coli. Hence, the active center was mu-
tated by replacing His102 with aspartic acid. The introduced negative charge prevents the
catalytic mechanism and barnase can be expressed to high levels in E.coli. Although the
wild type barstar protein is able to bind the mutated barnase protein (Hartley, 1993), a
compensatory positive charge was introduced by replacing Cys42 to a lysine. The obtained
crystal structure at 1.98Å resolution revealed that the aspartic acid and lysine side chains
are in very close proximity (2.7Å) probably forming an additional shielded salt bridge,
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which makes the complex comprised of this mutant protein pair extremely stable.
Barnase seems to have a very stable fold. It can be expressed in a soluble manner to high
amounts and it supports other proteins solubility when used as N-terminal fusion tag as
in case of full length streptavidin (preliminary data, not shown). By contrast, Barstar has
severe problems in solubility when expressed alone. Although its solubility is supported
by ZZ-fusion tags, H14-brSUMO or H14-brSUMO-MBP tags do not prevent insolubility
of the protein. Barstar contains a parallel β-sheet located on the opposite site of the
Barnase:Barstar interface, which seems to be imperfectly packed. Hydrophobic residues
are solvent exposed which makes the entire protein more prone to aggregation. By mu-
tating the β-sheet region, solubility could be slightly increased, however it still did not
result in an overall stable fold. Thus it is not suitable as N-terminal fusion tag, which was
also experimentally shown by expression of a Barstar-brSUMO-GFP construct resulting
in insoluble protein (data not shown).
Interestingly, although much is known about the binding and thus inhibition of Barnase
by Barstar, the question what happens to the complex in the cell in terms of degradation
remains unanswered. We speculate that the imperfect folding of the Barstar molecule,
which might even be enhanced upon barnase binding, is beneficial for a short protein
half-life and thus a quick degradation of the Barnase:Barstar complex, removing a highly
toxic protein from the cellular interior. How this degradation occurs, is however unclear.
Recently, an ubiquitin - like system was described for Mycobacterium tuberculosis (re-
viewed in Burns and Darwin, 2010). A prokaryotic ubiquitin-like protein (Pup) can be
attached to lysine residues of the target protein with the help of two additional proteins,
Dop and PafA, thus targeting the protein to the protease complexes, ClpP respectively.
The B.amyloliquefaciens Barstar proteins has two consecutive N-terminal lysine residues,
that are also fully exposed when looking at the structure, thus being putative degradation
targeting sites.
The Barstar solubility problem was solved by switching from the B.amyloliquefaciens se-
quence to the sequence identified from the thermophilic Bacillus species G.thermoglucosida-
sius, which is known to ideally grow at temperatures ranging from 40℃ to 70℃ (Nazina
et al., 2001). Proteins from thermophilic organisms tend to have a more stable fold and
thus could result in stable and soluble barstar protein when expressed and purified alone.
Comparing complexes containing different barnase and barstar proteins by Thermofluor
revealed that the pair containing not only Barstar but also the corresponding Barnase
protein from G.thermoglucosidasius has the highest melting temperature and thus is the
most stable complex tested. The elevated melting temperature of the complex can again
be explained by the increased stability of the individual proteins. When comparing the
Barstar sequences of the two organism, a significant N-terminal extension can be observed
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that potentially folds back onto the structure, thereby shielding the hydrophobic core of
the protein that seems to be solvent exposed in B.amyloliquefaciens Barstar. However,
full understanding of the fold of G.thermoglucosidasius Barstar required high resolution
structures.
3.3.2.1 Potential application
The aim of the project was, to identify a protein pair that can be used for affinity chro-
matography. The Barnase:Barstar system fulfills all our requirements regarding size,
monomeric state and high affinity binding. In addition, the proteins taken from the
hyperthermophilic Geobacillus thermoglucosidasius can be expressed in a soluble manner
and be produced in high amounts, the strong binding between the affinity pair prevents
leakage of the target protein from the resin and background binding towards the affinity
proteins is very low.
Frey and Görlich (2014b) published a strategy for stochiometric protein complex purifica-
tion based on two resins (here Ni2+ and ZZ-affibody resin) and two orthogonal proteases
(see figure 4.1). This system can be further expanded also for trimeric complexes by using
the Barnase:Barstar system together with an additional orthogonal protease, e.g. based
on the Atg8 system (unpublished data). We also intend to use the Barnase:Barstar system
as affinity pair during phage display, replacing the streptavidin:biotin system.
Besides affinity chromatography, the Barnase:Barstar pair can also be used to crosslink
other molecules without the need of chemical modifications. First approaches in this di-
rection were performed by Deyev et al. (2003), producing a multimeric miniantibody by
linking scFv fragments by heterodimeric B.amyloliquefaciens Barnase:Barstar complexes.
In principle the concept can be as well used to tether proteins to cellular structures also in
vivo, similar to the rapamycin inducible system based in FKBP12 and FRB (Banaszynski
et al., 2005).
3.4 Perspectives
In this study, we developed and characterized a new affinity resin based on a MADA ac-
tivated stationary phase and the Barnase:Barstar protein pair as affinity tag system. It
remains to be evaluated which of the two proteins is better suited as N-terminal tag or
as immobilized stationary phase, respectively. Requirements for a good tag protein would
be that the tag itself helps the fusion protein with regards to expression and solubility.
Preliminary data suggest that Barnase as N-terminal fusion tag is able to solubilize full
length streptavidin, a protein that can be solubly expressed when fused to larger tags
but remains insoluble when expressed with small tags such as H14-brSUMO only. Similar
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experiments need to be performed with Barstar as fusion protein. Good characteristics
for the stationary phase protein are a stable fold, that might even be able to tolerate
denaturation and subsequent renaturation. This would enable to recover the resin after
use. Currently, we examine the ability of a Barstar Sepharose and a Barnase Sepharose
to maintain their binding ability towards their corresponding partner even after thorough
washing with guanidine hydrochloride or SDS. The MADA Sepharose itself needs to be
further analyzed for ideal quenching components and long-term storage conditions.
In conjunction with the MADA resin, we would like to perform binding assays and pull-
down experiments, exploiting the extremely low background binding, the strong affinity
of the tag system and the ability to purify also large complexes in a native manner. We
aim to genetically modify bacterial ribosomes with the Barnase or Barstar tag, by fusing
them to the most exterior ribosomal proteins such as L1 protein. The tag would be ex-
tremely small with either 13kDa or 11kDa, decreasing the risk that the tag interferes with
the function of the ribosome. Pulling out the tagged ribosomes with MADA activated
magnetic beads containing the immobilized affinity partner and subsequent elution using
proteases would enable to purify ribosomes under native and rather mild conditions in
a one-step manner, circumventing tedious purification protocols using density centrifuga-
tion, respectively. If the procedure is successful, similar strategies can be applied for the
purification of entire organelles such as mitochondria.
In addition, we identified another potential affinity tag system based on the plasmid-
encoded antibacterial protein Colicin produced by some bacteria, such as E.coli. On the
same plasmid, immunity proteins are encoded in order to protect the bacteria against
the cytotoxic activity of the colicin. The affinity between the proteins is considered to
be one of the highest measured affinities between two proteins with a equilibrium disso-
ciation constant of 9.3 x 10-17 M (reviewed in Kolade et al., 2002). So far preliminary
experiments with the non-toxic C-terminal domain of colicin E9 and its full length immu-
nity protein 9 were performed, showing that both of them can be expressed in E.coli and
further purified. Binding assays revealed that the recombinant proteins bind to each other.
Finally we aim to share our findings with the scientific community, thereby giving a guide
how to easily produce a reasonable and tailor-made affinity resin for an extremely broad
range of individual applications. Additionally, we aim to establish the Barnase:Barstar
system as beneficial alternative to the - partially - disadvantageous streptavidin:biotin
system.
4 Materials and Methods
4.1 Materials
4.1.1 Chemicals and Reagents
If not stated otherwise, all chemical were purchased to the highest available purity from
Calbiochem (San Diego, California, USA), Gibco Life Technologies (Paisley, United Kingdom),
Merck (Darmstadt, Germany), MoBiTech (Göttingen, Germany), Pharmacia (Uppsala,
Sweden), Pierce (part of ThermoScientific, Rockford, Illinois, USA), Promega (Madison,
Wisconsin, USA), Quiagen (Hilden, Germany), Roche Diagnostics (Mannheim, Germany),
Carl Roth (Karlsruhe, Germany) or Sigma-Aldrich (St. Louis, Missouri, USA).
4.1.2 Instruments
ÄKTA Purifyer Pharmacia, Upsala, Schweden
Biophotometer-plus Eppendorf AG, Hamburg, Germany
BioTek Synergy H4 Plate Reader BioTek, Friedrichshall, Germany
Climo - Shaker ISF1-X Kuhner AG, Basel, Switzerland
FLA-7000 Scanner Fujifilm, Tokio, Japan
GenePulserTM BioRad, Hercules, California, USA
Microlab Star Pipetting Robot Hamilton Robotics, Bonaduz, Switzerland
iMac 3.1 GHz Intel Core i5 Apple, Cupertino, California, USA
NanoDrop 2000c PeqLab, Erlangen, Germany
Nikon D300 Nikon, Tokio, Japan
Odyssey Licor, Lincoln, Nebraska, USA
Perfection V700 Photo Scanner Epson, Tokio, Japan
Pipetman pipettes Gilson, Middleton, Wisconsin, USA
SensoQuest Lab Cycler SensoQuest, Göttingen, Germany
Sieving machine AS300 Retsch, Germany
Sonifier 450 Branson, United Kingdom
Thermomixer comfort Eppendorf AG, Hamburg, Germany




Cooled tabletop centrifuge - Eppendorf AG, Hamburg, Germany
Tabletop centrifuge - Eppendorf AG, Hamburg, Germany
Multifuge 3L-R - Thermo Scientific, Massachusetts, USA
RC6 Plus centrifuge F9, F10, F14 Sorvall/Thermo Scientific, Massachusetts, USA
WX Ultra centrifuge T647.5, T125.0 Sorvall/Thermo Scientific, Massachusetts, USA
Discovery M120 S45A, S55S Sorvall/Thermo Scientific, Massachusetts, USA
4.1.3 Software
Bookends 11.3.7 Sonny Software, Chevy Chase, Maryland, USA
ChemSketch 14.0 Advanced Chemistry Development, Inc., Toronto, Canada
GeneDesigner 2 DNA2.0, Menlo Park, California, USA
Illustrator CS3/5 Adobe Systems, San Jose, California, USA
Lasergene 8 DNA-Star, Madison, Wisconsin, USA
LATEX http://www.latex-pro ject.org/
Mac OS X Vers.10.6.7 Apple, Cupertino, California, USA
Microsoft Office Microsoft Cooperation, Champaign, Illinois, USA
Oligo 7 Molecular Biology Insights, Cascade, Colorado, USA
Photoshop CS3/5 Adobe Systems, San Jose, California, USA
Prism 5 GraphPad Software, La Jolla, California, USA
MacPyMol Schrödinger, Portland, Oregon, USA
Scaffold 3 Proteome Software, Portland, Oregon, USA
4.1.4 Bioinformatic Resources
BLAST (Basic Local Alignment Search Tool) http://blast.ncbi.nlm.nih.gov
NCBI protein database http://www.ncbi.nlm.nih.gov/protein
PDB (Protein Data Bank) http://www.rcsb.org/pdb
PFAM protein families database http://pfam.xfam.org




4.1.5 Escherichia coli medium
LB medium 2YT medium SOB TB
10 g Tryptone 16g Tryptone 100 g Tryptone 12g Tryptone
5g Yeast extract 10g Yeast extract 25 g Yeast extract 24g Yeast extract





ddH2O to 1L ddH2O to 1L ddH2O to 5L ddH2O to 1L
For the pouring of agar plates, 15g agar were added to 1 L of medium. For selection and
culturing of bacteria after transformation, 2TY plates were supplemented with the ap-
propriate antibiotics in the following concentrations: Ampicillin (100 µg/ml), Kanamycin
(25 µg/ml),Spectinomycin (50 µg/ml) or Chloramphenicol (50 µg/ml). The expression
cultures were grown in either 2YT or TB medium supplemented with the appropriate
antibiotics.
4.1.6 Escherichia coli strains
Table 4.1: E.coli strains used in this study
Strain Genotype Company
BL21 DE3 Star F-ompT gal dcm lon hsdSB(rB-mB-) λ(DE3 [lacI
lacUV5-T7 gene 1 ind1 sam7 nin5])
Invitrogen
(Karlsruhe)




NEB5α F´ F´ proA+B+ lacIq ∆(lacZ)M15 zzf::Tn10
(TetR) / fhuA2∆(argF-lacZ)U169 phoA glnV44





NEB10β F’ F’ ∆(ara-leu) 7697 araD139 fhuA ∆lacX74 galK16
galE15 e14-φ80dlacZ∆M15 recA1 relA1 endA1 nupG




NEB Express fhuA2 [lon] ompT gal sulA11 R(mcr-73::miniTn10–





TOP10F’ F’[lacQ, Tn10 TetR] mcrA ∆(mrr-hsdRMS-mcrBC),
80lacZ∆M15 ∆lacX74, deoR, recA1, araD139 (ara-





10x PfuS polymerase buffer:
20mM Tris-HCl pH9.0, 250mM KCl, 15mM MgSO4, 100mM (NH4)2SO4, 1% Tween20,
1mg/ml BSA
10x Ligation buffer:
500mM Tris pH7.5, 100mM MgCl2, 100mM DTT, 10mM ATP, 250µg/mL BSA
Orange G DNA loading buffer:
10mM Tris-HCl pH8.0, 10mM EDTA pH8.0, 50% Glycerol (w/v), 0.25% OrangeG (w/v)
DNA ladder:
50ng/µl 1kb-Ladder or 50ng/µl 100kb-Ladder in Orange sample buffer
50x TAE:
242g Tris Base, 57.1mL acetic acid, 100mL 0.5M EDTA pH8.0, add to 1L with ddH20
Tris/HCl pH 7.5:
Tris buffers were prepared according to Henderson-Hasselbach equation (pH = pKs +
log(S/B)). Prior to usage, the pH was measured and, if necessary, manually adjusted.
16.57g Tris Base and 136.04g Tris/HCl were diluted in 1L ddH2O.
0.5M EDTA pH 8.0:
372.3g EDTA were weight and added to 800ml ddH20. NaOH pellets were added to in-
crease the pH and thus allow EDTA to solve. Finally, the volume was adjusted to 1L with
ddH20.
SDS Sample Buffer:
3% SDS, 125mM Tris/HCl pH6.8, 50mM DTT, 1M sucrose, Bromphenolblue
10x SDS-PAGE running buffer:
300g Glycine, 60g Tris Base, 24g SDS, add to 2L with ddH20.
Coomassie stock solution:
2% (w/v) Coomassie brilliant blue G250 in 50% Ethanol
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Colloidal Coomassie stock solution:
0.08% (w/v) Coomassie brilliant blue G250, 1.6% (v/v) ortho-Phosphoric acid, 8% (w/v)
Ammonium sulfate, 20% (v/v) Methanol
10x Blotting Buffer:
100ml 10x SDS-PAGE running buffer, 200ml MeOH, 0.03% SDS, add to 1L with ddH20
10x TBS Buffer:
50g Tris/HCl, 14.5g Tris Base, 175.2g NaCl, add 20 1L with ddH20
10x PBS (pH 7.4):
137mM NaCl, 2.7mM KCl, 8.1mM Na2HPO4, 1.76mM KH2PO4
Fixation Buffer:
50% MeOH, 40% ddH20, 10% Acetic Acid
20x E-mix:
20mM HEPES pH7.5, 250mM Sucrose, 200mM Creatine phosphate, 10mM ATP, 10mM
GTP, 1mg/ml Creatine kinase
50x CPAG:
0.331g ATP, 0.0654g GTP, 2.616g creatine phosphate, fill up to 9ml with ddH20, adjust
pH to pH7.8 with KOH, then fill up to 10ml with ddH20.
4.1.8 Oligonucleotides
The oligonucleotides used in this study were designed using the Oligo 6.8 (Molecular Bi-
ology Insights Inc., Cascade, Colorado, USA) software and synthesized by Sigma-Aldrich
(St. Louis, Missouri, USA) or IBA GmbH (Göttingen, Germany). Standard oligos were
purified by desalting. HPLC-purified and 5’-phosphorylated oligos were used for mutage-
nesis PCR and cloning with annealed oligos.
4.1.9 Gene Synthesis
Several genes encoding proteins used in this study were designed for optimized expression
in E.coli using the GeneDesigner 2 (DNA2.0) software. In addition, these constructs were
rendered such that they lack internal ribosome binding sites or commonly used restric-
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tion enzyme recognition sites. The constructs were de novo synthesized by GeneScript
(Piscataway, New Jersey, USA).
4.1.10 Antibodies
The following antibodies were used in this study.
Table 4.2: Antibodies used in this study
Antibodies against translation factors were purified from rabbit sera. Antigens for rabbit im-
munization and sera preparation was performed by Dr. Cathrin Enke. Antibodies against
translation factors were raised against Triticum aestivum proteins (if not stated otherwise).







α-eIF3a primary 1µg/ml This study
α-eIF3b primary 1µg/ml yes This study
α-eIF3c primary 1µg/ml yes This study
α-eIF3d primary 1µg/ml yes This study
α-eIF3e primary 1µg/ml This study
α-eIF3f primary 1µg/ml This study
α-eIF3g primary 1µg/ml This study
α-eIF3h primary 1µg/ml This study
α-eIF3i primary 1µg/ml This study
α-eIF3j primary 1µg/ml This study
α-eIF3k primary 1µg/ml This study
α-eIF3L primary 1µg/ml This study
α-eIF3m primary 1µg/ml yes This study
α-eIF1 primary - yes Enke (2010)
α-eIF2α primary 1µg/ml yes Enke (2010)
α-eIF2β primary 1µg/ml Enke (2010)
α-eIF2Bβ primary - Enke (2010)
α-eIF5 primary 1µg/ml Enke (2010)
α-eEF1Bβ primary 1µg/ml Enke (2010)
α-hs eIF5A N-terminal primary 1µg/ml
Lipowsky
et al. (2000)
α-hs eIF5A internal primary 1µg/ml
Lipowsky
et al. (2000)
α-GFP primary 1µg/ml yes
D. Görlich
(unpublished)
α-M13 pIII monoclonal primary 1:1000 NEB
α-Flag M2 monoclonal primary 1:1000 SIGMA




IRDye 800CW Goat α-Rabbit secondary 1:50.000 Licor, USA
IRDye 700CW Goat α-Mouse secondary 1:50.000 Licor, USA
4.1.11 Plasmids
All plasmids used in this study were cloned using the standard techniques in molecular
biology described in 4.2.1. Plasmids were used either for in vitro translation (see table
4.3) or for protein expression in E.coli (see table 4.4).
Table 4.3: In vitro translation plasmids used in this study
All constructs described are based on the same backbone, containing an N-terminal T7 pro-
motor and a 5’UTR based on Kozak (1994). At the end of the open reading frame (ORF), a
TMV 3’ translation enhancer was introduced followed by a poly-A tail and the T7 terminator.
All constructs harbor a kanamycin resistance. The backbone was constructed by Dr. Cathrin
Enke. For details see Enke (2010).
Plasmid number Construct Reference
T38 H21-TEV-Firefly Luciferase Dissertation (Enke, 2010)
JS250 H10-12xPro-MS stretch-Nup98FG(P→S, short) This study
JS251 H10-12xSer-MS stretch-Nup98FG(P→S, long) This study
JS331 3xFLAG-12xPro-MS stretch-Nup98FG(P→S, short) This study
JS332 3x-FLAG-12xSer-MS stretch-Nup98FG(P→S, long) This study
JS359 3x-FLAG-12xSer-Firefly Luciferase This study
JS425 3x-FLAG-S.c.-Ldb17 This study





Table 4.4: E.coli expression vectors used in this study
The table lists the most important parameters when expressing and purifying the mentioned constructs. T= Tris/HCl, pH 7.5; N= NaCl; I= Imidazole;
D= DTT; M= MgCl2, H= Hepes/KOH, pH7.4. Protease elution was performed on-column with either SENP1 protease or NEDP1 protease.
Expression conditions Purification Conditions







pJS040 H14-eIF3a Kan ColE1 18℃ o/n Top10F’ 100 - - - This study
pJS041 H14-eIF3b Kan ColE1 18℃ o/n Top10F’ 100 50T, 500N, 2I, 1D 500 I - This study
pJS042 H14-eIF3c Kan ColE1 18℃ o/n Top10F’ 100 50T, 500N, 2I, 1D 500 I - This study
pJS043 H14-eIF3d Kan ColE1 18℃ o/n Top10F’ 100 50T, 500N, 2I, 1D 500 I - This study
pJS044 H14-eIF3e Kan ColE1 18℃ o/n Top10F’ 100 - - - This study
pJS045 H14-eIF3f Kan ColE1 18℃ o/n Top10F’ 100 - - - This study
pJS046 H14-eIF3g Kan ColE1 18℃ o/n Top10F’ 100 - - - This study
pJS047 H14-eIF3h Kan ColE1 18℃ o/n Top10F’ 100 50T, 500N, 2I, 1D 500 I - This study
pJS048 H14-eIF3i Kan ColE1 18℃ o/n Top10F’ 100 - - - This study
pJS049 H14-eIF3j Kan ColE1 18℃ o/n Top10F’ 100 50T, 500N, 2I, 1D 500 I - This study
pJS0410 H14-eIF3k Kan ColE1 18℃ o/n Top10F’ 100 50T, 500N, 2I, 1D 500 I - This study
pJS0411 H14-eIF3L Kan ColE1 18℃ o/n Top10F’ 100 - - - This study
pJS0412 H14-eIF3m Kan ColE1 18℃ o/n Top10F’ 100 - - - This study
T238 H14-TEV-eIF3a Kan ColE1 18℃ o/n Top10F’ 100 - - - Enke (2010)
T209 H14-TEV-eIF3b Kan ColE1 18℃ o/n Top10F’ 100 50T, 500N, 2I, 1D 500 I - Enke (2010)
T208 H14-TEV-eIF3c Kan ColE1 18℃ o/n Top10F’ 100 50T, 500N, 2I, 1D 500 I - Enke (2010)
T207 H14-TEV-eIF3d Kan ColE1 18℃ o/n Top10F’ 100 50T, 500N, 2I, 1D 500 I - Enke (2010)
T206 H14-TEV-eIF3e Kan ColE1 18℃ o/n Top10F’ 100 - - - Enke (2010)
T242 H14-TEV-eIF3f Kan ColE1 18℃ o/n Top10F’ 100 - - - Enke (2010)
T205 H14-TEV-eIF3g Kan ColE1 18℃ o/n Top10F’ 100 - - - Enke (2010)
T204 H14-TEV-eIF3h Kan ColE1 18℃ o/n Top10F’ 100 50T, 500N, 2I, 1D 500 I - Enke (2010)
T202 H14-TEV-eIF3i Kan ColE1 18℃ o/n Top10F’ 100 - - - Enke (2010)
T203 H14-TEV-eIF3j Kan ColE1 18℃ o/n Top10F’ 100 50T, 500N, 2I, 1D 500 I - Enke (2010)
T181 H14-TEV-eIF3k Kan ColE1 18℃ o/n Top10F’ 100 50T, 500N, 2I, 1D 500 I - Enke (2010)
T210 H14-TEV-eIF3L Kan ColE1 18℃ o/n Top10F’ 100 - - - Enke (2010)
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Kan ColE1 18℃ o/n Top10F’ 100 - - - This study
JS057 ZZ-TEV-eIF3a Kan ColE1 18℃ o/n Top10F’ 100 - - - This study
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JS058 ZZ-TEV-eIF3b Kan ColE1 18℃ o/n Top10F’ 100 50T, 500N, 2I, 1D 500 I - This study
JS059 ZZ-TEV-eIF3c Kan ColE1 18℃ o/n Top10F’ 100 50T, 500N, 2I, 1D 500 I - This study
JS060 ZZ-TEV-eIF3d Kan ColE1 18℃ o/n Top10F’ 100 50T, 500N, 2I, 1D 500 I - This study
JS061 ZZ-TEV-eIF3e Kan ColE1 18℃ o/n Top10F’ 100 50T, 500N, 2I, 1D 500 I - This study
JS062 ZZ-TEV-eIF3f Kan ColE1 18℃ o/n Top10F’ 100 50T, 500N, 2I, 1D 500 I - This study
JS063 ZZ-TEV-eIF3g Kan ColE1 18℃ o/n Top10F’ 100 50T, 500N, 2I, 1D 500 I - This study
JS064 ZZ-TEV-eIF3h Kan ColE1 18℃ o/n Top10F’ 100 50T, 500N, 2I, 1D 500 I - This study
JS065 ZZ-TEV-eIF3i Kan ColE1 18℃ o/n Top10F’ 100 50T, 500N, 2I, 1D 500 I- - This study
JS066 ZZ-TEV-eIF3j Kan ColE1 18℃ o/n Top10F’ 100 50T, 500N, 2I, 1D 500 I - This study
JS067 ZZ-TEV-eIF3k Kan ColE1 18℃ o/n Top10F’ 100 50T, 500N, 2I, 1D 500 I - This study
JS068 ZZ-TEV-eIF3L Kan ColE1 18℃ o/n Top10F’ 100 - - - This study












Amp pSC101 18℃ o/n Top10F’ 100
-50T, 500N,
2I, 1D




















Amp pSC101 18℃ o/n Top10F’ 100 50T, 500N, 2I, 1D 500 I - This study
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Kan ColE1 18℃ o/n Top10F’ 100 - - - This study
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Spec p15A 18℃ o/n Top10F’ 100 50T, 500N, 2I, 1D 500 I - This study





Table 4.4 – Continued from previous page
Expression conditions Purification Conditions






















Kan ColE1 18℃ o/n
NEB
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NEB
Express
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NEB
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NEB
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Kan ColE1 18℃ o/n
NEB
Express




Kan ColE1 18℃ o/n
NEB
Express




Kan ColE1 18℃ o/n
NEB
Express
100 50T, 300N, 2I, 1D Protease - This study
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Kan ColE1 18℃ o/n
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NEB
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Kan ColE1 18℃ o/n
NEB
Express




Kan ColE1 18℃ o/n
NEB
Express
100 50T, 300N, 2I, 1D Protease - This study
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Kan ColE1 18℃ o/n
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Kan ColE1 18℃ o/n
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NEB
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Kan ColE1 18℃ o/n
NEB
Express
100 50T, 300N, 2I, 1D Protease - This study
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Kan ColE1 18℃ o/n
NEB
Express




Kan ColE1 25℃ 6h
NEB
Express





Kan ColE1 25℃ 6h
NEB
Express





Kan ColE1 18℃ o/n
NEB
Express






Kan ColE1 18℃ o/n
NEB
Express






Kan ColE1 18℃ o/n
NEB
Express






Kan ColE1 provided by K.Gencalp
K.Gencalp
(unpublished)
pDG81 H14-TEV-CAS Kan ColE1 25℃ 6h
NEB
Express






Kan ColE1 30℃ 6h
NEB
Express


















Kan ColE1 18℃ o/n
NEB
Express






Kan ColE1 18℃ o/n
NEB
Express
200 50T, 200N, 2I, 1D Protease -
H.Chug
(unpublished)





Table 4.4 – Continued from previous page
Expression conditions Purification Conditions










Kan ColE1 18℃ o/n
NEB
Express






Kan ColE1 30℃ 3h
NEB
Express






Kan ColE1 30℃ 3h
NEB
Express







Kan ColE1 30℃ 3h
NEB
Express






Amp ColE1 30℃ 3h
NEB
Express
200 50T, 500N 500 I -
S.Frey
(unpublished)
pDG2376 H14-ZpA963(cys) Kan ColE1 30℃ 3h
NEB
Express






Amp ColE1 30℃ 3h
NEB
Express







Kan ColE1 30℃ 3h
NEB
Express





Kan ColE1 30℃ 3h
NEB
Express












Kan CoLE1 provided by T.Pleiner
T.Pleiner
(unpublished)
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Kan ColE1 30℃ 3h
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Kan ColE1 30℃ 3h
NEB
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Kan ColE1 30℃ 3h
NEB
Express






Kan ColE1 30℃ 3h
NEB
Express






Kan ColE1 30℃ 3h
NEB
Express
200 50T, 300N, 2I, 1D - -
D.Görlich
(unpublished)
pDG2455 ZZ-Barstar(C42K) Kan ColE1 30℃ 3h
NEB
Express
200 50T, 300N, 2I, 1D - -
D.Görlich
(unpublished)
pDG2456 ZZ-Barstar(C42A) Kan ColE1 30℃ 3h
NEB
Express
200 50T, 300N, 2I, 1D - -
D.Görlich
(unpublished)
pDG2457 ZZ-Barstar(C42V) Kan ColE1 30℃ 3h
NEB
Express
200 50T, 300N, 2I, 1D - -
D.Görlich
(unpublished)
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pDG2458 ZZ-Barstar(C42I) Kan ColE1 30℃ 3h
NEB
Express






Kan ColE1 30℃ 3h
NEB
Express
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Express
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NEB
Express





Kan ColE1 30℃ 3h
NEB
Express
200 50T, 300N, 2I, 1D Protease - This study
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Kan ColE1 30℃ 3h
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Kan ColE1 30℃ 3h
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Express
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Kan ColE1 30℃ 3h
NEB
Express
200 50T, 300N, 2I, 1D - - This study
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Kan ColE1 30℃ 3h
NEB
Express





Kan ColE1 30℃ 3h
NEB
Express




Kan ColE1 30℃ 3h
NEB
Express




Kan ColE1 30℃ 3h
NEB
Express




Kan ColE1 30℃ 3h
NEB
Express




Kan ColE1 30℃ 3h
NEB
Express
200 50T, 300N, 2I, 1D Protease + This study
JS514 ZZ-G.t.Barstar Kan ColE1 30℃ 3h
NEB
Express
200 50T, 300N, 2I, 1D - - This study
JS515 ZZ-B.puBarstar Kan ColE1 30℃ 3h
NEB
Express
200 50T, 300N, 2I, 1D - - This study
JS516 ZZ-B.pl1Barstar Kan ColE1 30℃ 3h
NEB
Express
200 50T, 300N, 2I, 1D - - This study
JS517 ZZ-B.pl2Barstar Kan ColE1 30℃ 3h
NEB
Express





Kan ColE1 30℃ 3h
NEB
Express





Amp pSC101 30℃ 3h
NEB
Express
200 50T, 300N, 2I, 1D Protease + This study
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Amp pSC101 30℃ 3h
NEB
Express





Amp pSC101 30℃ 3h
NEB
Express
200 50T, 300N, 2I, 1D - Protease This study











pSF1878 ZZ-B.pl2Barstar Kan ColE1 180℃ o/nh
NEB
Express
200 50T, 300N, 2I, 1D 500 I +
S.Frey
(unpublished)





4.2.1 Standard Techniques in Molecular Biology
All standard methods in Molecular Biology were performed on the basis of Sambrook and
Russell (2001).
4.2.1.1 Polymerase Chain Reaction (PCR)
Polymerase Chain reaction (PCR; Mullis et al., 1986) was used to amplify defined frag-
ments from a DNA template. Synthesized primers (Sigma-Aldrich, Germany) allowed to
introduce either endonuclease restriction sites on both ends of the generated DNA frag-
ment or overlapping regions on both sites for cloning using Gibson Assembly (see 4.2.1.7).
A 50µl PCR reaction was composed as described below:
xµl template DNA solution (∼ 50ng)
5µl 2.5mM dNTP-mix (containing 2,5mM of each: dGTP, dATP, dTTP, dCTP)
0.5µl 100µM forward primer
0.5µl 100µM reverse primer
0.5µl DNA polymerase
5µl 10× polymerase buffer
fill with H2O to a total volume of 50µl
For general cloning, a PfuS polymerase Tripple Mix (100ng/µl PfuS DNA polymerase,
15ng/µl Pab pyrophosphates, 2.5ng/µl Pab dUTPase (all produced in the lab by S. Frey)
and the corresponding 10x PfuS buffer (200 mM Tris/HCl pH9, 250 mM KCl, 15 mM
MgSO4, 10 mM (NH4)2SO4, 1% Tween-20, 1 mg/ml BSA) was used.
PCR reactions were performed using a SensoQuest Lab Cycler, programmed with the re-
quired temperatures and duration times.
Initial denaturation step
98℃ 2min







Tempannealing describes an average annealing temperature of a specific primer pair calcu-
lated by the Oligo software, tamplification describes the duration of amplification, depending
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on the size of the DNA fragment to be amplified and the amplification rate of the DNA
polymerase (∼30sec/kb for PfuS polymerase).
4.2.1.2 Mutagenesis Polymerase Chain Reaction
Mutagenesis PCR was performed to render DNA sequence in various ways: small parts of
a gene can be deleted, single amino acids or short amino acid stretches can be exchanged
or a single amino acid or a short amino acid stretch can be additionally added to the DNA
sequence.
For this purpose PCR primers were designed that amplify the entire plasmid of interest
therewhile introducing the intended changes by non-complementary base-pairing of the
primers. For mutagenesis PCR the primers were ordered HPLC-purified and phosphory-
lated at the 5’ end. The PCR reaction was performed as described in 4.2.1.1.
After the reaction, the PCR products were purified using the MSB Spin PCRapace Kit
(STRATEC Biomedical AG, Germany) and further digested with 1µl Dpn1 (the reaction
contained NEB buffer 3 in a ratio of 1:10) over night at 37℃ to remove the methylated
template DNA. Subsequently, the reaction was purified by DNA gel purification (4.2.1.5)
and ligated over night at 16℃. 1µl ligation reaction was then transformed into E.coli cells
and plated on selective medium.
4.2.1.3 Error-prone Polymerase Chain Reaction
Error-prone PCR reactions were performed to randomize a defined DNA sequence. Primers
were synthesized flanking and amplifying the specific sequence during the reaction. Intro-
duced endonuclease restriction sites on both ends of the DNA fragment enables subsequent
cloning, e.g. in display vectors.
Error-prone PCR was performed using the JBS Error-Prone Kit (Jena Biosciences, Ger-
many) according to the manufacturer’s instruction.
4.2.1.4 DNA Gel Electrophoresis
Agarose gel electrophoresis was used to separate DNA fragments resulting from either
PCR amplification or enzymatic restriction digest according to their size. Agarose con-
centrations varied from 0.8% (w/v) to 2.0% (w/v), depending on the expected fragment
size. DNA samples were mixed in a 1:10 (v/v) ratio with Orange-G loading buffer. For
reference, a standard marker (1kb DNA ladder, Fermentas, St.Leon-Roth, Germany) was
included.
Electrophoresis was carried out at ∼160V for 40 minutes. To visualize the DNA under
UV light, 3µl of a 20 mg/ml ethidium bromide solution were added to 100ml agarose gel.
Agarose gels were formed and run in 1x TAE buffer.
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4.2.1.5 Purification of DNA Fragments from Agarose Gel and Concentration
Determination
After DNA gel electrophoresis, DNA fragments were cut from the gel and purified by using
the Zymoclean Gel DNA recovery kit (Zymoclean Research, CA, USA) according to the
manufacturer’s instruction. In case of PCR products, the reactions were directly purified
using the MSB Spin PCRapace Kit (STRATEC Biomedical AG, Germany).
DNA concentrations were determined with a NanoDrop-2000 spectrophotometer (Thermo
Scientific, DE, USA).
4.2.1.6 Enzymatic Restriction Digest
Enzymatic restriction digest were performed to generate DNA fragments (vector back-
bones or insert) with complementary overhangs for further cloning.
All restriction endonucleases were obtained from NEB (New England Biolabs, Beverly,
MA, USA). The cleavage reaction was performed according to the manufacturer’s instruc-
tions using the provided buffers and reagents. The restriction enzymes were used in at
least 2-fold excess for 1h reaction at 37℃. A decreased amount of enzyme was added to
the reaction when incubating the reaction over night.
In case of digested vector backbones, 1µl fast alkaline phosphatase (Fermentas, St.Leon-
Roth, Germany) was added subsequently and the reaction was further incubated at 37℃
for 30 minutes. Dephosphorylation of the vector backbone prevents religation during fol-
lowing cloning steps.
4.2.1.7 Gibson Assembly Cloning
Gibson Assembly is an alternative, restriction enzyme free cloning method in which mul-
tiple double stranded DNA fragments are joined in a single isothermal reaction. Joining
occurs via overlapping ends that should ideally have a melting temperature of ≥48℃ (Gib-
son et al., 2009).
Primers containing the overlapping ends were designed using the Seqbuilder software and
primers were synthesized by Sigma-Aldrich. Next, the individual DNA fragments were
amplified by PCR and the reaction was digested with Dpn1 to remove all residual plasmid
DNA. After purification via MSB Spin PCRapace Kit, the Gibson Assembly reaction was
mixed as describes below:
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xµl DNA fragment I (∼ 30 fmol)
xµl DNA fragment II (∼ 30 fmol)
2.5µl 2x Gibson Assembly Mix
fill with H2O to a total volume of 5µlL
The reaction was incubated at 50℃ for 30 minutes prior to transformation. After recovery
the cells were plated on selective agar plates.
4.2.1.8 Ligation of DNA
Ligation was performed using the T4 ligase (prepared in the lab, 100ng/µl). Approxi-
mately 30fmol (20ng/kb) vector DNA and 60fmol (40ng/kb) insert DNA were mixed with
1µl T4 DNA ligase and 1µl 10x ligase buffer (0.5M Tris-HCl pH 7.5, 100mM MgCl2,
100mM DTT, 10mM ATP, 250µg/ml BSA) and filled up to a total volume of 10µl with
ddH2O.
After mixing, the ligation reaction was either incubated at 37℃ for 30 minutes or overnight
at 16℃. 1µl ligation reaction was then used to transform E. coli cells by electroporation.
4.2.1.9 Transformation of E. coli with DNA by electroporation
40 µl electro-competent E.coli cell suspension (prepared in the department by G. Kopp)
were mixed with either 1µl ligation reaction or 50ng plasmid DNA in electroporation cu-
vettes (Biorad, Burlington, USA) on ice. Electroporation was performed using a GenePulser
(Biorad, Burlington, USA) according to manufacturers instructions. For recovery, cells
were mixed with 1ml fresh 2YT media and incubated for 1h at 37℃ using a Thermomixer
comfort (Eppendorf, Germany) shaking at 1300 rpm. Subsequently, cells were plated on
selective agar plates and incubated over night at 37℃. Alternatively, transformed cells
were directly added to selective liquid culture and were incubated at 27℃ or 37℃.
4.2.1.10 Validation of positive clones by testexpression
Colonies on selective agar plates need to be analyzed for correctness prior to plasmid DNA
preparation. Therefore, single colonies were carefully picked and resuspended in 200µl 2YT
media containing the corresponding antibiotics. These small cultures were incubated at
37℃ while shaking until they turn slightly turbid. 50µl were transferred to separate tubes
for later inoculation of DNA plasmid preparation cultures. The remaining cultures were
induced with 1mM IPTG (Isopropyl-β-D-thiogalactopyranosid) and incubated at 37℃ for
2-3h. The cultures were spun down using a table-top centrifuge (Eppendorf, Germany)
at 1300rpm. After discarding the supernatant, the cell pellet was resuspended in 80µl
SDS loading buffer, heated to 95℃ for 5 minutes and subsequently loaded on SDS-PAGE.
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The major expressed band should correspond to the expected size of the cloned construct.
Cultures for DNA plasmid preparation were inoculated.
4.2.1.11 Plasmid DNA Purification from E. coli
Plasmid DNA from E. coli was either purified at analytical scale (mini preps) by using the
NucleoSpin Plasmid Kit (Macherey Nagel, Germany) or at preparative scale (midi preps)
using the NucleoBond PC100 Kit (Macherey Nagel, Germany), in each case according to
the manufacturers instructions. Purification was mainly performed by G.Kopp.
4ml LB media containing the corresponding antibiotics were inoculated for analytical
purification, 250ml cultures were inoculated for preparative purifications. The cultures
were incubated over night at 37℃.
4.2.1.12 Primer Synthesis and DNA Sequencing
Primers for sequencing purposes were designed using the SeqBuilder software (part of the
DNAStar software package). Primers were mainly synthesized by Sigma-Aldrich, Ger-
many, partially also by IBA GmBH, Germany.
DNA sequencing reactions of plasmids or purified DNA fragments were performed by
SEQLAB Sequence Laboratories Göttingen GmbH, Germany. Results were analyzed us-
ing the SeqMan software (DNAStar).
4.2.2 Protein Expression and Purification
4.2.2.1 Protein Expression
All proteins used in this study were expressed in E. coli expression strains (see 4.1). Pro-
tein quality and yield greatly depend on a variety of different parameters such as used
E. coli expression strains, expression conditions (expression time, expression temperature
and induction strength) but also the expression construct itself (AT-content in the cod-
ing sequence, secondary structure of the resulting mRNA transcript, solubility enhancing
fusion tags, etc.). Thus, the ideal construct design and expression conditions were deter-
mined for every protein produced and summarized in table 4.4.
In general, the plasmid coding for the protein sequence of interest and an antibiotic resis-
tance cassette was transformed into electro-competent E. coli cells, recovered in 1ml 2YT
media for 1h at 37℃ and subsequently streaked out on agarose plates containing the cor-
responding antibiotics. After over night incubation at 37℃, a single colony was inoculated
in 100ml media (2YT or TB, depending on the protein expressed) supplemented with an-
tibiotics and grown over night at 27℃ - 30℃ while shaking at 95rpm. Next, the cultures
were diluted with 700ml fresh, antibiotic containing media and induced with IPTG (100-
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200µM). Ideally, the OD600 at the time point of induction should be between 0.8-1.0. The
cultures were further incubated at the preferred expression temperature for an defined
expression time while shaking with 85rpm.
Prior to harvest, the OD600 was measured and the culture was supplemented with 1mM
PMSF (phenylmethanesulfonylfluoride) and 10mM EDTA in order to inhibit proteases
during the following treatment. Bacterial cells were then pelleted by centrifugation (4℃,
10 minutes, 4000rpm). The resulting bacterial pellet was resuspended in native resuspen-
sion buffer (if not stated otherwise: 50mM Tris/HCl, pH 7.5, 300-500mM NaCl, 2mM
imidazole, 1mM DTT) to a final ratio of 3.5OD600 = 45ml. The cell suspension was then
snap-frozen in liquid nitrogen and stored at -80℃ until further proceeding.
4.2.2.2 Cell lysis
Bacterial cell walls were disrupted by mechanical stress induced by a freeze/thawing cycle.
In addition, the cells were further lysed by ultra-sonication, disrupting cell structures and
shearing the released DNA to smaller fragments. Therefor resuspended cells were thawn
in hand warm water and placed on ice after completeness. Sonication was performed using
the Sonifier 450 (Branson, UK) for 2x 2minutes on ice with a maximum output and 40%
duty cycle. To clear the supernatant from cell debris and insoluble proteins, the ruptured
cells were ultracentrifuged for 1-2h at 370.000rpm, 4℃, using the T647.5 rotor (Sorvall).
4.2.2.3 Native Protein Purification
To separate the recombinantly expressed protein of interest from other proteins present in
the cleared lysate, Ni2+ affinity chromatography was performed. The protein of interest
was expressed as a fusion construct with a stretch of histidine residues (H14- or H10- tags).
The imidazole ring of the histidine side chains can complex bivalent metal ions such as
Ni2+ or Co2+ at physiological pH. By using a 6% Ni2+-chelate 500Å silica matrix (prepared
in the lab by D. Görlich) as affinity resin, tagged proteins of interest can be pulled out
specifically whereas other proteins in the lysate show no or only little affinity towards the
matrix and thus do not bind efficiantly.
Depending on the amount of expressed protein of interest in the lysate, an appropriate
volume of 6% Ni2+-chelate 500Å silica was equilibrated with the resuspension buffer,
subsequently mixed with the cleared lysate and incubated for at least 1h at 4℃ while gently
rotating to facilitate binding of the tagged protein to the affinity resin. The buffer contains
low amounts of imidazole (2mM) to reduce unspecific binding of bacterial proteins. After
incubation, the suspension was filled to a gravity flow column (1.5 x 1.0cm, Sigma-Aldrich)
and the supernatant was collected and checked for remaining amount of the protein of
interest subsequently. Ideally, the matrix should be slightly overloaded to avoid non-
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specific binding of bacteria proteins.
The matrix was then thoroughly washed with resuspension buffer. In special cases, either
a high salt wash step (1M salt to remove RNA contaminations) or an ATP wash step
(1-5mM ATP) to remove bound chaperones was included prior to elution. Elution was
performed either by protease cleavage (see 4.2.2.4) or by addition of high concentrations
of imidazole in the elution buffer. Depending on the protein of interest and the length of
the used histidine stretch, concentrations between 300mM and 1M imidazole were used.
Imidazole competes out the His-tagged proteins thereby displacing the protein of interest
from the resin. Elution was performed in 500µl to 1ml steps, the fractions were tested
for their protein content by quick staining with amid black solution (1µl of the elution
fractions was spotted on nitrocellulose membrane and incubated for 1min with the amido
black staining solution) and the protein containing fractions were pooled.
The pooled protein elution was supplements with 250mM sucrose to prevent freezing
damage and the protein concentrations were determined spectroscopically by absorption
measurements at 280nm. Concentrations were then calculated using the following formula:
c[M]= A280[cm
−1]/ ε280[M
−1cm−1]. Subsequently, the protein elution was snap-frozen in
liquid nitrogen and stored at -80℃.
4.2.2.4 Protease Cleavage
Protein tags can be used for a variety of reasons, e.g. affinity tags such as the previously
described poly-histidine tag to provide affinity towards the Ni2+-chelate 500Å silica. But
tags can also function as expression or solubility enhancers for the protein of interest,
such as the maltose binding protein (MBP). However, these tags can be rather bulky and
might be disadvantageous for downstream applications. To efficiently remove these tags,
specific endoprotease cleavage sites can be included in the expression construct. For this
purpose, either the TEV protease recognition sequence, the SUMO protein or the NEDD8
protein (both from from Brachypodium distachyon) were fused between the N-terminal
expression tag and the protein sequence of interest.
TEV protease is derived from the Tobacco etch virus. The virus encodes its genome as a
single polyprotein which then has to be cleaved by specific proteases, one of them being the
TEV protease. Cleavage was performed by direct addition of the TEV protease (produced
in the lab by S. Frey) to the Ni2+ elute. The cleavage reaction was performed for 1h at
RT or over night at 4℃ using ∼10µM TEV protease for efficient cleavage. After cleavage,
the solution was either applied to size exclusion chromatography to separate the protein of
interest from the tag (see 4.2.2.8) or a reverse Ni2+ chromatography was performed. Here,
the cleaved sample was applied once again to 6% Ni2+-chelate 500Å silica. The cleaved
off protein should have lost its ability to bind the resin whereas the tag should remain
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bound. The flow through after 1h of incubation was collected in 0.5-1ml fractions and an-
alyzed for their protein content using amido black staining. Protein containing fractions
were pooled, the protein concentration was measured and the samples were snap-frozen in
liquid nitrogen and stored at -80℃.
SUMO and NEDD8 are small proteins that can be post-translationally attached to target
proteins and thus modify them. However, these modifications are reversible and spe-
cific proteases can cleave off the SUMO or NEDD8 moiety. Cleavage was performed on-
column with 0.1µM SENP1 (SUMO-protease) or 1µM NEDP1 (NEDD8-protease) (Frey
and Görlich, 2014a). After binding of the protein of interest to the affinity resin, the resin
was washed with buffer, the protease was added (diluted in the previously used buffer)
and the column was plugged. Incubation was performed at 4℃ for 1-2h. After on-column
cleavage, the cut protein was eluted in 0.5ml steps with buffer (without protease). The
collected fractions were analyzed for their protein content using amido black staining.
Protein containing fractions were pooled, the protein concentration was measured and the
samples were snap-frozen in liquid nitrogen and stored at -80℃.
4.2.2.5 Buffer Exchange
During direct cleavage of the Ni2+ elute with TEV protease, the buffer still contains high
concentrations of imidazole (see 4.2.2.3). For reverse Ni2+ chromatography this competi-
tor has to be removed. The most efficient way is to rebuffed the elution fraction to a
buffer containing no imidazole. For thus purpose a PD10 or a NAP5 column (depending
on the sample volume, GE Healthcare) were used according to the manufacturers instruc-
tions. The resulting elution fractions were analyzed for their protein content using amido
black staining. Protein containing fractions were pooled, the protein concentration was
measured and the samples were either snap-frozen in liquid nitrogen and stored at -80℃
or immediately used for downstream applications.
4.2.2.6 Stochiometric complex assembly using two affinity tag systems and an
orthogonal protease system
In order to obtain highly pure and stochiometric heterodimeric complexes for crystalliza-
tion, a purification approach utilizing two affinity tag systems and an orthogonal protease
pair was performed (Frey and Görlich, 2014b).
As shown in figure 4.1 a lysate containing both subunits of the target complex was applied
to two consecutive affinity chromatography steps. The lysate was optioned by either co-
expressing the two subunits or by expressing them individually and mixing the lysates prior
to purification.The lysate containing a H14-brSUMO tagged subunit and a ZZ-brNEDD8
tagged subunit was first applied to a reasonable amount of 6% Ni2+-chelate 500Å silica.
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Figure 4.1: Purification of stochiometric heterodimeric complexes using two affinity tag
systems and on-column cleavage (A) Description of components used in the following schemes.
A lysate containing the two subunits S1 and S2 of the target complex (B) is applied to the first affinity resin,
which allows binding of the affinity tag present on subunit S1 (C). Elution from affinity resin 1 is performed
by on-column cleavage using protease 1 recognizing the protease recognition site on S1 (D). S1 subunits
either alone or bound to the S2 subunit are eluted and subsequently bound to affinity resin 2 which binds
the affinity tag present on subunit S2 (F). Surplus S1 subunits pass the column without binding. Protease
2 recognizing the recognition site on the S2 subunits (G) and heterodimeric, stochiometric complexes
elute from affinity resin 2 (H). If it is necessary for further applications to remove residual amounts of
remaining protease 2, the protease can also be applied in a tagged form and subsequently be removed
by applying the elution to an affinity resin 3. The figure was extracted from Frey and Görlich (2014b)
After binding in batch for 1h at 4℃, the flow through was collected and the resin was
thoroughly washed and incubated with 0.1µM SENP1 for 1h at 4℃. Elution was performed
in 1ml steps and the resulting fractions were checked for their protein content using amid
black staining. The protein containing fractions were diluted 1:5 with buffer and applied
to a reasonable amount of ZpA963 2B Sepharose (ZpA963 is an affibody recognizing the
ZZ tag on subunit 2; Lindborg et al., 2013). After binding in batch for 1h at 4℃, the flow
through was collected and the resin was washed. Subsequently, 1µM NEDP1 protease
was added to the resin recognizing the brNEDD8 stretch on the directly bound subunit.
The elution was performed in 1ml steps and the resulting fractions were analyzed for their
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protein content. The elution should contain a highly pure, stochiometric heterodimeric
complex.
Samples were taken during the entire procedure and were analyzed by SDS-PAGE.
4.2.2.7 Biotinylation of proteins
The streptavidin:biotin system is commonly used in affinity chromatography. Streptavidin
molecules form homotetramers that non-covalently binds biotin with femtomolar affinity.
Binding assays on streptavidin resins (silica, agarose beads or magnetic beads) require
biotinylation of the bait protein in order to efficiently bind the target protein. To be able
to biotinylate the protein of interest, an Avi tag was included in the expression construct,
comprised of a 15 amino acid long stretch (GLNDIFEAQKIEWHE). The tag is recognized
by the biotin holoenzyme synthetase BirA and the biotin moiety is covalently attached to
the Avi-tag (Beckett et al., 1999).
Biotinalytion was achieved by co-expressing the protein of interest with a plasmid coding
for BirA (prepared by S. Frey). Upon induction, 20µg/ml biotin was added to the culture
to enable efficient incorporation. In addition, biotinylation can also be performed in
vitro by incubating the Avi-tag containing protein with 1x biotinylation buffer (50mM
Tris/HCl, pH 7.5, 50mM NaCl, 5mM DTT, 10mM ATP, 12.5mM MgCl2, 250µM biotin)
and recombinantly expressed BirA enzyme in a 1:1000 ratio. The reaction takes place while
incubating the sample at RT for 2-4h. After incubation, the sample has to be rebuffered
to remove remaining free biotin.
4.2.2.8 Size Exclusion Chromatograph (SEC)
Size exclusion chromatography is used to separate proteins or protein complexes in solution
according to their size or molecular weight. It is based on the principle that smaller
molecules can enter the pores of the porous resin more efficiently than larger molecules
and thus larger molecules pass the column quicker and elute earlier. For SEC either a
Superdex 200 or a Superdex 75 column (Pharmacia) was used. The SD200 can separate
proteins in a range from 10kDa - 600kDa, the SD75 separates in a range of 3kDa-70kDa.
The chromatography was performed using an ÄKTA Purifier System according to the
manufacturers instructions. The column was equilibrated in the desired buffer using a
default flow rate. The protein samples were ultracentrifuged at 40.000rpm to remove
precipitates and subsequently loaded to the equilibrated column. All elution fractions
were collected and analyzed by SDS-PAGE. Protein containing fractions were pooled, the
protein concentration was measured and the samples were either snap-frozen in liquid
nitrogen and stored at -80℃ or immediately used for downstream applications.
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4.2.2.9 SDS PAGE
Analysis of protein samples was performed by discontinuous sodiumdodecylsulfate poly-
acrylamide gel electrophoresis (SDS-PAGE) according to standard protocols (Laemmli,
1970; Sambrook and Russell, 2001). The gradient SDS-polyacrylamid gels (composition
see below) were prepared by G. Kopp and J. Schünemann.
Gels were run at 50mA constant current for ∼60-70 minutes until the bromphenol blue
dye present in the sample buffer reaches the end of the gel. Subsequently, the gels were
fixed and stained by heating the gel in 3% acetic acid and 1:100 dilution of the Coomassie
stock solution (2% (w/v) Coomassie Brilliant Blue G520 in 50% Ethanol). Gels were
subsequently destained in desalted water and finally scanned for documentation using the
EPSON scanner.
Heavy Gel 16% Light Gel 7.5 % Stacking Gel 4.5%
200ml 200ml 200 ml
2M Tris pH8.8 40ml 40ml -
0.5M Tris pH6.8 - - 15ml
H2O 32ml 107ml 68ml
2M sucrose 10ml - -
Glycerol (87%) 8ml - -
10% SDS 2ml 2ml 1ml
Rotiphorese Gel 30 108ml 51 ml 15 ml
TEMED 120µl 120µl 100µl
APS 10% 2x 580µl 2x 580µl 1ml
4.2.2.10 Western Blot
SDS gels, Whatman papers and nitrocellulose membranes were equilibrated for 10 minutes
in 1x Blotting buffer (see 4.1.7), which was also used as transfer buffer during blotting.
The SDS gel was placed on a layer of Whatman paper (3.0mm, Whatman, Germany),
followed by the nitrocellulose membrane. On top another layer of Whatman paper was
placed and all air bubbles were carefully removed by streaking them out. The membrane
was positioned such that it faces the positive pole of the blotting chamber to enable the
proteins intercalated with negatively charged SDS can migrate towards the membrane.
Blotting was performed at 4℃ either for 4h at 400mA or over night at 100mA while
gently stirring.
Subsequently, the membrane was carefully removed from the chamber and blocked by
incubation for at least 1h with blocking buffer (4g milk powder in 100ml 1xTBS buffer).
The blocking buffer was then exchanged by a milk-TBS solution containing the primary
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antibody in appropriate dilutions (1:100-1:50.000 or 1µg/l). The membrane was incubated
with the first antibody either at room temperature for 1-2h or over night at 4℃. Next,
the membrane was washed with 1x TBS buffer (3x 10 minutes) and incubated with the
secondary antibody (Goat α-rabbit IRdye; Goat α-mouse IRdye, Licor, USA) for 1h at
room temperature wrapped in foil to avoid any fading of the signal. After washing 3x 10
minutes with 1x TBS, the membrane was air-dried and subsequently scanned at 700nm
and 800nm wavelength using the Odyssey scanner (Licor, USA).
4.2.3 Binding Assays
Binding Assays were performed to analyze the direct interactions between two proteins.
In this study, binding assays were performed on Streptavidin agarose or magnetic beads
recognizing biotinylated proteins, ZZ-Affibody or IgG beads, which enables ZZ-tagged
proteins to bind, and Ni2+-chelate matrix recognizing poly-histidine stretches. Binding
assays were performed either with pre-purified recombinant proteins or by mixing lysates
containing the expressed proteins of interest. Furthermore binding assays were performed
with immobilized baits, meaning that the bait protein was immobilized to the beads first,
the excess was washed away and the prey protein was subsequently provided. Alterna-
tively, prey and bait protein were premixed before adding the affinity resin.
In general, 20µl of beads were equilibrated with 2x 500µl binding buffer (50mM Tris/HCl,
pH 7.5, 2mM imidazole, 1mM DTT, 100-500mM NaCl, depending on the specific inter-
action to be analyzed). Next, the bait protein was added in slight excess to the beads
and incubated for 1h at 4℃ while gently rotating. The flow through was collected and
analyzed for its unbound protein fraction, the beads were washed 3x with 500µl binding
buffer prior to addition of the prey protein. The samples were incubated for 2h at 4℃
while gently rotating. Next, the flow through was collected and the beads were washed
2x with 500µl binding buffer, 1x with 500µl binding buffer while rotating for 5 minutes
and finally a last wash with 500µl binding buffer. Elution was performed either direct by
adding 2x 25µl SDS loading buffer (in case of streptavidin:biotin, the samples must be
heated to 99℃ during elution with SDS to release biotin from streptavidin) or by protein
cleavage. 50-100µl binding buffer containing the protease were incubated with the beads
for 1h at 4℃ prior to elution. All samples were analyzed by SDS-PAGE.
Additionally, some binding assays were also performed by immobilizing the bait protein
to the beads and incubating these with wheat germ extract or HeLa lysate. The aim was
to identify not only the direct interaction between two proteins but the interactome of a
specific protein in the context of cell lysates, e.g. the interaction partners of RanQ69L in
HeLa lysate.
30µl ZZ-affibody beads were equilibrated in binding buffer (50mM Tris/HCl pH 7.5,
4.2 Methods 132
400mM NaCl, 5mM MgAc, 30µM GTP, 1mM DTT) prior to addition of 4µM Ran (H14-
ZZ-SUMOStar-RanQ69L5-18)) in a total volume of 200µl. The beads were incubated for
1h at 4℃ to enable the Ran construct to bind to the beads. Next, the flow through was
collected, the beads were washed with binding buffer and 400µl HeLa lysate was added
(supplemented with 5mM MgAc and 30µM GTP). The mixture was incubated for 2h
at 4℃. The flow through was collected and the beads were washed with low salt buffer
(50mM Tris/HCl pH 7.5, 50mM NaCl, 5mM MgAc, 30µM GTP, 1mM DTT). Elution was
performed either by addition of 2x 30µl SDS-loading buffer or by protease cleavage with
1µM SUMOStar protease (in 100µl buffer). Cleavage was performed for 2h at 4℃. All
samples were analyzed by SDS-PAGE.
4.2.4 Protein Characterization
4.2.4.1 Protein Identification by Mass Spectrometry
Samples to be analyzed by Mass Spectrometry were loaded on 10%precasted Bis-Tris gels
(NuPAGE, Life Technologies) and stained over night with Colloidal Coomassie. Either
entire lanes were analyzed by being cut in 23 equally sized slices (complete analysis) or indi-
vidual bands that were carefully cut out from the gel. Subsequently, in-gel tryptic digestion
and peptide extraction were performed as previously described (Shevchenko et al., 1996).
The digested peptides from each band or slice were separated by reverse-phase HPLC using
a Reprosil C18 column (Dr. Maisch GmbH) and eluted into the LTQ-Orbitrap XL mass
spectrometer (Thermo Fisher Scientific; performed by the department of Bioanalytical
Mass Spectrometry). The resulting MS/MS spectra were searched against the NCBI non-
redundant database with appropriate taxonomy filters (here against Viridiplantae (green
plants)) using the MASCOT v2.2 software. MASCOT search results were further analyzed
using the Scaffold 3.0 software.
4.2.4.2 Thermofluor
The Thermofluor assay is a temperature-based technique to analyze the stability of either
individual proteins or protein complexes. Small amounts of the protein solution are mixed
with a dye that binds to hydrophobic patches and fluoresces. By increasing temperature
(using a real time PCR machine, BioRad), the proteins start to unfold and thus, the
fluorescence signal increases. The resulting melting curves enable to determine the melting
temperature and thus the stability of the sample (Pantoliano et al., 2001; Niesen et al.,
2007).
8µl protein solution at a concentration of 0.5mg/ml were mixed with 2µl Sypro Orange®
and transferred to a BioRad real time PCR machine for monitoring. The samples war
heated from 30℃ to 110℃ at 1℃/min steps.
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4.2.4.3 Protein Crystallization
Protein complexes were purified as shown in figure 4.1 and were subsequently applied to
gelfiltration (20mM Tris/HCl pH7.5, 100mM NaCl, 1mM DTT) to further increase the pu-
rity. Samples were concentrated to ∼10mg/ml using Amicon® Ultra Filters (Merck Mili-
pore). The Barnase:Barstar complex was crystallized from 50mM HEPES/KOH pH7.0 or
Bis/Tris phosphate-citrate pH 7.1 supplemented with 15% PEG6000, 1.2M LiCl and 10µl
MPD (2-Methyl-2,4-pentanediol). Crystals grew at 18℃ as small prism shaped crystals.
Prior to mounting using 0.08mm loops, the crystals were dehydrated using ammonium
sulfate. The data was collected at the Swiss Light Source (SLS) using beam line PXII
and was further processed by XDS (Kabsch, 1993). The phase was solved by molecular
replacement using 1BRS (Buckle et al., 1994) as phasing model. The structure was fur-
ther refined using Phenix (Adams et al., 2002) and Coot (Emsley and Cowtan, 2004).
Data collection and refinement statistics are shown in table 4.5. Crystallization trails and
structure solving was performed by Dr. Sergei Trakhanov.
Table 4.5: X-ray data collection and refinement statistics Barnase:Barstar complex
BarnaseH102D:BarstarC42K complex was purified as shown in figure 2.24. The elution samples were concentrated
to 10mg/ml and subsequently crystallized in 50mM BTP-citrate, 1.2mM LiCl, 15% PEG 6000. Crystallization
trails and structure solving were performed by Dr. Sergei Trakhanov. *= no H in calculation of No. of atoms
Data Collection Refinement (Phenix)
Space Group C222 (20) Resolution(Å) 28.6 - 1.95
Unit cell Dimensions (Å)
a=44.15 b=113.10
c=98.57
No. of reflections 16857
Solvent content (%) 53.5 Completeness (%) 96.3
Temperature (K) 100 R/Rfree 0.215/0.246




Oscillation Angle (°) 0.2 No. of atoms (Protein)* 3220
Resolution (Å) 50 - 1.9 No. of atoms (Solvent)* 144
Mosaicity (°) 0.26 R.m.s deviation from




ideal (Bond angles (°)) 0.77














Wilson B-factor (Å2) 37.3
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4.2.5 Antibody Purification and Immunoprecipitation Experiments
4.2.5.1 Antibody Production
The antibodies used and purified in this study were mainly raised in rabbits (see 4.1.10).
By injecting recombinantly produced antigens to the rabbit, either as natively purified
proteins or as inclusion bodies, the rabbit raises specific antibodies against the antigen
presented. Recombinant proteins were rebuffered to a suitable buffer (20mM Tris/HCl,
pH7.5, 150mM NaCl, 250mM sorbitol) and ∼500µg protein were adjusted to 500µl with
1x PBS and emulsioned in 50% Freund’s adjuvant complete (Sigma), 0.2% Tween-20 and
60µg/ml adjuvant peptide (Sigma). Inclusion bodies were adjusted to 500µl with 1x PBS.
The immunization itself was performed by injecting the antigen (boost) to the rabbit every
four weeks, the first bleed was taken after the second injection. Subsequently, 20ml blood
were taken after each boost. These were then incubated at 37℃ for 2h followed by an over
night incubation at 4℃. Agglutination occurs during this time, thus the samples were
centrifuged for 1h at 7000rpm to remove formed aggregates. The supernatant (serum)
was collected, supplemented with sodium azide and stored at 4℃ for further use.
4.2.5.2 Antibody Purification
Prior to antibody purification, the antigen against which the antibody was raised was
immobilized to a resin, e.g. maleimide Sepharose or later MADA Sepharose. Coupling
occurred via the maleimide moiety on the resin and reduced cystein side chains at the
C-terminus of the recombinantly expressed antigen.
2ml of maleimide Sepharose were transferred to a gravity flow column and equilibrated in
coupling buffer (20mM K2HPO4 pH 7.3, 200mM NaCl). In parallel, the antigen was freshly
reduced by incubation for 10 minutes with 10mM DTT and subsequently rebuffered to
DTT free coupling buffer. To monitor the DTT separation, 1µl Ellman’s reagent (10mM
DTNB in 1M imidazole) was mixed with 4µl of protein solution.
The antigen was then added to the equilibrated resin at concentrations of 5-10mg protein
per ml matrix, mixed immediately and gently rotated for 30 minutes at room temperature.
After incubation, the flow through was collected and analyzed for its protein content. The
antigen coupled matrix was quenched with 0.1M β-mercaptoethanol for 20 minutes at RT
prior to thorough washing with 1x PBS. The columns were stored at 4℃ until further use.
The capacity of the antigen column towards the antibodies in the rabbit sera vary greatly
depending in the antibody titer. As a standard, 25ml sera were used to be purified via
2ml antigen matrix. The sera was mixed 1:1 with 1xPBS and centrifuged at 10.000rpm
for 10 minutes to remove any aggregates. The matrix was washed twice with 1x PBS, pre-
eluted with 2x 10ml 0.1M glycine pH2.2 and subsequently equilibrated in 1x PBS. The
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sera was then applied twice to the antigen columns and the flow through was collected.
After washing the column with 1xPBS, elution was performed using 3x 5ml 0.1M glycine,
pH2.2. To neutralize the eluate, it was immediately mixed with 1ml 1M K2HPO4 pH
7.3. The antibody suspension was precipitated with 30ml 4M ammonium sulfate over
night at 4℃. Next, the suspension was centrifuged for 1h at 10.000rpm and most of the
supernatant was carefully removed. The antibody pellet was resuspended in the remaining
supernatant and stored at 4℃.
Input, flow through and elution samples were subsequently analyzed by Western Blot using
a 1:100 dilution of the input and flow through and 1µg/ml of the eluted antibody.
To obtain highly pure antibodies, the sera was not only purified via the antigen coupled
column. In addition, the sera passed a column to which E. coli proteins were immobilized
and a column containing immobilized fusion tags if these were injected to the rabbit during
immunization. The aim was to pre-deplete any non-specific antibodies prior to possible
antigen binding.
4.2.5.3 Covalent Coupling of Antibodies to ProteinA
In order to perform immunoprecipitation (IP) experiments, the antibodies raised against
the desired target were covalently coupled to ProteinA immobilized on Sepharose (prepared
in the lab, recombinantly expressed ProteinA was immobilized to maleimide Sepharose or
MADA Sepharose via reduced cysteins).
150µg antibody were suspended in 400µl 2xPBS. In parallel, 50µl ProteinA-Sepharose
were pre-eluted with 500µl 0.1M glycine pH2.2 and subsequently equilibrated with 2x
500µl 1xPBS. Next, the antibody solution was transferred to the beads and incubated
for 1h at 4℃ while gently rotating. After incubation, the flow through was collected by
low speed centrifugation (800-1000rpm) and the beads were washed 3x with 500µl 2xPBS
followed by 3x wash with 200mM NaPO4 pH8.0. The beads were then gently resuspended
in 500µl 0.02% glutaraldehyde (GA) for cross linking the antibodies to the ProteinA and
incubated for 1h at room temperature while rotating. Glutaraldehyde was removed by
gentle centrifugation and the beads were resuspended in 400µl 3mg/ml NaCNBH3 (solu-
bilized in 50mM NaPO4 pH7.5) in order to reduce the formed Schiff bases to stable amino
bonds. After incubated for 1h at room temperature, the flow through was removed and the
beads were resuspended in 500µl 3mg/ml NaCNBH3 (solubilized in 50mM NaPO4 pH7.5,
50mM glycine pH7.5) and incubated for 20 minutes to quench the remaining aldehyde
groups. Finally, the beads were washed 2x with 500µl 1xPBS and stored in 20% ethanol
at 4℃ until further use.
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4.2.5.4 Immunoprecipitation Experiments
Immunoprecipitation is a technique to pull out desired target proteins and their interaction
partners from a lysate, e.g. wheat germ extract, by specific antibodies against the target
protein.
The specific antibodies were coupled on ProteinA Sepharose (see 4.2.5.3). 10µl antibody
beads were transferred to a fresh Mobicol column (Mobitec GmbH, Germany) and pre-
eluted with 2x 25µl 0.1M glycine pH2.2 and subsequently equilibrated in 500µl buffer
(50mM Tris pH7.5, 500mM NaCl, 5mM MgAc). Next, the beads were incubated with
500µl - 2ml wheat germ extract (depends on the amount of the target protein in the
lysate) at 4℃ while gently rotating. After removing the unbound fraction, the beads were
washed 3x with 500µl buffer followed by washing once with 500µl buffer + 0.2% TritonX-
100. After washing once more with 500µl buffer, the bound proteins were eluted with 2x
50µl 0.1M glycine pH2.2 into a fresh Eppendorf tube containing 20µl 1M Tris/HCl pH8.8
for immediate neutralization. The elute was then precipitated with trichloroacetic acid
(TCA) and the resulting pellet was carefully resuspended in 15-50µl SDS loading buffer
(depending on the size of the pellet). Elution samples were analyzed by SDS-PAGE. The
beads were washed once more with 500µl 1xPBS and stored at 4℃.
4.2.6 In vitro Translation
In vitro translation systems are used to produce proteins of interest in a cell-free envi-
ronment. Mainly eukaryotic in vitro translation systems are of great interest as they are
able to produce eukaryotic proteins in an eukaryotic surrounding, providing chaperones,
modifying enzymes and potential assembly factors. These are lacking when expressing
eukaryotic proteins in E.coli.
Moreover, eukaryotic in vitro translation systems enable to monitor and analyze (eukary-
otic) protein synthesis and to massively manipulate this process. In an in vivo system
these manipulations would often lead to severe or even lethal phenotypes.
In this study two eukaryotic in vitro translation systems were used: the wheat germ extract
to study the necessity of certain translation initiation factors, and the rabbit reticulocyte
lysate system (RRL) to study the effects of nuclear transport factors on overall translation
rates.
4.2.6.1 mRNA preparation
In oder to perform in vitro translation using the wheat germ extract, mRNA of the reporter
was produced. The T7 RiboMAXTM Kit (Promega) was used for initial mRNA produc-
tion from a linearized DNA plasmid, the ScriptCap m7G Capping System (Biozyme) for
subsequent capping of the mRNA.
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5µg T38 plasmid (H21-TEV-Firefly Luciferase, produced by Dr. Cathrin Enke) was lin-
earized using EcoRI restriction enzyme. After purification of the DNA using the Zymo-
clean Gel DNA recovery Kit, 2µg DNA were incubated with 20µl T7 5x Buffer, 7.5µl
of each rNTPs and 10µl T7 Enzyme Mix (all components of the T7 RiboMAXTM Kit).
The reaction was filled up to 100µl with RNAse free water and incubated at 37℃ for
4h. The mRNA was subsequently purified by a phenol-chloroform extraction and ethanol
precipitation. 80µg recovered mRNA were heated to 65℃ for 10 minutes and placed on
ice immediately. The sample was mixed with 10µl 10x ScriptCap Capping Buffer, 10µl
10mM GTP and 0.5µl 20mM SAM stock solution. After mixing, 3µl ScriptGuard RNase
inhibitor and 5µl ScriptCap Capping Enzyme was added and the reaction was incubated
at 37℃ for 2h. Subsequently, 5µl ScriptCap 2’-O-Methyltransferase were added, followed
by another incubation at 37℃ for 1h. After a final phenol-chloroform extraction, the
capped mRNA were aliquoted in small fractions and stored at -80℃.
4.2.6.2 In vitro Wheat Germ Translation System
The in vitro wheat germ extract translation assay allows to monitor the translation effi-
ciency of the system towards a given reporter under certain conditions. The wheat germ
extract (WGE) was mixed with mRNAs coding for the reporter (e.g. Firefly luciferase),
amino acids and an energy regenerating system. After successful translation, the amount
of produced reporter proteins was read out by the luciferase activity assay. The lumines-
cence measured can be directly correlated to the efficiency of translation under the given
conditions.
Figure 4.2: In vitro wheat germ translation assay In-house produced wheat germ extracts are
mixed with mRNA encoding for Firefly Luciferase, amino acids and an energy regenerating system and
incubated at 27℃ for 90 minutes to enable efficient translation of the firefly luciferase reporter construct.
The amount of translated protein is estimated by measuring the emitted light during the luciferase activity
assay using a BioTek Synergy H4 Plate Reader.
The wheat germ extracts (WGE) used in this study were produced in house (for detailed
protocol see Enke, 2010). The WGEs were stored at -150℃ in 20mM Hepes/KOH pH7.8,
115mM KAc, 2.5mM MgAc, 4mM DTT and % glycerol as freeze protectant. Prior to
translation, the WGE was supplemented with 1.2mM ATP, 0.25mM GTP, 16mM creatine
phosphate and 100µg/ml creatine kinase.




xµl 1M KAc (to adjust KAc concentration to 80mM)




0.3µl 5mM amino acid mix (0.075mM of each of the 20 amino acids)
xµl DTT (to adjust the DTT concentration to 4mM)
fill with 1M Hepes/HOH pH7.8 to a total volume of 20µl
For efficient translation, all components but the mRNA were pipetted on ice and thor-
oughly mixed to homogeneity. The mRNA was added last and mixing was performed as
gentle as possible to avoid rupture of the mRNA. The reaction was incubated at 27℃
for 90 minutes. After incubation, the reaction was stopped by adding 5mM EDTA and
subsequently 10µl of the reaction were mixed with 10µl of water and the luciferase activity
assay was performed. The assay is based on the conversion of luciferin to oxyluficerin. The
enzymatic reaction was started by adding 80µl of the injection buffer (125µM luciferin,
15mM MgSO4, 20mM glycyl-glycin, 5mM ATP, 1mM DTT, ddH2O) to the translation
sample in an automated manner and bioluminescence was measured using the BioTek
Synergy H4 Plate Reader.
4.2.6.3 In vitro Rabbit Reticulocyte Lysate (RRL) Translation System
In this study, the in vitro rabbit reticulocyte lysate was used to analyze the effect of
nuclear transport factors on overall translation rates. For this purpose, the TNT® Coupled
Reticulocyte Lysate Systems (Promega) was used. As reporters, plasmids were constructed
containing from - N-terminus to C-terminus - a 3x-FLAG tag, a poly-serine or a poly-
proline stretch, a short methionine/serine rich stretch for proper 35S-Met incorporation
and the reporter protein, either the firefly luciferase or parts of the Nup98 FG domain.
Figure 4.3: In vitro translation using rabbit reticulocyte lysate The in vitro translation assay uses
the TNT® Coupled Reticulocyte Lysate System provided by Promega. The lysate is supplemented with
the plasmid coding for the reporter construct and 35S Met. After incubation for 2h at 30℃, the reaction
is precipitated using ammonium sulfate to remove hemoglobin. The samples are then loaded on SDS-
PAGE and the resulting gel is visualized by radiography.
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The translation reaction was comprised out of the following:
25µl TnT lysate
2µl TnT reaction buffer
1µl TnT polymerase
1µl amino acid mix - methionine
2µl 35S-methionine
1µl RNAsin
2µl Plasmid DNA (0.5µg)
xµl purified nuclear transport receptor (5µM)
xµl purified RanQ69L (15µM)
fill with translation buffer to a total volume of 50µl
The translation buffer was comprised of the following: 50mM Tris/HCl pH 7.5, 150mM
NaCl, 1mM DTT, 250mM sucrose.
The reaction was incubated for 90 minutes at 30℃ and was subsequently precipitated
with a mixture of 200µl 1xPBS and 500µl 4M ammonium sulfate to remove most of the
hemoglobin present in the reticulocyte lysate. The samples were incubated over night
at 4℃ and were then centrifuged for 10 minutes at 15.000 rpm. The supernatant was
carefully removed and the pellet was resuspended in 40µl SDS loading buffer. The gel was
subsequently incubated in a fixation solution (50% MeOH, 40%H2O, 10% acetic acid) and
carefully dried. The dried gel was then applied to a radiographic film. After over night
incubation, the film was scanned using the Fujifilm FLA7000 scanning device.
4.2.7 Matrix Characterization
4.2.7.1 Direct coupling
MADA is a proprietary chemistry on beads developed in our lab, which is able to form
a covalent link with the thiol groups of reduced cysteins. To test the specificity of the
matrix, mCherry and mCherrycys were expressed, purified and freshly reduced with 10mM
DTT. Remaining DTT was subsequently removed by buffer exchange. 50µl of the MADA
resin were incubated with 5µM mCherry or mCherrycys in 50mM Tris/HCl, pH7.5, 300mM
NACl in a total volume of 200µl. After incubation for 1h at 4℃, the flow through was
collected and the beads were washed. The process was documented by taking pictures of
the Input fractions, the beads after incubation, the flow through fraction and the beads
after washing.
Besides specificity, the binding capacity of proteins with reduced cysteins towards the
resin was analyzed. Either ProteinAcys or Streptavidincys were added in increasing con-
centrations (0-8µg/µl beads) to a constant amount of MADA beads. The Input and Flow
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through fractions were measured for their protein content at A280nm and analyzed by
SDS-PAGE.
4.2.8 Indirect pulldowns
ProteinA MADA Sepharose was analyzed for its ability to specifically pull out IgG molecules
from rabbit sera. Increasing amounts of ProteinA (0-8µg/µl beads) were coupled to a con-
stant amount of MADA beads (20µl). Next, the resin was incubated with constant volumes
of rabbit sera (200µl). The elution was performed by SDS-loading buffer and analyzes was
performed by SDS-PAGE.
The streptavidin MADA Sepharose was analyzed for the ability to pull out biotinylated
baits from E.coli lysate. Therefor, streptavidin was covalenty attached to the resin, which
was subsequently incubated with E.coli lysate supplemented with 10µM biotinylated bait
(ataxin or Nup98 anchor domain). Elution was performed at 99℃ with SDS loading buffer.
Analysis was performed by SDS-PAGE.
To pull out large complexes from e.g. the wheat germ extract, a “binding construct” (H14-
ZZ domain-SUMOStar-Cys) was coupled to the resin. In parallel, the WGE was incubated
with IgGs against the target complex (here eIF3 complex and α-eIF3c/d/m). After wash-
ing off uncoupled binding constructs from the resin, it was mixed with the IgG supple-
mented WGE for 1h at 4℃ to allow binding. After thorough washing, the elution was
performed using 1µM SUMOStar protease (S.c.Ulp1). The elution factions were analyzed
by SDS-PAGE. To remove the remaining binding construct (H14-ZZ domain-SUMOStar),
the elution fraction was run over MADA matrix coupled to ZZ-affibody (ZpA963). The
remaining binding construct should bind the resin, whereas the complex of interest should
not bind the resin and thus should be found in the flow through fraction. All steps were
analyzed by SDS-PAGE.
4.2.9 Phage Display
Phage Display in an in vitro selection technique by which proteins with desired properties
can be extracted from a great mixture of different variants. Therefore, a library of the
protein of interest is cloned into phagemids such, that it is fused to the phage coat protein
pIII. New phage particles display the encoded protein at their tip as fusion construct
to pIII. By binding assays, beneficial variants of the protein of interest are accumulated,
containing not only the protein but also the underlying sequence encoded on the phagmid.
Hence, this technique enables a direct link between genotype and phenotype.
Standard phage display methods were performed according to Clackson and Lowman
(2004) with modifications described in the following section.
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4.2.9.1 Library construction
To introduce random mutations to the protein of interest, error-prone PCR was performed
using the JBS Error-Prone Kit (Jena Bioscience). The PCR reaction was performed
according to the manufacturers instruction. After purifying the PCR reaction using the
MSB Spin PCRapace Kit, the elute was used as template for a subsequent PCR reaction
to amplify the DNA fragments. PCR primers contained enzymatic restriction sites by
which the resulting fragments were ligated into the display vectors (pelB signal sequence-
MCS-HA tag-pIII minor coat protein, prepared by T. Pleiner). After determination of
the transformation efficiency of the library, the library was transformed into TG1 E.coli
cells to reach a library size of 1x107. The transformed cells were incubated for 1h at 37℃
in recovery medium and further incubated over night in 2YT medium supplemented with
ampicillin and 2% glucose.
The cells were carefully harvested after incubation and supplemented with 15% glycerol
and stored at -80℃ till further use.
4.2.9.2 Bacteriophage harvest and purification
Cells transformed with the library of interest were further used to produce bacteriophages
displaying the different protein variants as fusion with the pIII coat protein. 100-fold more
cells than the library size (here 1x107) were grown in 2YT Medium (+Ampicillin and 2%
glucose) to an OD600=0.8 at 37℃. When OD600=0.8 was reached, the cultures were in-
fected with a 20-fold surplus of helper-phage (M13KO7, prepared by T. Pleiner) over cells
and incubated for 30 minutes at 37℃ without shaking to allow infection. The cells were
subsequently harvested by centrifugation for 10 minutes at 4℃ and the supernatant con-
taining excess of helper-phages was discarded. The remaining pellet was resuspended in
250ml 2YT media containing ampicillin and kanamycin and incubated over night at 37℃.
Next, the cultures were centrifuged for 10 minutes at 7000rpm and the supernatant was
mixed with pre chilled buffer (20%PEG-8000, 2.5M NaCl) in a 1:5 ratio (buffer: super-
natant). The mixture was incubated on ice for at least 30 minutes to allow precipitation.
The samples were then centrifuged for 15 minutes at 4000rpm and the supernatant was
carefully removed. The resulting white phage pellet was resuspended in 20ml 50mM
Tris/HCl pH7.5, 300mM NaCl and centrifuged 10 minutes at 15.000g to remove all re-
maining cells and aggregates. The supernatant was mixed with 5ml 20%PEG-8000, 2.5M
NaCl for 30 minutes on ice for precipitation. The samples were centrifuged at 2200 rpm
for 15 minutes and the pellet was gently resuspended in 3-5ml 50mM Tris/HCl pH7.5,
300mM NaCl. After the pellet was completely resuspended, the suspension was filled in
2ml Eppendorf tubes and centrifuged at 13.000 rpm for 10 minutes. The supernatant was





The phages were supplemented with 0.1% BSA and stored at 4℃ for further use.
4.2.9.3 Phage selection
The selection procedure can vary greatly depending on the interaction between the bait
and the phage itself and the properties to select for. The following describes a very general
selection procedure.
1mg magnetic streptavidin beads (Dynabeads Streptavidin T1, Invitrogen) were washed
twice with 500µl wash and block buffer (WBB, 50mM Tris/HCl pH 7.5, 300mM NaCl,
0.1% BSA) and incubated in 1ml WBB for at least 30 minutes. In parallel, 2ml Eppen-
dorf tubes were blocked with 2ml WBB buffer for at least 30 minutes. To decrease the
background binding of the displaying phages to the beads, the phage pool used during the
selection was pre-depleted by adding the phages in a total volume of 1ml WBB to 1mg
magnetic streptavidin beads and incubated for at least 30 minutes. The amount of phages
used per selection reaction was usually 1x1012.
The binding of bait and phages can either be performed in solution or by immobilizing the
bait to the magnetic beads beforehand. When performing in solution binding, the bait is
diluted to the favored concentration in WBB and then mixed with the pre-depleted phages
to a total volume of 1ml WBB and incubated for 1-2h while gently rotating. Subsequently,
the mixture was added to 1mg pre-blocked magnetic beads and further incubated for 10
minutes while rotating.
When immobilizing the bait to the beads beforehand, the appropriate amount of bait pro-
tein was diluted in a total volume of 1ml WBB and incubated with 1mg magnetic beads
for 30 minutes while gently rotating. After binding, the flow through was discarded and
the beads were washed twice with 1ml WBB to remove any non-bound bait. Subsequently,
the phages were added to the beads in a total volume of 1ml WBB and incubate while
rotating for 1h.
After binding, the beads were thoroughly washed in subsequent steps with WBB and
WBB supplemented with 0.1% Tween-20. After individual washing steps, the tubes were
changed to remove all phages sticking to the tube walls.
Elution was performed by protease cleavage. The bait constructs were designed such that
the spacer between the biotin moiety and the actual bait protein contained a protease
cleavage site. The wash buffer was carefully removed and 200µl WBB supplemented with
the corresponding protease were added to the beads and incubated for at least 30 min-
utes while rotating. The supernatant containing the cleaved off phage:bait complexes was
carefully removed and used for re-infection and iteration of the eluted phages.
For reinfection, 190µl of the eluted phages were used to infect 20ml of exponentially grow-
4.2 Methods 143
ing TG1 E.coli cells. The cultures were incubated for 30 minutes at 37℃ without shaking
and subsequently diluted with 80ml 2YT media containing ampicillin and 2% glucose. The
cultures were incubated for 30 minutes at 37℃ while shaking prior to infection with 1012
M13KO7 helper-phages. After another 30 minutes incubation at 37℃ without shaking,
the cultures were centrifuged for 10 minutes at 4000 rpm, the pellet was resuspended in
200ml 2YT media containing ampicillin and kanamycin and the cultures were incubated
over night at 37℃.
To analyze the enrichment of phages and the selection rate, the eluted phages were in
addition titrated. The remaining 10µl of eluted phages were mixed with 90µl 2YT media
containing 2% glucose. A 1:10 dilution series (10-1 - 10-8) was prepared and 10µl of each
dilution were mixed with 90µl exponentially growing TG1 E.coli cells. The samples were
incubated at 37℃ for 30 minutes and subsequently, 10µl of cells were plated on ampicillin
agar plates containing 2% glucose. The agar plates were incubated over night at 37℃. In
addition, 50µl of the exponentially growing TG1 cells were plated on ampicillin containing
agar plates to check for possible contaminations.
To be able to sequence and clone the phagmids coding for selected binders, 80µl of the cells
infected with 10-1 eluted phages were incubated over night at 37℃ in LB media containing
2% glucose. The phagmids were subsequently purified by standard DNA preparation (see
4.2.1.11).
4.2.9.4 Analysis of Binders
Phages displaying potential binders to the bait protein were enriched during the phage
selection procedure. The pool of binding phages was used to infect TG1 cells. These
were then used as starting culture for plasmid preparation, leading to a DNA preparation
containing the phagmids encoding the sequence of the bait binding proteins. The DNA
was subsequently cloned into expression vectors (here H14-brSUMO-MCS) using standard
restriction enzymes. After ligation, the cells were plated on agarose plates containing the
appropriate antibiotics. 96 single colonies from different round of selection were picked af-
ter over night incubation at 37℃ and send for sequencing (performed by GATC Biotech).
After analysis of the sequences, different classes of binders can be defined and representa-
tives of each class are expressed in E.coli and characterized.
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Mönecke, T., Güttler, T., Neumann, P., Dickmanns, A., Görlich, D., and Ficner, R. (2009). Crystal
structure of the nuclear export receptor CRM1 in complex with Snurportin1 and RanGTP.
Science, 324(5930):1087–1091.
Mossakowska, D., Nyberg, K., and Fersht, A. (1989). Kinetic characterization of the recombi-
nant ribonuclease from Bacillus amyloliquefaciens (barnase) and investigation of key residues in
catalysis by site-directed mutagenesis. Biochemistry, 28(9):3843–3850.
Mullis, K., Faloona, F., Scharf, S., Saiki, R., Horn, G., and Erlich, H. (1986). Specific enzymatic
amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb Symp Quant
Biol, 51 Pt 1:263–273.
Nathanson, L., Xia, T., and Deutscher, M. (2003). Nuclear protein synthesis: a re-evaluation.
RNA, 9(1):9–13.
Nazina, T., Tourova, T., Poltaraus, A., Novikova, E., Grigoryan, A., Ivanova, A., Lysenko, A.,
Petrunyaka, V., Osipov, G., Belyaev, S., and Ivanov, M. (2001). Taxonomic study of aerobic
thermophilic bacilli: descriptions of Geobacillus subterraneus gen. nov., sp. nov. and Geobacil-
lus uzenensis sp. nov. from petroleum reservoirs and transfer of Bacillus stearothermophilus,
Bacillus thermocatenulatus, Bacillus thermoleovorans, Bacillus kaustophilus, Bacillus thermod-
enitrificans to Geobacillus as the new combinations G. stearothermophilus, G. th. Int J Syst
Evol Microbiol, 51(Pt 2):433–446.
Nielsen, K., Valasek, L., Sykes, C., Jivotovskaya, A., and Hinnebusch, A. (2006). Interaction of
the RNP1 motif in PRT1 with HCR1 promotes 40S binding of eukaryotic initiation factor 3 in
yeast. Mol Cell Biol, 26(8):2984–2998.
Niesen, F., Berglund, H., and Vedadi, M. (2007). The use of differential scanning fluorimetry to
detect ligand interactions that promote protein stability. Nat Protoc, 2(9):2212–2221.
Nilsson, B., Moks, T., Jansson, B., Abrahmsen, L., Elmblad, A., Holmgren, E., Henrichson, C.,
Jones, T., and Uhlen, M. (1987). A synthetic IgG-binding domain based on staphylococcal
protein A. Protein Eng, 1(2):107–113.
Nirenberg, M. and Matthaei, J. (1961). The dependence of cell-free protein synthesis in E. coli upon
naturally occurring or synthetic polyribonucleotides. Proc Natl Acad Sci U S A, 47:1588–1602.
Nishi, K., Yoshida, M., Fujiwara, D., Nishikawa, M., Horinouchi, S., and Beppu, T. (1994). Lepto-
mycin B targets a regulatory cascade of crm1, a fission yeast nuclear protein, involved in control
of higher order chromosome structure and gene expression. J Biol Chem, 269(9):6320–6324.
Ohgushi, M. and Wada, A. (1983). ’Molten-globule state’: a compact form of globular proteins
with mobile side-chains. FEBS Lett, 164(1):21–24.
Olsen, D., Savner, E., Mathew, A., Zhang, F., Krishnamoorthy, T., Phan, L., and Hinnebusch, A.
(2003). Domains of eIF1A that mediate binding to eIF2, eIF3 and eIF5B and promote ternary
complex recruitment in vivo. EMBO J, 22(2):193–204.
Panavas, T., Sanders, C., and Butt, T. (2009). SUMO fusion technology for enhanced protein
production in prokaryotic and eukaryotic expression systems. Methods Mol Biol, 497:303–317.
Bibliography 151
Pantoliano, M., Petrella, E., Kwasnoski, J., Lobanov, V., Myslik, J., Graf, E., Carver, T., Asel, E.,
Springer, B., Lane, P., and Salemme, F. (2001). High-density miniaturized thermal shift assays
as a general strategy for drug discovery. J Biomol Screen, 6(6):429–440.
Paraskeva, E., Izaurralde, E., Bischoff, F., Huber, J., Kutay, U., Hartmann, E., Lührmann, R.,
and Görlich, D. (1999). CRM1-mediated recycling of snurportin 1 to the cytoplasm. J Cell Biol,
145(2):255–264.
Park, H., Himmelbach, A., Browning, K., Hohn, T., and Ryabova, L. (2001). A plant viral rr-
einitiationffactor interacts with the host translational machinery. Cell, 106(6):723–733.
Passmore, L., Schmeing, T., Maag, D., Applefield, D., Acker, M., Algire, M., Lorsch, J., and
Ramakrishnan, V. (2007). The eukaryotic translation initiation factors eIF1 and eIF1A induce
an open conformation of the 40S ribosome. Mol Cell, 26(1):41–50.
Pelham, H. and Jackson, R. (1976). An efficient mRNA-dependent translation system from retic-
ulocyte lysates. Eur J Biochem, 67(1):247–256.
Peng, L., Calton, G., and Burnett, J. (1987). Effect of borohydride reduction on antibodies. Appl
Biochem Biotechnol, 14(2):91–99.
Pestova, T., Lomakin, I., Lee, J., Choi, S., Dever, T., and Hellen, C. (2000). The joining of
ribosomal subunits in eukaryotes requires eIF5B. Nature, 403(6767):332–335.
Pestova, T., Shatsky, I., and Hellen, C. (1996). Functional dissection of eukaryotic initiation factor
4F: the 4A subunit and the central domain of the 4G subunit are sufficient to mediate internal
entry of 43S preinitiation complexes. Mol Cell Biol, 16(12):6870–6878.
Phan, L., Schoenfeld, L., Valasek, L., Nielsen, K., and Hinnebusch, A. (2001). A subcomplex
of three eIF3 subunits binds eIF1 and eIF5 and stimulates ribosome binding of mRNA and
tRNA(i)Met. EMBO J, 20(11):2954–2965.
Phan, L., Zhang, X., Asano, K., Anderson, J., Vornlocher, H., Greenberg, J., Qin, J., and Hinneb-
usch, A. (1998). Identification of a translation initiation factor 3 (eIF3) core complex, conserved
in yeast and mammals, that interacts with eIF5. Mol Cell Biol, 18(8):4935–4946.
Pisarev, A., Hellen, C., and Pestova, T. (2007). Recycling of eukaryotic posttermination ribosomal
complexes. Cell, 131(2):286–299.
Pisarev, A., Skabkin, M., Pisareva, V., Skabkina, O., Rakotondrafara, A., Hentze, M., Hellen, C.,
and Pestova, T. (2010). The role of ABCE1 in eukaryotic posttermination ribosomal recycling.
Mol Cell, 37(2):196–210.
Porath, J., Carlsson, J., Olsson, I., and Belfrage, G. (1975). Metal chelate affinity chromatography,
a new approach to protein fractionation. Nature, 258(5536):598–599.
Pryor, K. and Leiting, B. (1997). High-level expression of soluble protein in Escherichia coli
using a His6-tag and maltose-binding-protein double-affinity fusion system. Protein Expr Purif,
10(3):309–319.
Querol-Audi, J., Sun, C., Vogan, J., Smith, M., Gu, Y., Cate, J., and Nogales, E. (2013). Archi-
tecture of human translation initiation factor 3. Structure, 21(6):920–928.
Bibliography 152
Rabl, J., Leibundgut, M., Ataide, S., Haag, A., and Ban, N. (2011). Crystal structure of the
eukaryotic 40S ribosomal subunit in complex with initiation factor 1. Science, 331(6018):730–
736.
Reichelt, R., Holzenburg, A., Buhle, E. J., Jarnik, M., Engel, A., and Aebi, U. (1990). Correlation
between structure and mass distribution of the nuclear pore complex and of distinct pore complex
components. J Cell Biol, 110(4):883–894.
Ribbeck, K. and Görlich, D. (2001). Kinetic analysis of translocation through nuclear pore com-
plexes. EMBO J, 20(6):1320–1330.
Ribbeck, K., Lipowsky, G., Kent, H., Stewart, M., and Görlich, D. (1998). NTF2 mediates nuclear
import of Ran. EMBO J, 17(22):6587–6598.
Roberts, B. and Paterson, B. (1973). Efficient translation of tobacco mosaic virus RNA and rabbit
globin 9S RNA in a cell-free system from commercial wheat germ. Proc Natl Acad Sci U S A,
70(8):2330–2334.
Rogers, G. J., Richter, N., Lima, W., and Merrick, W. (2001). Modulation of the helicase activity
of eIF4A by eIF4B, eIF4H, and eIF4F. J Biol Chem, 276(33):30914–30922.
Russell, D. and Spremulli, L. (1979). Purification and characterization of a ribosome dissociation
factor (eukaryotic initiation factor 6) from wheat germ. J Biol Chem, 254(18):8796–8800.
Ruud, K., Kuhlow, C., Goss, D., and Browning, K. (1998). Identification and characterization of
a novel cap-binding protein from Arabidopsis thaliana. J Biol Chem, 273(17):10325–10330.
Sachdev, D. and Chirgwin, J. (1999). Properties of soluble fusions between mammalian aspartic
proteinases and bacterial maltose-binding protein. J Protein Chem, 18(1):127–136.
Safarik, I. and Safarikova, M. (2004). Magnetic techniques for the isolation and purification of
proteins and peptides. Biomagn Res Technol, 2(1):7.
Saini, A., Nanda, J., Martin-Marcos, P., Dong, J., Zhang, F., Bhardwaj, M., Lorsch, J., and Hin-
nebusch, A. (2014). Eukaryotic translation initiation factor eIF5 promotes the accuracy of start
codon recognition by regulating Pi release and conformational transitions of the preinitiation
complex. Nucleic Acids Res.
Sambrook, J. and Russell, D. (2001). Molecular Cloning: A Laboratory Manual. Cold Spring
Harbor Laboratory Press.
Sano, T., Pandori, M., Chen, X., Smith, C., and Cantor, C. (1995). Recombinant core streptavidins.
A minimum-sized core streptavidin has enhanced structural stability and higher accessibility to
biotinylated macromolecules. J Biol Chem, 270(47):28204–28209.
Schatz, P. (1993). Use of peptide libraries to map the substrate specificity of a peptide-modifying
enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli. Biotechnology
(N Y), 11(10):1138–1143.
Schmidt, T., Koepke, J., Frank, R., and Skerra, A. (1996). Molecular interaction between the
Strep-tag affinity peptide and its cognate target, streptavidin. J Mol Biol, 255(5):753–766.
Schreiber, G. (2001). Methods for studying the interaction of barnase with its inhibitor barstar.
Methods Mol Biol, 160:213–226.
Bibliography 153
Schreiber, G. and Fersht, A. (1993). Interaction of barnase with its polypeptide inhibitor barstar
studied by protein engineering. Biochemistry, 32(19):5145–5150.
Shalev, A., Valasek, L., Pise-Masison, C., Radonovich, M., Phan, L., Clayton, J., He, H., Brady,
J., Hinnebusch, A., and Asano, K. (2001). Saccharomyces cerevisiae protein Pci8p and human
protein eIF3e/Int-6 interact with the eIF3 core complex by binding to cognate eIF3b subunits.
J Biol Chem, 276(37):34948–34957.
Shevchenko, A., Wilm, M., Vorm, O., Jensen, O., Podtelejnikov, A., Neubauer, G., Shevchenko,
A., Mortensen, P., and Mann, M. (1996). A strategy for identifying gel-separated proteins in
sequence databases by MS alone. Biochem Soc Trans, 24(3):893–896.
Shimizu, Y., Inoue, A., Tomari, Y., Suzuki, T., Yokogawa, T., Nishikawa, K., and Ueda, T. (2001).
Cell-free translation reconstituted with purified components. Nat Biotechnol, 19(8):751–755.
Siridechadilok, B., Fraser, C., Hall, R., Doudna, J., and Nogales, E. (2005). Structural roles for
human translation factor eIF3 in initiation of protein synthesis. Science, 310(5753):1513–1515.
Smith, D. and Johnson, K. (1988). Single-step purification of polypeptides expressed in Escherichia
coli as fusions with glutathione S-transferase. Gene, 67(1):31–40.
Smyth, D., Blumenfeld, O., and Königsberg, W. (1964). Reactions of N-ethylmaleimide with
peptides and amino acids. Biochem J, 91(3):589–595.
Smyth, D., Mrozkiewicz, M., McGrath, W., Listwan, P., and Kobe, B. (2003). Crystal structures
of fusion proteins with large-affinity tags. Protein Sci, 12(7):1313–1322.
Sørensen, H., Sperling-Petersen, H., and Mortensen, K. (2003). A favorable solubility partner for
the recombinant expression of streptavidin. Protein Expr Purif, 32(2):252–259.
Staak, C., Salchow, F., Clausen, P., and Luge, E. (1996). Polystyrene as an affinity chromatography
matrix for the purification of antibodies. J Immunol Methods, 194(2):141–146.
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would not have made it without you.
First I want to thank my supervisor Prof. Dirk Görlich. During the last four years you
taught me what being a scientist is all about. How to ask the right questions and how
to address them by elegant and straight forward experiments. I am thankful for all the
experiences I was allowed to make.
Further I want to thank my additional Thesis Committee members Prof. Marina Rodnina
and Prof. Volker Lipka. Although I confronted you with a multitude of different ideas
and approaches every time we met, you were always interested and supportive with good
comments and ideas on hand.
I would also like to thank Prof. Doenecke, Prof. Urlaub and Prof. Wintermeyer for ac-
cepting to be part of my extended Thesis Committee.
Further I would like to thank the IMPRS Molecular Biology, specially Dr. Steffen Burkhardt
and Kerstin Grüniger for supporting me throughout the last five years.
A huge “Thank You” goes to our wonderful technicians, with whom is was always a great
pleasure to work. Jens, I thank you for your constant help and support during wheat germ
extract production and in front of that blackbox called Susi. Both things would have been
far less fun without you! Susanne and Gabi, thank you so much for the enormous amount
of plasmids you cloned and purified for me. Jürgen, I am extremely grateful for all your
help and support mainly during the last few months. It allowed me to focus on writing
without all the other things pausing. Heike and Renate, thank you for supplying me with
plasmids and lysates and always offering help and support. Knowing that I can always
count on all of you is priceless. Further I would like to acknowledge my awesome lab
rotation students Metin Aksu and Muna Khan.
Cathrin, you supported me during my lab rotation and the first year of Ph.D. You shared
all your experience and wisdom with me, showed me how the 10600 department works and
carefully introduced me into the depths of the project. I never had the feeling we were
competing but working side by side to get the project to work. I am sorry it did not work
out the way both of us wished it would.
Steffen, I not only want to thank you for supplying me with plasmids and proteins from
your seemingly infinite treasure chamber (also called freezer), but also for the scientific and
non-scientific discussions we had. Many of these conversations were not only informative
but also extremely encouraging and supportive.
My dear colleagues, I want to thank all of you for providing a really nice working atmo-
sphere. I am grateful for all the scientific chats (special thanks to Koray, Kevser, Hema,
157
158
Broder, Bastian, Metin, Tino, Volker and Micha), for sharing plasmids, proteins and chem-
icals with me and also for the one or the other barbecue, breakfast or football match.
Den Rest gibt es nun auf Deutsch:
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